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  Due to increased regulation and mounting consumer concerns, utilization of in-feed 
antibiotics to promote productivity is declining in modern U.S. livestock production systems. For 
that reason, there is increased interest and opportunities to identify novel feed additives or value-
added feed ingredients that may function as nutritional interventions to improve the health and 
productivity of our livestock species. Previously, swine nutrition research has found that pigs 
experiencing high levels of inflammatory stress performed better when fed greater amounts of 
soybean meal in the diet though it was unclear which component of this soy protein source was 
conferring these benefits. Among potential components, soy-derived isoflavones show promise 
as a nutritional intervention against a pathogenic challenge due to their antiviral and anti-
inflammatory properties. For swine in particular, there are a number of pathogenic challenges a 
pig may face throughout its productive life, with immediately post-weaning being a particularly 
vulnerable phase. A series of three experiments was conducted in order to investigate the effect 
of dietary soy isoflavones on the growth and immune responses of weaned pigs to a common and 
pervasive viral pathogen affecting U.S. swine herds, porcine reproductive and respiratory 
syndrome virus (PRRSV). In the first experiment we sought to determine if soy isoflavones fed 
at concentrations typically found in standard commercial swine diets would demonstrate 
protective effects against an acute PRRSV infection in weaned pigs in the presence of two soy 
protein sources (soy protein concentrate [SPC] and enzyme-treated soybean meal [ETSBM]). 
While isoflavones minimally impacted growth performance during this acute challenge, they 
modified the cellular immune response to PRRSV infection by reducing PRRSV-induced band 
neutrophilia and improving cytotoxic-to-helper T-cell ratios with only a few interactions 
occurring between soy protein type and isoflavones supplementation across all remaining 
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immune measures collected. These results suggested that isoflavones, regardless of protein 
source, may influence the activation of adaptive immune system and may facilitate recovery 
from and clearance of PRRSV infections. To extend those findings, we next sought to determine 
if soy isoflavones fed at the same level would demonstrate protective effects against both the 
acute and recovery phases of a PRRSV infection in weaned pigs and if those effects would 
benefit the growth performance across the entire growth period from weaning to market. Similar 
to the first experiment, soy isoflavones elicited inconsistent effects on growth performance, but 
again influenced cellular and global immune responses to PRRSV infection. Isoflavone 
supplementation increased neutrophil cell counts and the relative proportion of memory T-cells, 
and decreased the time to full PRRSV clearance from oral fluids. However, the most notable 
effect isoflavones had in this experiment was reducing pathogen-associated mortality by ~50%, 
which may have significant economic implications for producers. These findings suggested that 
isoflavones enable sufficient immune responses needed to reduce mortality in this infection 
model, but it remained unclear if isoflavones were eliciting these effects directly or if they 
functioned through an indirect route such as alteration of the gastrointestinal microbiome. For 
that reason, a third experiment was conducted to evaluate how the ingestion of soy isoflavones in 
the context of a PRRSV-infection affected the composition of the gastrointestinal microbiome 
across the entire growth period. Across all time points measured, microbiome analyses indicated 
that the relative abundance of only a few bacterial populations were directly affected by 
isoflavones and differences detected were mainly due to PRRSV infection alone. These findings 
imply that previously observed performance benefits conferred by isoflavones within this 
PRRSV infection model were not likely due to changes in microbiome composition. Overall, this 
research demonstrates that isoflavones do not negatively impact the productivity of PRRSV-
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challenged pigs and may confer additional health benefits through supporting systemic immune 
responses in the face of a pathogenic challenge, though more research in robust live animal 
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CHAPTER 1: INTRODUCTION 
 As modern animal agriculture continues to progress and evolve, new challenges are 
regularly presented to livestock producers. Increased consumer concerns about the risks of 
antibiotic resistance driven by normal practices in large scale livestock production have led to 
increased regulation and potential incentives against utilizing in-feed antibiotics. With the 
passing of the U.S. Veterinary Feed Directed in 2017, a government mandate seeking to cease 
long-term applications of in-feed antibiotics as growth promotants, livestock producers and 
nutritionists are tasked with the transition of feeding livestock with greater limitations on the use 
of sub-therapeutic antibiotic interventions (FDA, 2015). For that reason, there has been increased 
interest in the development of feed additives or value-added feed ingredients and their potential 
to mitigate negative performance responses to disease in today’s livestock herds. 
 Regarding specifically pork production, among feed ingredients commonly used soybean 
meal (SBM) has been associated with better performance in growing pigs under inflammatory 
conditions caused by disease. In a novel observation by Boyd et al. in 2010, pigs that 
experienced an unplanned pathogenic challenge grew better by industry standard measures when 
they received higher levels of SBM in the diet than their experimental counterparts that received 
crystalline amino acid products. This has led swine nutrition researchers to question how these 
benefits were derived from this whole soy protein source. Was it simply due to increased amino 
acid availability in the diet or were there other naturally occurring components of soybeans 
driving these effects? 
 Focusing on the latter of those two possibilities, one such component that demonstrates 
biological potential to mediate the physiological response to disease are soy isoflavones. While 
more commonly recognized in human health applications for their structural similarity to 
2 
 
endogenous estrogens, soy isoflavones have been shown to possess anti-inflammatory and anti-
viral activity in both in vitro and in vivo experimental models. These activities include direct 
modification of cell signaling pathways, interruption of viral replication or spread, and 
alterations of key immune responses to pathogens (Andres et al., 2007; Dia et al., 2008; Andres 
et al., 2009; Smith and Dilger, 2018). While a majority of these effects have been demonstrated 
in human disease models, there has been evidence that isoflavones have potential to mitigate the 
response to swine-specific pathogens, particularly those causing respiratory or gastrointestinal 
disease (Smith and Dilger, 2018).  
Among pathogens affecting U.S. swine herds today, porcine reproductive and respiratory 
syndrome virus (PRRSV) is one of the most pervasive and economically detrimental pathogens 
facing pork producers today (Holtkamp et al., 2013). For that reason, it is an extremely relevant 
disease model when determining the efficacy of novel health-promoting feed additives. Against 
PRRSV, there is evidence that individually supplemented soy isoflavones (Greiner et al., 2001a; 
Greiner et al., 2001b) and diets containing higher levels of soy isoflavones from increased SBM 
inclusion (Rochell et al., 2015) both improved both growth performance and certain immune 
responses to PRRSV infection. However, at the completion of these studies it is was still unclear 
whether isoflavones, if provided at levels and ratios that are typical of standard commercial 
swine diets, would still provide performance benefits to pigs infected with PRRSV, particularly 
if the protein content of the diet is controlled. More so, if protein levels are controlled is it 
possible to determine if soy isoflavones are causing these benefits directly or is their biological 
activity through an indirect mechanism such as modification of their metabolism through shifts 
in gastrointestinal microbiome composition. 
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For those reasons, the overarching objective of the current research described in the 
following document was to determine if dietary soy isoflavones provide performance benefits to 
growing pigs faced with a pathogenic challenge and, if they do confer benefits, attempt to 
identify a potential biological mechanism. This objective was approached by three different 
experimental aims: 
Aim 1) Determine if soy-derived isoflavones fed to weanling pigs would demonstrate 
protective effects during the acute phase of a PRRSV-infection in the presence of two 
different soy protein sources 
 
Aim 2) Determine if soy-derived isoflavones fed to weanling pigs would demonstrate 
protective effects during both acute and recovery phases of a PRRSV-infection in the 
presence of a single soy protein source and how those effects, if present, influence 
performance over the entire growth period from weaning to market 
 
Aim 3) Evaluate how consumption of soy-derived isoflavones by PRRSV-infected pigs 
affects the longitudinal composition of the gastrointestinal microbiome throughout the 
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CHAPTER 2: LITERATURE REVIEW 
 
Role of Soy Protein in Swine Production1 
Soybeans have a rich history of use as valuable protein and fat sources in both human and 
animal diets. By 1982, soybean meal (SBM) became the most commonly used protein source in 
livestock diets in the United States, over other popular sources including cottonseed meal and 
fish meal by a wide margin (Shurtleff and Aoyagi, 2007). According to the USDA National 
Agricultural Statistics Service, ~30,035 metric tons of soybeans were used domestically for 
livestock feed in 2016 alone (USDA-NASS, 2017). SBM is created through the collection of soy 
oil, a process by which soybeans are cleaned, cracked, de-hulled, and heat-treated before being 
crushed into flakes. Flakes are then washed with a volatile solvent, such as hexane, to extract 
crude oil, thereby leaving behind a high-quality protein ingredient. Oil-extracted flakes (i.e., 
defatted soybeans) undergo an additional heating step (i.e., toasting) to remove residual solvent 
and, in many cases, are mixed back in with soybean hulls and ground to form SBM, which can 
be fed to livestock. Toasting soybean flakes towards the end of processing also contributes to the 
removal of certain antinutritional factors, mainly urease and lipoxygenase enzymes (Shurtleff 
and Aoyagi, 2016). SBM is the most commonly used plant-based protein source in swine diets 
throughout the post-weaning growth period in the United States. Its popularity stems from a 
relatively high digestible protein fraction, high lysine content to complement dietary corn 
inclusion, and the ability to extract antinutritional factors through processing (Pettigrew et al., 
2017). And while SBM remains a widely used protein source in swine diets, advancements in 
soybean processing techniques and applications have resulted in development of value-added 
feedstuffs. Soy protein concentrate (SPC) is produced from defatted soybean flakes, as is SBM, 
 
1
Sections adapted from Smith, B. N. and R. N. Dilger. 2018. Immunomodulatory potential of dietary soybean-




but undergoes additional processing steps to remove the soluble carbohydrate fraction. Two 
methods are employed for this step, extraction or enzymatic digestion, with extraction being 
more common. Extraction is the process of solubilizing carbohydrates with an aqueous alcohol 
solution, removing not only vulnerable soluble carbohydrates but also residual antinutritional 
factors including oligosaccharides, as well as estrogenic and antigenic factors (Peisker, 2001). 
Soy protein isolate (SPI) is essentially the same as SPC, with the residual non-soluble 
carbohydrate fraction left behind after alcohol extraction removed. Further processing of 
soybeans into SPC and SPI results in products with a higher protein composition compared with 
SBM (65% to 90% and ≥ 90% vs. 40% to 50% for SPC, SPI, and SBM, respectively; Shurtleff 
and Aoyagi, 2016).  
Despite the popularity of using SBM in swine diets, among the different growth phases of 
current production systems, diets of early-weaned pigs traditionally contain minimal amounts of 
soy. This practice of low SBM inclusion is largely driven by immaturity of the weanling pig’s 
digestive capacity and effectiveness, in addition to presence of dietary antinutritional factors to 
which young pigs are more sensitive. However, developments in soy processing (described 
above) and treatment of SBM-containing diets have made feeding soy protein to early-weaned 
pigs more appropriate. In addition to removal of antinutritional factors through production of 
SPC and SPI, microbial fermentation of soy feedstuffs can be utilized during this sensitive period 
for weaned pigs. Early-weaned pigs provided fermented liquid diets during the initial post-
weaning period typically show improved growth performance (~22% improvement for average 
daily gain) and reduced disease level with respect to enteric pathogens such as Escherichia coli 
and Salmonella due to unfavorable acidic gastrointestinal environment (Stein, 2002). Early-
weaned pigs that receive microbial-fermented soy protein sources in more traditional dry diets 
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similarly show improved growth performance, increased nutrient digestibility, and, under certain 
experimental conditions, reduced diarrhea scores, an important indicator of improved disease 
status in young pigs (Cho et al., 2007; Kim et al., 2007; Kim et al., 2010; Zhang et al., 2013). 
Soy Protein and Swine Health2 
In addition to the challenges that dietary transitions and protein source can pose to young 
pigs, the early weaning period in general presents a myriad of stressors to the growing pig. The 
stress of weaning, mixing, and movement to an unfamiliar environment all contribute to 
decreased performance during this time of transition and also puts young pigs at greater risk of 
succumbing to unfamiliar pathogens. Interestingly, there is evidence that under inflammatory 
conditions, diets high in SBM improved average daily gain (ADG), feed conversion ratio (FCR), 
and whole-body and carcass lean tissue accretion in pigs. This is in contrast to utilizing 
crystalline amino acids (AA) in diets of growing pigs, which has been reported to improve 
growth performance of healthy pigs when compared with intact protein sources. The practical 
implication is that crystalline AA may be economical and effective to feed to healthy pigs, but 
SBM should be utilized in pigs or herds under high inflammatory stress. The benefits of SBM in 
this context are confounded, however, with crude protein (CP) content of the diet. Benefits could 
be due to anti-inflammatory properties of compounds such as isoflavones or saponins or could be 
due to increased availability of AA in the diet to support immune tissues (Boyd et al., 2010). 
While several groups have attempted to elucidate what particular component of the soybean 
confers additional benefit to pigs facing strong inflammatory stressors, our group found 
particular interest in investigating soy isoflavones due to their range of bioactivity.  
 
2Sections adapted from Smith, B. N. and R. N. Dilger. 2018. Immunomodulatory potential of dietary soybean-




Structure and Metabolism 
Isoflavones (ISF) are naturally occurring flavonoid compounds found at high 
concentrations in the soybean plant. They are characterized as phytoestrogens due to their 
structural similarities to 17β-estradiol (E2), though their biological action is not exclusively 
estrogenic in nature. Genistein and daidzein comprise the majority of isoflavones found in 
soybeans and are the subject of most ongoing research. Isoflavones exist in the plant as non-
bioavailable glycoside forms (e.g., genistin and daidzin). For isoflavones to be absorbed and 
biologically available, they must be hydrolyzed within the digestive tract by host-derived or 
microbial β-glycosidases to their aglycone forms (e.g., genistein and daidzein). β-Glycosidases 
are present as brush border enzymes in the small intestine, but are more prevalent as microbial 
enzymes in the hindgut of the gastrointestinal tract of monogastric species like the pig (Cassidy 
et al., 2006). Genistein and daidzein are either directly absorbed in the intestine or undergo 
further metabolism via hydrogenation to other bioactive compounds, including equol, O-
desmethylangolensin (ODMA), 5,7,4-rihydroxyisoflavan, 4,7,4-trihydroxyflavan, 
dihydrodiadzein (DHD), dihydrogenistein (DHG), and others. These hydrogenation reactions are 
non-specific, resulting in non-uniform mixtures of these compounds (Chang et al., 1995; Nakatsu 
et al., 2014). In humans, isoflavones absorbed from the gastrointestinal tract are present in 
plasma for 5 to 8 h post-prandial (Cassidy et al., 2006). Only a small fraction (<2%) of 
isoflavones enter circulation with a majority of soy isoflavones being directly metabolized by 
enterocytes, which may indicate that isoflavones exert maximum functionality locally in the 
gastrointestinal tract (Masilamani et al., 2012). Similar plasma concentrations of isoflavones 
 
3Sections adapted from Smith, B. N. and R. N. Dilger. 2018. Immunomodulatory potential of dietary soybean-
derived isoflavones and saponins in pigs. J. Anim. Sci. 96:1288-1304. doi: 10.1093/jas/sky036. 
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have been observed in humans and pigs receiving soy-containing diets, though the proportions of 
different isoflavones and their metabolites excreted in urine differ, suggesting that individual 
isoflavone biological activity and cellular consumption may also differ between species (Gu et 
al., 2006). In addition to differences in metabolism of dietary isoflavones, the bioavailability of 
isoflavones in a given feedstuff can vary significantly.  
Factors Affecting Bioavailability of Soy Isoflavones 
There are several factors that affect bioavailability of dietary isoflavones, the first of 
which influence isoflavone content in the soybean plant itself. Factors such as plant variety, 
location, and growing conditions can all affect isoflavone contents of any given yield and 
variations of these factors have been considered for some time. Studies have demonstrated that 
total glycoside isoflavone content of a single soybean plant variety can vary as much as 200 
mg/g when the same variety is grown at different regional locations. On a year-to-year basis, 
variation in isoflavone concentrations of up to 50% has been reported within the same growing 
location (Eldridge and Kwolek, 1983). Additionally, differing patterns of individual isoflavone 
distribution among soybean crops maintained in different countries (including United States, 
Brazil, Argentina, and Japan) suggest that plant genetics have an effect on isoflavone 
development and metabolism (Wang and Murphy, 1994; Goerke et al., 2012). Although plant 
variation contributes to total isoflavone content within the raw soybean, soybean processing has 
an even greater influence on final product concentrations. 
Processing techniques, such as the ones described in the previous sections, can greatly 
affect the final isoflavone content in soy products and, subsequently, their bioavailability. 
Although most of the data available for soy processing effects are from products for human 
consumption, the principles remain the same for livestock feedstuffs. Roasted soy products, 
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including SBM, contain the highest bioavailable content of glycoside isoflavones, whereas SPC 
and SPI contain the lowest concentrations (Erdman et al., 2004). This difference is due to 
ingredient processing methods, and while the defatting process of full fat soybeans in the 
generation of SBM does not affect isoflavone concentrations, aqueous alcohol extraction utilized 
to generate SPC removes >95% of total isoflavones (Kuhn et al., 2004). Manufacturing processes 
for SPI, a product mostly devoid of fats and carbohydrates, result in over a 50% reduction in 
isoflavone content due to the alkaline extraction methods used. A summary of typical isoflavone 
concentrations in SBM, SPC, and SPI can be found in Table 2.1. Thus, isoflavones are lost into 
the alkaline-insoluble fraction, which is typically discarded in the processing procedure. 
Alternatively fermented soy products contain a higher bioavailable content due to microbial 
enzyme hydrolysis of isoflavones from their glycoside to aglycone forms (Wang and Murphy, 
1996). 
Food matrix may also affect isoflavone metabolism kinetics. In a human trial, liquid diets 
resulted in faster isoflavone absorption rates and higher peak plasma concentrations compared 
with solid diets (Cassidy et al., 2006). As mentioned previously, fermented liquid feeding and 
fermented SBM have been suggested to improve nursery pig performance. Although no 
confirmatory evidence exists, it may be possible that the isoflavone fraction of diets containing 
fermented soy products may be more bioavailable, resulting in faster absorption and delivery to 
target cells, thereby contributing to beneficial performance effects. 
Estrogenic Properties of Soy Isoflavones 
Due to their structural similarities to 17β-estradiol (E2), isoflavones have the ability to 
act as weak agonists or antagonists for endogenous estrogen, depending on the concentrations 
present at the cellular level. Isoflavones, especially genistein, preferentially bind estrogen 
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receptor-β (ER-β) vs. estrogen receptor-α (ER-α). Estrogen receptor-β is expressed on a variety 
of cell types, including uterine epithelial cells and immune cells such as blood monocytes and 
tissue macrophages, and is the most prevalent estrogen receptor found within the gastrointestinal 
tract. Although isoflavones may act as estrogen receptor modulators, their potency is 1,000-fold 
lower than that of endogenous estrogen, so it is unlikely physiological effects induced by 
isoflavones, especially in regard to response to disease, is through estrogenic activity alone 
(Andres et al., 2009). There is evidence that ER-β modulates ER-α activity during uterine 
development in mice via anti-proliferative effects, which could indicate that circulating 
isoflavones may influence reproductive development (Weihua et al., 2000). In pigs, there is less 
information available on the effects of soy isoflavones on the reproductive tract of intact females. 
One study evaluated the effect of oral genistein administration on hormonal patterns of gilts 
during estrus and following artificial insemination (AI). Gilts exposed to genistein via oral 
administration (1 mg/kg body weight [BW] twice daily) demonstrated increased plasma 
concentrations of oxytocin and prostaglandin E2 (PGE2) and a more frequent pulsatile pattern in 
prostaglandin F2-α (PGF2-α) concentrations around administration of AI. Alternatively, 
genistein decreased plasma luteinizing hormone (LH) concentrations after AI was administered 
compared with control gilts. These results suggest that hormonal release may be altered by soy 
isoflavones, likely through interactions with estrogenic receptors, but the impact of these 
alterations on gilt reproductive performance is not well understood (Norrby et al., 2011). 
Anti-Inflammatory and Antioxidant Properties of Soy Isoflavones 
Soy isoflavones possess both anti-inflammatory and antioxidant activities, which has 
generated a lot of attention for applications in both humans and animals. These activities are 
mainly observed through isoflavones’ inhibitory effects on tyrosine-specific protein kinases and 
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nuclear factor-κB (NF-κB) transcription. Tyrosine-specific protein kinases act as regulators for a 
broad spectrum of cellular functions. These protein kinases respond to several cell-signaling 
molecules including growth factors (i.e., epithelial growth factor, insulin-like growth factor-1) 
and cytokines, regulating cell proliferation and transformation properties (Akiyama et al., 1987). 
They are also the target of several virus types and are likely the main mechanism of action of 
reducing viral infectivity, though several effects have been reported and thus the reduction in 
infectivity is likely a combination of several pathways (Andres et al., 2009). For the purpose of 
this review, effects of isoflavones on the antigen-specific immune response, anti-oxidative 
cellular pathways, and viral infectivity will be discussed in more detail.  
Soy isoflavones have been found to suppress antigen-specific immune responses in 
addition to exhibiting broad anti-inflammatory activities. Antigen-specific immune responses are 
highly involved in sensitization to dietary antigens, establishment of allergic responses, and 
autoimmune reactions. Of the antigen-specific immunomodulatory effects mediated by 
isoflavones, interactions with dendritic cells seem to be involved in the mechanism of action. 
Mice fed genistein- and daidzein-enriched diets that were orally sensitized and challenged with 
peanut-derived proteins exhibited reduced anaphylactic symptoms, with 35% to 40% having no 
or significantly less severe symptoms compared with control mice, and 25% to 30% decrease in 
mast cell degranulation. Isoflavones also decreased the synthesis of peanut-specific IgE and 
IgG2a humoral antibodies, which suggests that these isoflavones may also mediate B-cell 
activity. However, since these effects were not maintained when peanut-derived proteins were 
injected intra-peritoneally, the authors suggested that diet-derived isoflavones may be more 
likely to elicit local inhibition of dendritic cells, such that supra-physiological concentrations 
would be necessary for total systemic suppression of allergic sensitization (Masilamani et al., 
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2011). In an in vivo collagen-induced arthritis model, representative of an autoimmune reaction, 
mice injected subcutaneously with genistein had suppressed delayed-type hypersensitivity 
reactions to oxazolone and granulocyte-mediated responses compared with control animals. The 
suppression of cell-mediated responses was likely not through estrogen-receptor binding since 
co-injection with ICI 182,780, an estrogen-receptor antagonist, did not prevent the inhibitory 
action of genistein. More likely, the mechanism of action for cell-mediated immune inhibition is 
through protein kinase inhibition in B-cells. This inhibition of protein kinase activity in B-cells 
results in decreased antigen processing and subsequent antibody production (Verdrengh et al., 
2003). Although these findings are relevant, especially for human medical researchers, the 
antioxidant potential for isoflavones may be of stronger interest for animal nutritionists. 
The antioxidant activity of isoflavones is mainly mediated by their inhibition of NF-κB, a 
protein complex that controls the transcription of many pro-inflammatory genes. Based on in 
vitro findings, anti-oxidative effects via NF-κB inhibition include reduction in inducible nitric 
oxide synthase (iNOS) expression, nitric oxide (NO) production, cyclooxygenase-2 (COX-2) 
expression, and PGE2 production (Dia et al., 2008). In lipopolysaccharide (LPS)-stimulated 
RAW 264.7 macrophages, genistein decreased NO production in a dose-dependent manner (IC50 
= 69.4 μM) without adverse effects on cell viability, suggesting that genistein disrupted the 
induction of iNOS expression and production of downstream products (e.g., nitric oxide). In a 
similar experiment, 50 and 100 μM concentrations of genistein-reduced accumulation of 
thiobarbituric acid reactive substance (TBARS), an indicator of lipid oxidation, increased 
concentrations of glutathione, an important antioxidant, and increased activities of anti-oxidative 
enzymes superoxide dismutase and catalase (Choi et al., 2003). When provided individually, 
genistein and daidzein decreased NO production and iNOS expression in a dose-dependent 
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manner (genistein at 10 μM vs. daidzein at 100 μM), decreased PGE2 production, and decreased 
COX-2 expression (genistein at 100 μM vs. daidzein at 300 μM). However, the magnitude of 
inhibitory effects was highest when a mixture of soy isoflavone glycosides was used, suggesting 
interactions among the isoflavone forms (Dia et al., 2008). Similarly, in LPS-activated murine 
J774 macrophages, genistein and daidzein were shown to elicit moderate inhibitory effects via 
NF-κB on iNOS expression (57% to 72% inhibition, IC50 for genistein and daidzein was ~30 and 
~70 μM, respectively) (Hämäläinen et al., 2007). Many of these pathways are employed directly 
during bacterial and viral insults, but there is additional evidence that isoflavones may also affect 
specific viral infectious pathways that may lead to reduced viral infectivity. 
Anti-viral Properties of Soy Isoflavones 
Building upon the backdrop of broad immunomodulatory actions of isoflavones, soy 
isoflavones may benefit the immune response under viral-challenged conditions. Although many 
of the findings discussed in this section were gathered from studies involving in vitro human cell 
lines or mice, many of the viruses investigated are some of the same classes of viruses 
commonly present in the swine industry.  
Rotavirus, a virus that causes acute enteritis in neonates of several mammalian species, is 
one such virus whose infectivity is modulated by soy isoflavones. In a study by Andres et al., 
genistein and daidzein inhibited infectivity of human rotavirus in cultured macrophages (MA-
104 cell line). Action by genistein alone reduced rotaviral infectivity by 33% to 62% and a 
mixture of isoflavones resulted in a reduction of 66% to 72%. Mixtures not containing genistein 
lost antiviral activity, indicating that genistein is likely the most active isoflavone in mediating 
rotaviral inhibition. This particular inhibition was thought to be through inhibition of tyrosine-
specific protein kinase-induced activation of α2-β1 binding of the virion (Andres et al., 2007). 
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In an in vitro assay evaluating flavonoid modulation on infectivity of another common 
virus, herpes simplex virus types-1 and -2 (HSV-1 and HSV-2), genistein exhibited high 
inhibitory activity against cytopathic effects (CPE; i.e., structural changes caused by viral 
infection in host cells that result in host cell death). These effects were considered moderate 
(50% to 80% CPE inhibition at 5 μM concentrations), but were observed for both viral types 
(Lyu et al., 2005). Reductions in herpes virus infectivity by genistein were also demonstrated for 
Bovine herpesvirus (BHV-1), where genistein reduced BHV-1 viral replication by 90% by 18 h 
post-inoculation when infected cells were treated with 25 μM at 0 and 12 h (Akula et al., 2002).  
While these in vitro studies confirm that soy isoflavones demonstrate suppressive activity 
against certain viral pathogens, regarding their potential role in swine health, we are specifically 
interested in their potential to modulate the response to common swine diseases in the live 
animal. For that reason, the focus of the current research described in the following data chapters 
has been how soy isoflavones modulate the clinical response of growing pigs to one of the most 
common viral pathogens facing U.S. swine production, porcine reproductive and respiratory 
syndrome virus. 
Porcine Reproductive and Respiratory Syndrome Virus: The Porcine Immune System and 
Its Response to PRRSV 
Porcine Reproductive and Respiratory Syndrome Virus 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a positive-stranded, 
enveloped RNA virus of the family Arteriviridae. It is species-specific (i.e. only affecting swine) 
and, due to it being an RNA virus, is highly variable. Infection causes abortions, stillborn piglets, 
and other reproduction-related failures in sows, increased pre-weaning death, acute respiratory 
disease, anorexia, and reduced growth performance in nursing and growing pigs, and acute 
respiratory disease, anorexia, and reduction of semen quality in boars (Tousignant et al., 2015). It 
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is currently one of the most economically important diseases affecting swine, resulting in 
production losses within breeding and growing swine herds to the tune of hundreds of millions of 
dollars annually (Holtkamp et al., 2013; Schweer et al., 2017). Of the contributing factors to 
these losses, ease of transmission between animals, heterogenic properties of the virus itself, and 
inconsistent and ineffective immune responses to PRRSV by individual pigs resulting in failure 
to development herd immunity are among the most significant. 
Pigs can be exposed to PRRSV through a number of routes. The virus is transmitted 
through virtually all bodily secretions: saliva, nasal secretions, urine, semen, and feces. Gilts and 
sows that are exposed during late gestation (i.e., third trimester) can transfer the virus 
transplacentally to fetuses or through colostrum and milk. Not all routes are as equally 
susceptible to establishment of infection, but the most common susceptible routes of horizontal 
transmission are as follows: parenteral (i.e., breaks in the skin barrier) or intramuscular, 
intranasal, and oral. Airborne transmission (in addition to arthropod-borne transmission) also 
contributes to horizontal transfer, but is difficult to document under field conditions 
(Zimmerman, 2006). PRRSV preferentially targets cells of monocyte/macrophage lineage, 
specifically porcine alveolar macrophages (PAM) of the respiratory tract which express 
macrophage-specific scavenger receptor CD163 (Kim et al., 2006; Welch and Calvert, 2010). 
Due to its tropism being an important cell for both the innate and adaptive immune response, the 
virus’s ability to manipulate the host response to PRRSV poses a unique challenge to swine 
producers.  
Introduction to the Porcine Immune System 
 In order to fully understand how PRRSV manipulates the host immune response, it’s 
helpful to understand how the immune system functions under normal conditions. The immune 
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system is comprised of two functional sub-systems: the innate immune system and the adaptive 
immune system. While these two systems work in concert during active immune responses, often 
performing effector functions that collectively enable pathogen clearance, it is easier to 
understand their role in the immune response if they are described separately. The innate 
immune system is often described as the “first line of defense” against a pathogen; it is 
comprised of physical epithelial and mucosal barriers, soluble proteins (i.e., complement), and 
effector cells that respond predictably to general, highly conserved pathogen-associated signals 
(i.e., pathogen-associated molecular patterns or PAMP) (Murphy and Weaver, 2017). In the 
event that physical and chemical barriers of the innate immune system are breached, due to their 
ability to recognize these general signals, innate effectors cells are able to rapidly respond to the 
presence of a wide variety of pathogens. There are several cell types associated with the 
mammalian innate immune system including granulocytes (neutrophils, eosinophils, and 
basophils), macrophages, dendritic cells, and natural killer cells (NK) (Murphy and Weaver, 
2017). Granulocytes are categorized by their cytoplasmic granules and all demonstrate some 
phagocytic activity, though neutrophils exhibit the greatest phagocytic activity among them. 
Once these cells recognize a PAMP, they are rapidly activated to phagocytose pathogens and 
secrete signaling molecules called cytokines to help recruit additional immune cells to the site of 
infection. This response is extremely rapid, often taking place within minutes of a pathogen 
being detected (Murphy and Weaver, 2017).  
 In addition to granulocytes, macrophages function as the major phagocyte population of 
the innate immune system and reside in most peripheral tissues normally. They can develop from 
bone marrow progenitor cells or from activated circulating monocytes during infections or 
periods of inflammation. In addition to their phagocytic activity, macrophages also secrete 
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cytokines and function as antigen presenting cells (APC) alongside dendritic cells, a third class 
of phagocytic cells that reside in lymphoid and peripheral tissues, and B-cells, a cellular member 
of the adaptive immune system (Murphy and Weaver, 2017). The main function of antigen 
presentation is the activation of adaptive immune cells, which is a key way the two systems 
integrate together. 
 The adaptive immune system, unlike the innate immune system, responds less rapidly to  
primary apathogenic insult but with a much greater specificity for a particular pathogen. This not 
only helps facilitates more targeted clearance of a pathogen, it also results in the development of 
immunological memory or the ability to prevent an infection by the same pathogen from 
occurring again in the future. The adaptive immune system is comprised of two main cell types: 
T-cells, which drive cell-mediated immunity, and B-cells, which drive humoral immunity. In 
mammalian species, mature B-cells and T-cells reside in lymphoid tissues such as lymph nodes 
and undergo activation once presented with an antigen by an APC. For T-cells, this activation 
involves recognition of presented antigen on major histocompatibility (MHC) class I or II 
molecules. T-cells vary in their effector function, differentiated by cluster of differentiation (CD) 
cell surface markers. Two key effector T-cell types are cytotoxic T-cells and helper T-cells. 
Cytotoxic T-cells (CTL; positive for cell-surface marker CD8) recognize antigens presented on 
MHC class I molecules and their main function is targeted cell death of infected cells. Helper T-
cells (positive for cell-surface marker CD4) recognize antigens presented on MHC class II 
molecules and their main function is the coordination of immune response and the activation of 
B-cells. B-cells are activated by recognition of an antigen by surface immunoglobulin receptors. 
Once these receptors recognize and bind their antigen, they then present the antigen in MHC 
class II molecules in order to bind helper T-cells, which complete the activation process. Fully 
19 
 
activated B-cells will proliferate and mature into antibody secreting cells (i.e., plasma cells), 
which further support pathogen clearance and immunological memory (Murphy and Weaver, 
2017).  
 Understanding the general components and dynamics of the immune system, the normal 
immune response to viral pathogens specifically may be described in more detail. Being that they 
are typically categorized as intracellular pathogens, in the event of a viral infection virions enter 
a cell where it recognized by intracellular pathogen recognition receptors (PRR), endosomal 
Toll-like receptors (TLR) and cytoplasmic PRR. Regarding TLR specifically, the TLR 
responsible for viral recognition include TLR3, TLR7, TLR8, and TLR9, which are highly 
expressed in APC of the innate immune system such as macrophages and dendritic cells. Once 
the receptors recognize the virus, they activate several cellular pathways that result in the 
production of inflammatory cytokines, chemotactic factors (i.e., chemokines, proteins similar to 
cytokines that help direct other immune cells to the site of infection), and antiviral cytokines 
interferon-α (IFN-α) and interferon-β (IFN-β) (Murphy and Weaver, 2017). Of these actions, the 
production of type I interferons IFN-α and IFN-β result in direct anti-viral effects including 
induced resistance to viral replication, increased MHC class I expression and antigen 
presentation to CTL, activation of dendritic cells and macrophages, activation of NK cells to kill 
virus-infected cells, and influence additional cytokine and chemokine secretion to recruit 
lymphocytes to the site of infection (Bogdan, 2000; Murphy and Weaver, 2017). The activation 
of these anti-viral pathways is key for the recognition and clearance of viral infections; if 
compromised, as it is in active PRRSV infections, then viral infections are able to persist, 




The Porcine Immune Response to PRRSV – The Innate Response 
As described, upon initial exposure to a viral insult tissue-resident innate immune cells 
macrophages and dendritic cells produce anti-viral, pro-inflammatory type I interferons, IFN-α 
and IFN-β (Loving et al., 2015). PRRSV dampens the type I interferon response, with peak IFN-
α titers being minimally 1,000-fold lower than that observed during other common swine 
respiratory viruses (e.g., swine influenza virus, SIV, and porcine respiratory circovirus, PRCV). 
It also appears to reduce the production of other key pro-inflammatory cytokines such as tumor 
necrosis factor-α (TNF-α) (van Reeth et al., 1999). It has been suggested that this inhibition is 
likely through PRRSV mediated down-regulation of TLR3, TLR7, and TLR8, which are 
important PRR for viruses. Of these, TLR3 appears particularly important for preventing PRRSV 
replication, demonstrating increased PRRSV replication and delayed IFN-α expression when its 
activation is reduced (Sang et al., 2008; Miller et al., 2009). This suppression of an anti-viral 
state facilitates slow replication (occurring 5-10 days post-inoculation), establishment of 
localized PRRSV infection, and failure to activate other innate immune cells such as NK cells, 
which is in stark contrast to other swine respiratory viruses (van Reeth et al., 1999; Murtaugh et 
al., 2002). Consequently, the average length of viremia induced by PRRSV infection, which can 
last up to 21 days or longer, also demonstrates this elongated period of active infection (Albina et 
al., 1998). This infectious stage can be clinically inapparent in susceptible pigs, making the risk 
of infecting other naïve animals within production systems very high (Zimmerman, 2006). 
Additionally, plasmacytoid dendritic cells (pDC), a rare subtype of dendritic cells which 
are important for the promotion and activation of CTL populations, appear to be negatively 
impacted by PRRSV. Even though pDC are not permissive to PRRSV infection, it appears that 
the virus is able to alter pDC function through a negative signal to the cell surface, preventing 
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co-stimulation of CTL at the time of antigen presentation (Calzada-Nova et al., 2010). Similar to 
its effects on PAM, reduced type-I interferon signaling and activation of pDCs reduce this 
population of APC ability to induce naïve T-cells differentiation into interferon-γ (IFN-γ) (a 
potent anti-viral type II interferon) secreting cells and CTL (Loving et al., 2015). 
The Porcine Immune Response to PRRSV – The Adaptive Response 
Following a delayed and reduced innate immune response, the adaptive immune system 
responds to PRRSV in two ways: cell-mediated viral clearance or humoral-mediated viral 
clearance. Regarding cell-mediated responses, T-cells play a critical role in anti-PRRSV 
immunity through their role in development and regulation of antigen-specific immunity: 
activation of B-cells, influence on cytokine secretions, cytotoxic effector functions, and 
regulation of these responses to control inflammation. T-cell populations important for response 
to PRRSV are cytotoxic T-cells (CTL) (CD8+), helper T-cells (CD4+), and memory T-cells 
(CD4+/CD8+). In general, initial PRRSV infection typically causes a somewhat delayed, 
transient reduction in helper T-cell populations and a longer increase in CTL populations 
(Shimizu et al., 1996; Nielsen and Botner, 1997; Albina et al., 1998). This trend is also observed 
for pigs infected in utero (Feng et al., 2002; Nielsen et al., 2003). Peripheral PRRSV-specific T-
cells appear in circulation approximately 2-4 weeks following infection, but levels are variable 
across time and between individual animals and there does not appear to be any correlation 
between PRRSV-specific T-cell population sizes and viral load of lymphoid tissues (Xiao et al., 
2004). During PRRSV-specific lymphocyte proliferation, helper T-cells appear to predominate, 
demonstrating type I cytokine expression phenotypes (i.e., secrete IFN-γ and IL-2) which is 
characteristic of a cell-mediated immune (CMI) response induced by intracellular pathogens 
(López Fuertes et al., 1999). Regardless of age at time of infection, amount of PRRSV-specific 
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IFN-γ secreting cells are low, which would be expected knowing limitations of the innate 
immune response to PRRSV (Klinge et al., 2009). Interestingly, cytotoxic effector function of 
CTL is not strongly linked to control of primary PRRSV infection, with increased CTL activity 
not observed until much later during infection (Costers et al., 2009). These findings suggest that 
CTL may be involved in the clearance of PRRSV-infected tissues, though evidence supporting 
this is inconsistent. Taken together, the inability for complete immunity to PRRSV may be due 
partly to inadequate T-cell responses, however due to poor representative in vitro models for 
PRRSV infection, it is hard to fully understand the functionality of helper T-cells and CTL under 
PRRSV-challenge (Loving et al., 2015).  
 Regarding the humoral response, PRRSV initiates a fairly robust anti-PRRSV antibody 
response, with detection possible 7-9 days post-infection. There is little evidence that this early 
antibody production is protective against PRRSV infection and some groups even found 
evidence of antibody-dependent enhancement (ADE) of PRRSV infectivity by anti-PRRSV 
antibodies (Yoon et al., 1996), though the degree of that contribution to overall pathology is 
inconsistent (Murtaugh and Genzow, 2011). Evidence of de novo synthesis and protection by 
neutralizing antibodies (NAb) against PRRSV has been relatively inconsistent and inconclusive 
across the literature, with the most promising effects being lowered levels of viremia (Loving et 
al., 2015). However, serum transfer experiments have been very successful in preventing PRRSV 
infection of pregnant females and piglets by action of NAb alone. Transfer of NAb in these 
experiments provided sterilizing immunity for both dams and piglets (Osorio et al., 2002). 
Separate passive transfer experiments demonstrated that NAb administration and subsequent 
protection against PRRSV infection was dose dependent, with concentrations under what would 
achieve antibody titers of 1:8 not providing sterilizing immunity and allowing viral transmission 
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to naïve pen-mates (Lopez et al., 2007). These findings suggest that NAb may provide effective 
protection against PRRSV infection, but are likely not synthesized rapidly enough de novo to 
promote clearance. This has made NAb a target for the production of PRRSV vaccines, but their 
success is highly limited to homologous conditions between the challenge strain of PRRSV and 
NAb specificity for that strain (Loving et al., 2015). 
Keeping the limitations of the PRRSV immune response in mind, the most protective 
component of the response is adaptive cell-mediated immunity. While significantly delayed due 
to suppression of type I interferons released by the innate immune response, CMI likely 
facilitates a majority of viral clearance following infection. An antibody response to PRRSV is 
evident, with detectable levels present relatively quickly following natural infection, but their 
efficacy in promoting clearance is inconsistent and has been found to actually increase the period 
of infectivity for certain PRRSV strains. The major gaps in our knowledge about the immune 
response to PRRSV are how to circumvent or reduce the inhibition of the initial innate immune 
response, the specific functionality of helper T-cell and CTL populations following PRRSV-
challenge, and how to generate cross-reactivity of NAb against PRRSV strains to reduce 
limitations currently facing their application as vaccines due to requirement of strain 
homogeneity. It is also these gaps in knowledge that motivates the investigation of alternative 
strategies to manage or modulate the immune response to PRRSV, such as nutritional 
interventions. Among alternatives researched, soy isoflavones have been shown to beneficially 
alter the immune response to PRRSV in live animal models. 
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Soy Isoflavones and PRRSV4 
Due to severity and pervasiveness of PRRSV in the swine industry, there have been 
several studies using PRRSV as the disease challenge model to assess the effects of feeding soy 
isoflavones on response to disease and performance. Prior to investigation of isoflavones as an 
immunomodulatory supplement against PRRSV, an experiment was performed to establish the 
influence of systemic PRRSV infection in weanling pigs on growth performance and immune 
responses. When inoculated at 29 d of age, weaned pigs naïve to PRRSV exhibited rapid 
increases in serum viral concentration and serum interferon (IFN) concentrations by 4 d post-
inoculation (DPI). Both average daily gain (ADG) and average daily feed intake (ADFI) 
declined for the first 8 DPI by 47.5% and 22.4%, respectively. These authors went on to 
demonstrate a negative relationship between serum viral concentration and growth performance 
measures, indicating that as serum virus concentrations increased, pig performance decreased. 
The implications of these early findings suggested that immunomodulators with potential to 
decrease systemic viral concentrations could improve weaned pig performance under disease 
challenge conditions (Greiner et al., 2000). 
After establishing the growth and immune responses to PRRSV infection in weanling 
pigs, further research sought to investigate whether supplementation with soy isoflavones 
genistein and daidzein could improve growth performance in the face of an active PRRSV 
infection. Pigs received purified dietary genistein at 0 to 800 mg/kg and were inoculated with 
live PRRSV at 29 d of age. Graded dietary intake of genistein caused a linear reduction in serum 
virus concentrations and a quadratic reduction is serum IFN concentrations, thereby indicating 
faster viral clearance. Additionally, dietary genistein ingestion improved ADG and ADFI, though 
 
4Sections adapted from Smith, B. N. and R. N. Dilger. 2018. Immunomodulatory potential of dietary soybean-
derived isoflavones and saponins in pigs. J. Anim. Sci. 96:1288-1304. doi: 10.1093/jas/sky036. 
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the magnitude of this response was greatest during the early post-inoculation period (4 to 12 
DPI) and only when pigs were fed 400 to 800 mg/kg genistein. These improvements in ADG 
were logarithmically related to serum virus concentration, with each log reduction of serum viral 
concentration resulting in an improvement of 0.034 kg in pigs averaging 5.3 kg BW and 0.004 
kg in pigs averaging 11 kg BW. Two mechanisms of action were suggested, including effects on 
function and intracellular signaling pathways of immune cells and interruptions in viral 
replication or attachment (Greiner et al., 2001a). Under the same experimental conditions, 
dietary daidzein fed at 0 to 800 mg/kg alone did not result in changes in serum virus 
concentrations. These authors also reported that 200 to 800 mg/kg of dietary daidzein resulted in 
increased serum IFN concentrations during early periods of high serum virus concentrations (0 to 
4 DPI), which is opposite from what was observed for genistein. Admittedly, 200 or 400 mg/kg 
of dietary daidzein did improve ADG, ADFI, and feed efficiency during periods of high serum 
virus concentrations (4 to 16 DPI), though these effects were lost as serum virus concentrations 
decreased (Greiner et al., 2001b). It is important to note that graded ingestion of genistein and 
daidzein during the pre-inoculation period resulted in linear decreases in ADG, suggesting that 
supplemental soy isoflavones may not benefit the performance of non-disease-challenged 
animals. However, the lack of a genistein supplementation and day interaction indicates that 
feeding genistein prior to inoculation may have aided in the pigs’ ability to resist viral infection 
initially or reduce viral infectivity, as suggested above. That could imply that while supplemental 
isoflavones do not appreciably benefit growth performance, they may help protect against 




After evaluating the effects of supplementing individual soy isoflavones in disease-
challenged pigs, a natural next step was to investigate potential effects of natural soy isoflavone-
containing feedstuffs. One study examined the effect of dietary SBM concentrations, a product 
with moderate-to-high levels of naturally occurring isoflavones, on the growth and immune 
responses of PRRSV-infected weanling pigs. Following a similar experimental design, weanling 
pigs receiving either a low SBM diet (LSBM, 17.5% SBM, 22.8% CP, 700 mg/kg total ISF) or 
high SBM diet (HSBM, 29.0% SBM, 26.7% CP, 1,246 mg/kg total ISF) were inoculated with 
active PRRSV. Post-inoculation, PRRSV-infected pigs receiving HSBM diets did not experience 
a decrease in ADG compared with a non-infected control group, whereas infected pigs receiving 
LSBM diets did. There were no effects of SBM inclusion on serum viral concentrations at 3 or 7 
DPI, but the HSBM-fed pigs did exhibit higher cycle threshold values (i.e., reduced viral 
concentrations) at 14 DPI compared with LSBM-fed pigs. Most inflammatory parameters were 
not affected by SBM concentration under PRRSV-challenge, though HSBM-fed pigs did have 
higher hematocrit concentrations than LSBM-fed pigs at 14 DPI, possibly indicating lessened 
stress on red blood cell reserves throughout the infection process (Rochell et al., 2015). Although 
higher concentrations of SBM in the diet improved growth in PRRSV-infected pigs, this study’s 
outcomes were limited by not being able to differentiate beneficial effects from biologically 
active compounds like isoflavones and increased crude protein or AA availability. 
In order to differentiate these effects, further research investigating soy isoflavones was 
performed by our laboratory and those findings are discussed in following data chapters. While 
our research does suggest that improved performance under PRRSV-challenge may be in part 
due to soy isoflavones, we recognize that isoflavones are dietary compounds partially subject to 
metabolism by organisms other than the animal to which they are fed: the gastrointestinal 
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microbiome. For that reason, we have to take into account the potential role the gastrointestinal 
microbiome plays in the response to systemic disease and how soy isoflavones may influence 
that response. 
The Microbiome, PRRSV, and Soy Isoflavones 
Factors That Influence Swine Gastrointestinal Microbiome Development 
With increasing evidence showing that nutritional interventions can influence whole-
body health, the role of the gastrointestinal microbiome has garnered great attention. Not only is 
the gastrointestinal microbiome responsible for the metabolism of a multitude of compounds that 
are non-digestible/metabolizable by mammalian enzymes, it is a dynamic population responsive 
to changes in dietary composition and is directly able to interact with the host (Quigley et al., 
2013; Frese et al., 2015). One important interaction the microbiome has with its host involves the 
development and regulation of the immune system, which has long-term health implications for 
growing pigs. Considering that soy isoflavones fall into the category of dietary components only 
partially metabolized by mammalian enzymes (Cassidy et al., 2006), understanding their impact 
on the gastrointestinal microbiome and how the microbiome changes the metabolism and 
bioavailability of isoflavone metabolites in both healthy and diseased pigs is an area of interest, 
especially when we consider their immunomodulatory potential.  
 Knowledge of the development of the gastrointestinal microbiome in growing pigs is 
essential to understanding the influence diet can have on its composition. As the weaned pig 
transitions from a diet comprised solely of sow’s milk to a more complex diet comprised of 
mainly plant-based components, populations comprising their intestinal microbiome also 
undergo transitions. According to metagenomic sequencing data, microbial community diversity 
(i.e., alpha diversity, a measure of the number of different species detected within a microbial 
ecosystem) gradually increases starting at birth, but that diversity quickly shifts based on diet 
28 
 
composition. During nursing (i.e., days 1-21 of life), microbial communities are fairly stable with 
the most abundant families being Bacteroidaceae (aka. Bacteroides), Clostridiaceae, 
Lachnospiraceae, Lactobacillaceae, and Enterobacteriaceae. From weaning until 7 weeks of 
age, populations of Bacteroidaceae and Enterobacteriaceae decline and populations of 
Lactobacillaceae, Ruminococcaceae, Veillonellaceae, and Prevotellaceae increase (Frese et al., 
2015), though there is some evidence that weaning may decrease some Lactobacillaceae 
subspecies (Niederwerder, 2017). Among pigs from approximately 3 weeks of age (i.e., 
weaning) until slaughter age (~24 weeks), Firmicutes and Bacteroides phyla accounted for 
nearly 85% of total 16S rRNA sequences across the gastrointestinal tract. Moreover, genera 
including Clostridium, Blautia, Lactobacillus, Prevotella, Ruminococcus, Roseburia, and 
Subdoligranulum were present in more than 90% of samples analyzed with Prevotella being the 
most abundant (Holman et al., 2017). While diet maintains the strongest influence over microbial 
composition, other factors that can influence the microbiota of growing pigs include host 
genetics, environment, mode of delivery (i.e., vaginal vs. caesarean), microbiome of the sow, 
antibiotic exposure, pathogenic stressors (particularly enteric pathogens), and 
handling/processing stressors (Niederwerder, 2017). Of these factors, pathogenic stressors are of 
particular concern for swine production, especially around the time of weaning when risks of 
encountering enteric and respiratory pathogens is high. 
The Microbiome, the Immune System, and the Gut-Lung Axis 
 Not only is the gastrointestinal microbiome a dynamic population and responsive to 
external factors, it itself exerts its own influence on its host. One particularly important 
relationship between the gastrointestinal microbiome and the host is its direct influence on the 
immune system’s development and function both locally and systemically. These influences 
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include directly impacting the development of the innate immune system, specifically helping 
maintain homeostasis and epithelial function at mucosal surfaces, influencing T-cell 
differentiation, modulating inflammation, and regulating the adaptive immune response (Kau et 
al., 2011; Hooper et al., 2012; Hauptmann and Schaible, 2016; Niederwerder, 2017). These 
effects are driven by microbial population composition and in part by their unique metabolic 
activity through the production of secondary metabolites by fermentation (Collado et al., 2018).  
This role is further emphasized by gnotobiotic animal models; in “germ-free” animals 
(i.e., those reared in an environment devoid of microbial organisms) where a microbiome is 
unestablished, tissues and organ systems associated with the immune system such as lymph 
nodes are less developed and these animals typically exhibit more severe clinical disease lesions 
in the presence of a pathogen challenge (Niederwerder, 2017). Even in animal models where a 
host microbiome has been established but is greatly depleted by the use of antibiotics we can 
observe immune system dysfunction. For example, in a microbiome-depleted mice model 
investigating the role of the microbiota in the host response to pneumococcal pneumonia, 
researchers found that microbiome-depleted mice had accelerated mortality rates, increased local 
lung and circulating bacterial concentrations, and increased pro-inflammatory IL-1β and IL-6 
serum cytokine concentrations compared to controls (Schuijt et al., 2016). In general, studies of 
this nature identified associations between increased microbiome diversity and improved clinical 
outcomes. Other studies have gone a step further and identified specific bacterial types that were 
found to be associated with immune responses to pathogen challenge. For example, under 
challenge with respiratory pathogens, increased relative abundance of lactic acid producing 
bacteria such as Lactobacillus species has been showed to increase NK cell activity, reduce pro-
inflammatory cytokine production, enhance antiviral responses, upregulate cell-mediated 
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cytotoxicity, and increase mucosal antibody production. Increased relative abundance of 
Bifidobacterium longum has been shown to reduce clinical signs, decrease weight loss, lower 
viral replication, and reduce lung pathology in in vivo influenza models (Niederwerder, 2017). 
While it seems reasonable that the microbiome and its constituents may influence the immune 
system locally, such as innate immune function including epithelial integrity and antigen 
recognition by innate immune cells at the level of the gut (Hooper et al., 2012; Niederwerder, 
2017), its ability to affect immune function systemically, as described by the studies referenced 
above, is in some ways unexpected. This ability has been the focus of numerous research groups, 
particularly regarding the connection between the gastrointestinal microbiome and respiratory 
illness. 
 Through continued research of this relationship, a well-documented phenomena known 
as the “gut-lung axis” has been established, which describes a bi-directional communication 
between microbial populations of the gastrointestinal and respiratory tracts. Within this context, 
the gastrointestinal and respiratory tracts have been shown to share a “common mucosal 
response”, which involves effects of the gastrointestinal microbiome on mucosal immunity 
driving immune responses at distal mucosal sites such as the lungs (Mcghee and Fujihashi, 2012; 
Hauptmann and Schaible, 2016; Date et al., 2017). Perhaps most interestingly, several dysbioses 
of the gastrointestinal microbiome have been associated with lung disorders and respiratory 
infections in humans, including viral pathogens (Collado et al., 2018). In respiratory viral 
pathogen models, microbiome composition and diversity has been shown to be directly 
associated with clinical outcomes including diseased progression, airway inflammation, immune 
response, and morbidity (Ober et al., 2017). Shifting focus back to swine production and health, 
the influence of the microbiome on immune system function and the relationship between the 
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microbiome and the respiratory tract is an area of new discussion for how nutritional 
interventions, like soy isoflavones, may modulate the immune response and improve 
productivity in pigs facing a respiratory pathogen challenge.  
Microbiome Response to PRRSV 
Due to increased interest in this area of research, there are recent studies evaluating the 
relationship between gastrointestinal microbiome composition and swine respiratory disease. 
Specifically focusing on disease models including a PRRSV-challenge component, there are 
notable differences in pig performance and clinical outcomes that correspond with differences in 
microbiome composition. In a PRRSV and porcine circovirus type 2 (PCV2) co-infection model 
in weanling pigs, researchers found that pigs with the best clinical outcomes (i.e., highest ADG 
from 0 to 63 DPI and lack of overt clinical disease) had greater fecal microbial diversity than 
pigs with the worst clinical outcomes (i.e., lowest ADG from 0 to 63 DPI and at least 10 days of 
moderate to severe clinical disease). In the worst clinical outcomes group, pigs experienced 
delayed peak PRRSV-infection with prolonged and increased viremia, higher peak PCV2 
viremia levels (non-significant), and increased serum concentrations of Bacillus cereus, 
suggesting these animals experienced a more severe systemic infection and compromised 
mucosal integrity. Regarding microbiome differences observed, in addition to differences in 
overall measures of microbiome diversity, pigs in the worst clinical outcomes group notably had 
no Escherichia coli (E. coli) detected in their fecal samples. Though swine are susceptible to a 
number of pathogenic strains of E. coli, in respiratory and gastrointestinal pathogen challenge 
models commensal E. coli presence has been associated with greater feed efficiency, greater 
weight gain, and reduced cachexia. Additionally, bacterial populations of the Proteobacteria 
phylum were only found in fecal samples from pigs in the best clinical outcome group, which 
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has been associated with improved clinical outcomes in other pathogen challenge models in 
swine (Niederwerder et al., 2016).  
Continuation of this research resulted in similar findings when researchers investigated 
what early microbiome properties may influence growth performance following co-infection in 
PRRSV/PCV2 co-infected pigs. They found that following subclinical infection with these two 
respiratory pathogens there was a clear divergence of between high and low growth rate groups 
starting at approximately 21 DPI. Pigs that fell within the high growth rate group had reduced 
PRRSV and PCV2 replication rates and decreased lung lesion severity compared to the low 
growth rate group, which was in accordance with previous findings. Also similar to previous 
findings, pigs that fell within the high growth rate group had greater fecal microbial diversity at 
the time of infection as well as increased species diversity in Ruminococcaceae and 
Streptococcaceae families, both of which have been previously associated with improved growth 
performance in swine (Ober et al., 2017). These data suggested that microbiome composition not 
only influences clinical outcomes during an active respiratory infection, but may confer these 
benefits as early as first exposure to these respiratory pathogens.  
Microbiome Response to Soy Isoflavones  
In that context, if increased microbial diversity is associated with better clinical outcomes 
in swine, knowing if nutritional interventions alter microbial composition of the animals to 
which they are fed is also of interest. Regarding soy isoflavones, most research evaluating their 
effect on the gastrointestinal microbiome has been conducted in humans. That said, dietary soy 
isoflavones have been shown to influence the relative proportions of several bacterial 
populations across different studies. In post-menopausal women, isoflavone consumption 
increased the relative proportions of a number of bacterial populations including 
33 
 
Bifidobacterium, Lactobacillus, and Eubacterium, though significant inter-individual variation 
occurs and effects do appear to dose-dependent (Nakatsu et al., 2014; Huang et al., 2016; 
Kolátorová et al., 2018). In a human breast cancer mice model, genistein alone increased 
butyrate-producing bacterial families, which is associated improved colon health, suppressed 
expression of pro-inflammatory/pro-oxidative cell signaling pathways, and increased expression 
of anti-inflammatory cell signaling pathways (Paul et al., 2017), which suggests that isoflavones 
may beneficially alter the microbiome in the context of certain disease processes. In vitro studies 
evaluating the effects of isoflavones and their associated metabolites on the growth of common 
gastrointestinal bacterial strains suggests that isoflavones may exhibit positive growth pressure 
on bacterial strains that are able to metabolize them or utilize them as an energy source (Vázquez 
et al., 2017). It is unclear how these effects would translate to swine, which are exposed to 
dietary isoflavones throughout their productive life, particularly when considering a majority of 
these findings are in mature females alone, which excludes interactions with growth and 
development and sex that may influence the ability of isoflavones to influence microbiome 
composition (Kolátorová et al., 2018).  
It is also important to note that a majority of these human studies focus on the potential 
differences of individuals to produce equol, a secondary metabolite of daidzein that is highly 
bioactive, more so than any other isoflavone or isoflavone metabolite. Equol is an isoflavandiol, 
nonsteroidal estrogen-like compound that maintains high biological activity. In in vitro studies, 
equol out competed both genistein and daidzein for growth inhibition of several fungal and 
common bacterial types, demonstrating the greatest antioxidant capacity among all isoflavones 
and their metabolites (Chang et al., 1995; Setchell et al., 2002). As a metabolite, equol appears to 
be relatively stable and tolerant of peripheral circulation in the body in its biologically active 
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form better than parent isoflavones themselves. However, the ability to synthesize equol is 
highly variable between species and individuals, largely owing to differences in composition of 
gastrointestinal microbial populations. In humans, only 30-50% of test populations have been 
found to be “equol-producers” (Setchell et al., 2002). Within swine populations, it appears that 
some have microbiomes that support equol production (Yu et al., 2008), but among U.S. breeds 
it seems more variable. A study evaluating equol production and contents in feces and urine from 
large white sows showed results similar to what had been demonstrated in humans with high 
inter-individual variability. Like humans, individual sows that had larger detectable levels of 
equol in their feces or urine had similar microbial population phenotypes to each other (Zheng et 
al., 2017). Moving forward, it is pertinent to understand how the microbiome populations in 
swine are influenced by isoflavones and if they are, do those differences correspond with 

















Table 2.1. Isoflavone concentrations (mg/kg of product) of common soybean-derived products1 
Item (mg/kg) Soybean meal Soybean protein concentrate Soybean protein isolate 
Genistein 1,147 52.6 573 
Daidzein 808 57.8 308 
Glycitein 161 15.7 85.4 
Total Isoflavones 2,096 115 911 
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CHAPTER 3: EFFECTS OF DIETARY SOY ISOFLAVONES AND SOY PROTEIN 
SOURCE ON RESPONSE OF WEANLING PIGS TO PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRAL INFECTION5 
Abstract 
Porcine reproductive and respiratory syndrome virus (PRRSV) is the most prevalent disease of 
swine globally. Infection of weanling pigs with PRRSV leads to a complex immune response 
resulting in significant disease and decreased growth performance. Previous experimental 
evidence suggests that increasing concentrations of soybean meal in the diet of young pigs confer 
benefits in terms of growth performance and immune parameters. The objective of this 
experiment was to identify potential modes of action for this benefit, specifically the ability for 
soy-derived isoflavones (ISF) to confer immunological benefits to young pigs infected with 
PRRSV. Four dietary treatments differing in soy protein source (soy protein concentrate vs. 
enzyme-treated soybean meal) and ISF supplementation (none vs. 1,500 mg total ISF/kg) were 
fed; the control diet (CON) contained soy protein concentrate and no supplemental ISF. 
Weanling pigs (60 barrows, 21 d of age, 5.71 ± 0.44 kg) from a naturally Mycoplasma 
hyopneumoniae (Mh)–infected source herd were individually housed in disease containment 
chambers and provided ad libitum access to experimental diets for 7 d before receiving either a 
sham inoculation or a 9.28 × 103 50% tissue culture infective dose of PRRSV at 28 d of age (0 d 
post-inoculation, DPI). A total of 5 experimental treatments included an uninfected group 
receiving the CON diet, plus four infected groups each receiving a different dietary treatment. 
Growth performance and rectal temperatures were recorded throughout the study, and blood was 
 
5
Associated Manuscript: Smith, B. N., A. Morris, M. L. Oelschlager, J. Connor, and R. N. Dilger. 2019. Effects of 
dietary soy isoflavones and soy protein source on response of weanling pigs to porcine reproductive and respiratory 




collected for quantification of serum PRRSV load, presence of anti-PRRSV antibodies, 
differential complete blood counts, cytokine concentrations, and T-cell immunophenotyping. 
Data were analyzed as a 2-way or 3-way ANOVA for all treatments including PRRSV-infected 
pigs, in addition to a single degree of freedom contrast to compare uninfected and infected pigs 
receiving the CON diet. PRRSV-infection reduced growth rate and efficiency compared with 
non-infected controls with minimal influences by ISF. Supplemental ISF reduced PRRSV-
induced band neutrophilia and improved cytotoxic-to-helper T-cell ratios. These results suggest 
that ISF contribute to activation of adaptive immune system pathways and could benefit recovery 
from and clearance of PRRSV infections. 
Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) continues to be one of the 
leading pathogens causing high economic impact on modern swine production. Previous studies 
estimated that production losses within breeding and growing swine herds to be more than 
US$650 million per year, costing producers US$3 to US$11 per pig infected (Holtkamp et al., 
2013; Schweer et al., 2017). Controlling spread and eradication of PRRSV has remained a 
challenge due to ease of transmission between animals, heterogenic properties of the virus itself, 
and its ability to persist within an animal host and environment. Although vaccination protocols 
are available, their efficacies vary and often do not result in complete sterilizing immunity 
(Loving et al., 2015). For those reasons, nutritional intervention of or management strategies is 
of high interest for common diseases affecting livestock due to relatively low cost and ease of 
implementation. It has been demonstrated that increasing the level of soybean meal in the diet 
fed to pigs under immune stress reduces adverse effects of illness and may improve growth 
performance (Boyd et al., 2010; Rochell et al., 2015). However, it remains to be seen whether 
46 
 
improved growth performance was due to differences in dietary amino acids or one or more 
other dietary components, though there appears to be evidence that differences are likely not due 
to differences in nutrient digestibility (Schweer et al., 2018). Isoflavones (ISF) are flavonoid 
compounds that are enriched in soybeans and possess anti-inflammatory and anti-oxidative 
properties (Smith and Dilger, 2018). With that in mind, the objective of this study was to 
determine whether soy-derived ISF, fed at dietary concentrations comparable to a commercial 
diet fed to weanling pigs, would demonstrate protective effects against a PRRSV-challenge. It 
was also of interest to determine whether soy protein source influenced the efficacy of dietary 
ISF modulating a disease challenge in weaning age pigs. 
Materials and Methods 
The protocol for this experiment was approved by the Institutional Animal Care and Use 
Committee and the Institutional Biosafety Committee of the University of Illinois at Urbana – 
Champaign.  
Animal Husbandry and Experimental Design  
Sixty weanling barrows (5.71 ± 0.44 kg initial body weight) were obtained from a 
PRRSV-negative, non-PRRS vaccinated commercial herd (1050 Cambro genetics; Carthage 
Veterinary Service, Ltd.) and housed in disease containment chambers in the Edward 
R. Madigan Laboratory at the University of Illinois (Urbana, IL) for 21 d (−7 to 14 d post-
inoculation, DPI) immediately after weaning at approximately 21 d of age. A single corridor of 
containment chambers was used, with access to 8 chambers each housing 4 individual pigs, and 
the total number of pigs was split into 2 separate cohorts (n = 28 and n = 32 in cohorts 1 and 2, 
respectively) that were conducted in successive months. Each chamber (3.34 m2 total floor 
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space) was divided into 4 individual pens (0.84 m2 per pen) and each was equipped with 1 nipple 
waterer and 1 feeder.  
Experimental diets were provided beginning at the time of allotment. Pigs were weighed 
upon arrival for allotment into 5 experimental treatment groups. Pigs were assigned to dietary 
treatments and allotted to containment chambers (blocks) based on body weight and litter so that 
weight distributions were similar within a chamber across all treatment groups. Litter of origin 
(14 litters total across the 2 cohorts) was taken into account, and pigs from each litter were 
stratified across treatment groups as evenly as possible. This allotment resulted in 12 pigs for 
each treatment group, with each chamber having 1 replicate pig per dietary treatment with the 
exception of the uninfected group (3 blocks total). One intramuscular injection of enrofloxacin 
(7.5 mg/kg BW; Baytril 100; Bayer, Shawnee Mission, KS) was administered on the day pigs 
arrived as a prophylactic measure against bacterial infections during transition to the new rearing 
environment. Pigs were provided their assigned experimental diet and allowed to adjust to 
housing conditions for 7 d prior to initiating inoculation procedures. Lights were maintained on a 
12-h light cycle throughout the study, with light provided from 0600 to 1800 h in a 
thermostatically controlled environment with containment chamber temperatures set at 28–29 °C 
throughout the study.  
As stated, 5 experimental treatments were used in this study, with 4 different diets and 2 
states of infection. A 2 × 2 + 1 factorial arrangement of dietary soy protein sources (soy protein 
concentrate [SPC], Arcon AF, ADM, Decatur, IL vs. enzyme-treated soybean meal [ETSBM], 
HP300; Hamlet Protein, Findlay, OH) and supplemental ISF (none vs. Novasoy400; ADM, 
Decatur, IL) constituted the total of dietary treatments (Table 3.1). Isoflavones were added to the 
test diets at levels that would be typical for a commercially relevant corn-SBM diet fed to pigs 
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with approximately 20% SBM inclusion. The control diet contained SPC as a protein source with 
no addition of soy ISF, and this diet was fed to both sham-inoculated and PRRSV-infected 
groups. Experimental diets were isocaloric and, with the exceptions of corn and protein source, 
identical in ingredient composition. Isoflavone and saponin concentrations of ingredients and 
experimental diets were quantified via HPLC at the USDA–ARS National Center for 
Agricultural Utilization Research (Peoria, IL) according to procedures of Berhow et al. (2006). 
Crude protein was determined by measuring nitrogen using a Leco analyzer (TruMac N, Leco 
Corp., St. Joseph, MI) standardized with EDTA and amino acid concentrations were determined 
at the University of Missouri Agricultural Experiment Station (Columbia, MO; Table 3.2) 
according to AOAC (2002) official methods [920.39 and 982.30 E(a, b, c), for crude protein and 
amino acid concentrations, respectively]. Gross energy of the experimental diets was determined 
using an adiabatic bomb calorimeter (Parr Instruments, Moline, IL), and DM (method 934.01, 
AOAC International, 2002) and OM were performed by determining percent ash (method 
942.05, AOAC International, 2002) and subtracting from 100. Diets were analyzed for total 
dietary fiber according to Prosky et al. (1994), but no separation of soluble and insoluble 
fractions was made. Diets were formulated on a standardized ileal digestible (SID) amino acid 
basis with identical concentrations across all diets (Table 3.3). All diets met or exceeded NRC 
(2012) nutrient requirements for weanling pigs and analyzed dietary concentrations are presented 
in Table 3.4.  
Following a 1-wk adaptation period to experimental diets, blood was collected from each 
pig to establish 0 DPI baseline measurements and to ensure that all pigs were PRRSV-negative at 
study initiation. Immediately following blood collection, pigs were administered via intranasal 
inoculation either 2 mL of a 2% fetal bovine serum + phosphate-buffered saline solution (sham-
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control) or 9.3 × 103 50% tissue culture infective dose (TCID50) of PRRS virus (strain NADC20, 
courtesy of Dr. Federico Zuckermann, University of Illinois, Urbana, IL).  
Although the model was designed to only utilize PRRSV as the immune challenge, the 
source herd for piglets used for this study tested positive for Mycobacterium hyopneumoniae 
(Mh) after completion of the first cohort and prior to delivery of pigs for the second cohort. We 
confirmed Mh status in individual pigs by quantitative real-time polymerase chain reaction 
(qRT-PCR) detection of the bacterium in lung tissue only from pigs included in the second 
cohort, but it is likely that pigs from the first cohort were also harboring the bacterium based on 
the length of time required for Mh to establish infection and present associated clinical signs 
(Maes et al. 2018). It should be noted that all but 2 pigs from the second cohort, including those 
not infected with PRRSV, tested positive for Mh specifically, though the 2 Mh-negative pigs did 
test positive for general Mycoplasma by qRT-PCR.  
Growth Performance, Rectal Temperatures, and Blood Collection  
Individual pig and feeder weights were recorded weekly throughout the study to allow for 
calculation of average daily gain (ADG), average daily feed intake (ADFI), and feed efficiency 
(gain to feed, G:F). Growth performance data are reported in reference to the inoculation 
schedule (−7 to 14 DPI). Rectal temperatures of all pigs were measured on 0, 3, 6, 8, 12, and 14 
DPI using an over-the-counter, consumer-grade digital thermometer in the morning prior to any 
blood sample collection. 
Blood (up to 8 mL total) was collected from the jugular vein of each pig into evacuated 
tubes (BD, Franklin Lakes, NJ) at 0, 3, 6, 12, and 14 DPI using a 21-gauge needle. Blood 
samples from 0 DPI were collected immediately before inoculation. Three milliliters of blood 
were collected into tubes containing EDTA as an anti-coagulant (i.e., whole blood), placed on 
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ice, and submitted to the University of Illinois Veterinary Clinical Pathology Laboratory for 
analysis as described in the following section. Three milliliters of blood were collected into 
serum tubes, allowed to clot at room temperature, and centrifuged at 1,300 × g for 15 min at 
20°C. Serum was removed from centrifuged samples and stored in 0.5 mL aliquots at -80°C 
pending subsequent analyses. On 12 DPI, a total of 8 mL of whole blood were collected from 
each animal, placed on ice, and used for isolation of peripheral blood mononuclear cells 
(PBMC) for immunophenotyping procedures as described below.  
Blood and Sera Measurements  
At 0, 3, 6, and 14 DPI, a multi-parameter, automated hematology analyzer (CELL-DYN 
3700, Abbott Laboratories, Abbott Park, IL) was used to determine the total and differential cell 
counts of whole blood by the University of Illinois Veterinary Clinical Pathology Laboratory. 
Serum from the same experimental time points was submitted to the University of Illinois 
Veterinary Diagnostic Laboratory to be analyzed for PRRSV load at 0, 3, 6, and 14 DPI by qRT-
PCR using Z-PRRSV Multiplex reagents (Tetracore, Rockville, MD) and identical extraction 
conditions and a single quantity of starting RNA material for all experimental samples. Both 
positive and “no-template” controls were run along the experimental samples. The assay used a 
single-tubed method based on fluorogenic probe hydrolysis (TaqMan, Applied Biosystems, 
Foster City, CA). Viral load was expressed as cycle threshold (Ct) values, where a higher Ct 
value represents a lower amount of PRRSV mRNA. Additionally, a PRRSV antibody screen by 
ELISA was performed on qRT-PCR-positive samples collected on 6 and 14 DPI for detection of 
anti-PRRSV antibodies. The results for this assay are expressed as a sample to positive ratio (S/P 
ratio) that represents the following relationship: [sample mean × (mean of optical absorbance) 
− negative control mean]/(positive control mean − negative control mean)]. An S/P ratio greater 
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than 0.4 is considered a positive result and the larger the number, the more anti-PRRSV 
antibodies that are present. Finally, serum concentrations of cytokines tumor necrosis factor-α 
(TNF-α), interferon-γ (IFN-γ), interleukin-1β (IL-1β), interleukin-10 (IL-10), interleukin-8 (IL-
8), interferon-α (IFN-α), and interleukin-4 (IL-4) were also measured at 0, 3, 6, and 14 DPI with 
the Swine Cytokine Magnetic 7-Plex Panel according to manufacturer instructions (Novex by 
Life Technologies, Frederick, MD).  
T-Cell Immunophenotyping  
Whole blood collected on 12 DPI was used for isolation of PBMC for a T-cell 
immunophenotyping procedure using flow cytometry. In brief, PBMC were isolated by placing 
individual whole blood samples over a density gradient (SepMate 15 [IVD] and Lymphoprep, 
StemCell Technologies, Cambridge, MA) and centrifuging at 1,200 × g for 25 min at 20°C. 
Isolated PBMC were then washed with phosphate buffer saline containing 2% fetal bovine serum 
before being counted using the Moxi Z Mini Automated Cell Counter (ORFLO Technologies, 
Ketchum, ID). Individual samples were prepared with 1.0 × 106 cells and treated with a protein 
transport inhibitor (BD Pharmingen, San Jose, CA) 4 hours at 37°C. Following this treatment, 
cells were incubated with a 2% porcine serum blocking solution for 15 minutes at 4°C. Cells 
were then labeled with external fluorescent antibodies against cell surface markers CD3 (PE-Cy7 
Mouse Anti-Pig CD3ε, BD Pharmingen, San Jose, CA), CD4 (Alexa Fluor 647 Mouse Anti-Pig 
CD4a, BD Pharmingen, San Jose, CA), and CD8 (PE Mouse Anti-Pig CD8b, BD Pharmingen, 
San Jose, CA). Following application of external antibodies for 45 minutes at 4°C, cells were 
permeabilized using the BD Perm/Wash Buffer (BD Biosciences, San Jose, CA) and fixed using 
4% paraformaldehyde solution for 20 minutes at 4°C. The following day, cells were labeled with 
an intracellular fluorescent antibody against IFN-γ (PerCP5.5 Mouse Anti-Pig IFN-γ, BD 
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Pharmingen, San Jose, CA). Prepared, labeled cells were evaluated at the University of Illinois 
Flow Cytometry Facility using a BD LSR II Flow Cytometry Analyzer (BD Biosciences, San 
Jose, CA) and flow cytometer outputs were analyzed using FCS Express 5 Plus (De Novo 
Software, Glendale, CA).  
To summarize our analysis and gating procedures, recorded cellular events were plotted 
by density using forward and side scatter areas on the y- and x-axes, respectively, to exclude 
dead cells and cellular debris and allow for the selection of lymphocyte cells based on size. A 
single gate was applied to the lymphocyte population, the content of which was then plotted by 
density using forward scatter width and side scatter on the y- and x-axes, respectively, to allow 
for the gating and analysis of single cell events within our lymphocyte population only. Utilizing 
single cellular events within our lymphocyte population, single-stain control samples were used 
to set our detection thresholds for each individual fluorochrome and creation of a CD3+ gate. 
Gated on CD3+ lymphocytes, a final density plot using our CD8+ and CD4+ fluorochrome 
channels on the y- and x-axes, respectively, was created and our individual fluorochrome 
detection levels were used to apply quadrants to the density plot. Statistics from each quadrant 
were then used for our individual effector T-cell proportions (e.g., Helper T-cells, CD3+/CD4+). 
Statistical Analyses  
Statistical analysis was dependent on whether outcomes were measured at a single time 
point or at multiple time points for the same subject. Apart from growth performance outcomes, 
individual pig was considered the experimental unit, with 12 replicate pens or pigs for each of 
the 5 experimental treatments. A total of 4 different diets were fed to PRRSV-infected pigs, 
whereas a single group of uninfected pigs received only the control diet. Thus, the 2- or 3-way 
analyses of variance described below involve effects between diets and within PRRSV-infected 
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pigs, whereas a separate analysis was used to compare uninfected and infected groups receiving 
the control diet. In all cases, interaction means are presented in data tables, whereas significant 
main effect means are presented in data figures.  
For all single time-point outcomes, a 2-way ANOVA was conducted using the MIXED 
procedure of SAS 9.3 (SAS Institute, Inc., Cary, NC) with factors including the dietary soy 
protein source (SPC vs. ETSBM) and addition of supplemental soy ISF (no vs. yes). Comparison 
of uninfected and infected groups each fed the control diet was made using a single degree of 
freedom contrast between these experimental treatments.  
With regard to repeated measures outcomes, a 3-way ANOVA was conducted for all 
outcomes involving samples collected from the same subject at multiple time points with factors 
including the dietary soy protein source (SPC vs. ETSBM), addition of supplemental soy ISF (no 
vs. yes), and time (DPI). Repeated measures were sliced by DPI for main effect and interaction 
means and those P-values are included in data tables. No 2-way or 3-way interactive effects 
involving DPI were significant, so these effects were removed from the statistical model. 
Comparison of uninfected and infected groups each fed the control diet was made using a single 
degree of freedom contrast between these experimental treatments. In all cases, outliers were 
identified as having an absolute Studentized residual value of 3 or greater and significance was 
accepted with at P ≤ 0.05. 
Results 
Growth Performance  
Growth performance results are shown in Table 3.5. Within the PRRSV-infected groups, 
no main or interactive effects were noted during the pre-inoculation period (P > 0.05; −7 to 0 
DPI). However, significant decreases (P < 0.01) in ADG were observed between uninfected and 
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infected groups fed the control diet throughout the post-inoculation period, thereby signifying a 
successful PRRSV-infection. During the infective period, there were main effects of ISF 
supplementation on G:F between 6 and 14 DPI and main effects of soy source on ADG and G:F 
over the entire 2-wk infection period (P < 0.05; 0 to 14 DPI). From 6 to 14 DPI, pigs receiving 
the ETSBM + ISF diet experienced less efficient growth compared with pigs receiving only 
ETSBM (173 vs. 484 g/kg, respectively; P < 0.05). Over the 2-wk infection period, pigs 
receiving the ETSBM diet maintained a higher ADG compared with pigs fed the Control diet, 
regardless of ISF supplementation (219 vs. 137 g/d, respectively; P < 0.05). Additionally, pigs 
receiving ETSBM, regardless of ISF supplementation, had greater feed efficiency compared with 
pigs receiving the Control + ISF diet over the 2-wk infection period (P < 0.05). Overall, PRRSV-
infection reduced ADG and G:F during the 2-wk infection period (0 to 14 DPI) resulting in a 
lower final body weight (P < 0.0001) for PRRSV-infected pigs compared with uninfected pigs 
fed the Control diet. 
Rectal Temperatures  
Rectal temperature data were collected frequently over the entire infection period (0 to 14 
DPI; Table 3.6). Infection with PRRSV increased (P < 0.05) rectal temperatures of pigs at 0, 3, 
6, and 8 DPI, but there was no influence (P > 0.05) of dietary soy source or ISF supplementation 
on this outcome.  
Serum Viral Load and Anti-PRRSV Antibody Presence  
Results for serum viral load and presence of anti-PRRSV antibody assays can be found in 
Table 3.7. Analysis of serum by qRT-PCR indicated that all pigs were PRRSV-negative at 0 
DPI. At 3, 6, and 14 DPI, all pigs in the uninfected group remained free of PRRSV as shown by 
negative qRT-PCR results, whereas all pigs inoculated with PRRSV tested positive for PRRSV 
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mRNA. Among the PRRSV-infected groups, a main effect of ISF was observed at 3 DPI with Ct 
values, the number PCR cycles required to detect presence the viral genome, being lower (i.e., 
more viral mRNA copies present) in pigs receiving supplemental ISF than those pigs un-
supplemented (14.27 vs. 17.19, respectively; P < 0.05; Figure 3.1). Additionally, there was an 
interaction main effect observed at 3 DPI with pigs fed the ETSBM + ISF diet having lower Ct 
values compared with pigs in all other groups (P < 0.05).  
The presence of anti-PRRSV antibodies was also assessed on qRT-PCR-positive samples 
collected on 6 and 14 DPI by IDEXX-ELISA (Table 3.7). As a reminder, an S/P ratio greater 
than 0.4 is considered a positive result and the larger the number, the more anti-PRRSV 
antibodies that are present. Although there were no main or interactive effects observed at 6 DPI, 
a main effect of soy source was observed on 14 DPI (P < 0.05). Pigs receiving the Control diets 
had greater concentrations of anti-PRRSV antibodies than those receiving the ETSBM diets, 
regardless of ISF supplementation (1.649 vs. 1.458, respectively; P < 0.05). Please note that this 
assay was for total IgG anti-PRRSV antibody presence and was not specific for neutralizing 
antibody types. 
Red Blood Cell Measurements  
Results for red blood cell measurements can be found in Table 3.8. Between non-
infected and infected pigs, PRRSV-infection resulted in reductions of red blood cell counts 
(RBC, 1 × 106 cells/mL), hemoglobin concentrations (HGB, g/dL), hematocrit (HCT, %), mean 
corpsucular volume (MCV, fl), and mean corpuscular hemoglobin (MCH, pg) at 14 DPI 
(P < 0.05), but no other time points were affected. No main effects of soy source or ISF 
supplementation were observed for any red blood cell parameters. The only significant 
interaction effect between soy source and ISF supplementation was for mean corpuscular 
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hemoglobin concentration (MCHC, g/dL) at 14 DPI. PRRSV-infected pigs receiving the 
ETSBM + ISF diet had lower MCHC compared with all other infected groups (P < 0.05). 
Leukocyte Measurements  
Results for leukocyte measurements are shown in Table 3.9. Regarding relative 
proportions of individual white blood cell (WBC) populations, PRRSV-infection resulted in 
leukopenia at 6 and 14 DPI, neutrophilia at 6 and 14 DPI, greater circulatory concentrations of 
band cells (i.e., circulating immature neutrophils; BAND) at 3 and 6 DPI, and lymphopenia at 3, 
6, and 14 DPI when comparing non-infected and infected control pigs (P < 0.05). Infected 
control pigs also exhibited greater monocyte populations than non-infected controls, though this 
was only observed at 0 DPI (P < 0.05). There were main effects of ISF supplementation for band 
cells. Animals receiving supplemental ISF had lower (P < 0.05) concentrations of circulatory 
band cells, though this effect was only observed at 3 DPI (2.14% vs. 6.32%, respectively; Figure 
3.2). There were main effects of soy source for total WBC counts and eosinophil concentrations. 
Animals receiving the ETSBM diet without supplemental ISF had greater (P < 0.05) WBC 
counts than all other treatments at 6 DPI, but this effect was not maintained at any other time 
point (19.47 × 103 cells/µL vs. 12.32 × 103 cells/µL, respectively; Figure 3.2). Additionally, pigs 
fed the ETSBM diet had lower (P < 0.05) circulatory eosinophil concentrations compared with 
pigs receiving the Control diet at 3 DPI, with pigs receiving the Control + ISF having the 
greatest (1.17% vs. 3.03%, respectively). There were interaction effects for WBC counts and 
eosinophils. Within infected groups, pigs receiving the ETSBM + ISF diet experienced the least 
severe (P < 0.05) leukopenia at 6 DPI (i.e., smaller reduction in WBC counts) compared with all 
other treatments. Additionally, as previously discussed for the main effect of soy source, pigs 
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receiving the Control + ISF treatment had greater (P < 0.05) eosinophil concentrations than both 
ETSBM treatments, regardless of ISF supplementation. 
Serum Cytokine Concentrations 
Serum cytokine concentrations, quantified using a porcine-specific multiplexed ELISA, 
are shown in Table 3.10. Due to large numbers of samples with low or absent detection, 
cytokines IL-1β, IL-8, and IL-4 were omitted from analysis. PRRSV-infected pigs had higher 
circulating concentrations of IFN-α and TNF-α at 3 and 14 DPI, respectively, compared with 
uninfected controls. No other cytokines or time points were influenced by infection status. There 
were main effects for both soy source and ISF supplementation and interaction effects for IFN-α 
concentration at 3 DPI (Figure 3.1). Pigs that received the ETSBM + ISF diet expressed the 
greatest (P < 0.05) concentrations of IFN-α when compared with pigs fed the Control diet, 
regardless of ISF supplementation. Additionally, there were interaction and main effects for ISF 
supplementation on IFN-γ at 3 DPI (Figure 3.1). Pigs receiving the Control diet without 
supplemental ISF concentrations at 3 DPI had greater (P < 0.05) IFN-γ than all other treatments, 
though this effect was not observed at any other time point. 
T-Cell Immunophenotyping 
Results for immunophenotyping analysis of PBMC using flow cytometry can be found in 
Table 3.11. Relative proportions of total T-cells (i.e., positive for the CD3 cell-surface marker) 
and helper T-cells (i.e., positive for the CD3 and CD4 cell-surface markers) did not differ 
between uninfected and infected control animals. However, PRRSV-infection increased (P < 
0.05) the relative proportion of cytotoxic T-cells (i.e., positive for the CD3 and CD8 cell-surface 
markers) in the total lymphocyte population when compared with uninfected pigs receiving the 
Control diet. PRRSV-infection also increased (P < 0.05) the proportion of dual-positive T-cells 
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(i.e., positive for the CD3, CD4, and CD8 cell-surface markers), but showed a reduction in the 
percentage of dual-positive T-cells with active antiviral effector pathways (i.e., dual-positive T-
cells also expressing intracellular maker IFN-γ). 
Among PRRSV-infected pigs, there was a main effect (P = 0.011) of ISF 
supplementation on the relative proportion of helper T-cell populations, with ISF 
supplementation increasing (P < 0.05) the proportion of helper T-cells (Figure 3.3). PRRSV-
infected pigs receiving the ETSBM + ISF diet maintained the largest proportion of helper T-cells 
(26.4%), which was higher than pigs receiving the Control or ETSBM diets without 
supplemental ISF. Pigs receiving the Control + ISF diet maintained the second largest 
proportion, which was not different from other treatment groups. Across all immunophenotyping 
parameters, there were no main effects of soy source or interaction between soy source and ISF 
supplementation. 
Discussion 
Isoflavones are bioactive components that have been shown to have antiviral activity and 
are found in high concentrations in soybeans and soybean-derived feedstuffs (Wang and 
Murphy, 1996). This activity has been demonstrated against PRRSV specifically in live animal 
studies previously (Greiner et al., 2001a; Greiner et al., 2001b; Rochell et al., 2015). However, 
these studies were unable to identify the effects of soy ISF when present in normal 
concentrations and proportions found naturally in soybean meal without confounding effects of 
differing amino acid concentrations or sources in the diet. For that reason, one of our aims was to 
determine effects of industry relevant concentrations of soy ISF in diets otherwise devoid of 
these compounds and balanced for SID amino acid concentrations on the response of pigs to 
disease challenge. The two protein sources used for this study were a soy protein concentrate 
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(SPC; Arcon AF, ADM, Decatur, IL) and enzyme-treated soybean meal (ETSBM; HP300, 
Hamlet Protein, Findlay, OH), both of which are soy protein sources that have undergone 
additional processing beyond that of SBM. Soybean meal, while an affordable protein option, is 
often limited in weanling pig diets for the first few weeks post-weaning due to the immaturity of 
the weanling pig’s digestive capacity and presence of antinutritional factors such as 
oligosaccharides that can exacerbate gastrointestinal distress in young pigs (Stein, 2002). 
However, additional processing of SBM to either SPC or ETSBM can remove some of these 
antinutritional factors by solubilizing and removing residual carbohydrate fractions (Peisker, 
2001). Soy protein concentrate typically contains larger residual carbohydrate fractions than soy 
protein isolate, but both will have a greater proportions of protein than SBM (Shurtleff and 
Aoyagi, 2016). It is important to note that during the manufacturing of SPC and SPI, much of the 
estrogenic and antigenic factors such as soy ISF are also removed, which allowed us to develop 
basal diets with minimal to no ISF present. Using protein sources largely devoid of ISF ensured 
that we could supplement soy-derived ISF directly using a highly enriched source to reach 
concentrations near that of what is normally observed in SBM at typical inclusion levels for a 
nursery swine diet (USDA-ARS, 2016).  
In general, our disease challenge model reduced ADG and growth efficiency of infected 
individuals, indicating that a successful infection with PRRSV was established. This was also 
supported by increased rectal temperatures in our infected pigs over that of our non-infected 
controls throughout the post-inoculation period, which is expected during acute PRRSV 
infections. Reductions in ADG supported previous findings of foundational PRRSV-challenge 
studies performed by our laboratory and others, though we observed a more severe reduction in 
performance than expected (Greiner et al., 2000; Rochell et al., 2015), likely due to differences 
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in PRRSV strain virulence between studies. Additionally, the presence of an unintended Mh 
coinfection may have further diverted available energy sources away from body weight gain in 
our pigs, exacerbating the negative effects of our PRRSV intervention. To the contrary, we did 
not observe reductions in feed intake following PRRSV-inoculation, which was not in agreement 
with the findings by Greiner et al. who observed an approximate 22% decrease in ADFI from the 
4 d immediately preceding inoculation to days 4 to 8 post-inoculation (Greiner et al., 2000). 
When determining potential causes for this difference, we should note that there was observable 
feed wasting by the pigs as they transitioned onto their pelleted diet post-weaning. With that in 
mind, an improved G:F ratio was observed over the entire growth period from 0 to 14 DPI for 
pigs fed ETSBM as a protein source. This could be due to the additional processing that ETSBM 
undergoes as a soy protein product, resulting in greater removal of residual antinutritional factors 
(e.g., raffinose and stachyose) that may contribute to higher digestibility values of the total 
mixed diet (Peisker M, 2001).  
Aside from reduction in growth performance, other common indicators of infection status 
in swine respiratory models are serum viral load and circulating inflammatory cytokine 
concentrations. In previous PRRSV-challenge models, PRRSV infection caused rapid increases 
in serum viral concentrations when pigs were experimentally inoculated at 29 d of age, peaking 
at 4 DPI (Greiner et al., 2000). In subsequent studies by the same group evaluating the effects of 
individual soy ISF supplementation, similar results were observed with serum viral 
concentrations peaking at 4 DPI (Greiner et al., 2001a; Greiner et al., 2001b). When weaning age 
pigs were supplemented with soy genistein alone, the primary ISF found in soybeans, a linear 
reduction of serum PRRS viral concentrations was observed (Greiner et al., 2001a). However, 
when supplemented with daidzein alone, the second most prevalent ISF found in soybeans, no 
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effects on serum PRRS viral concentrations were observed, suggesting that other ISF fractions or 
interactions between ISF fractions possess more antiviral activity (Greiner et al., 2001b; Dia 
et al., 2008).  
Although no significant main effects for soy source were observed in our study, ISF 
supplementation increased serum PRRS viral concentrations on 3 DPI. A strong interaction 
between soy source and ISF supplementation was observed, which was most evident in our 
ETSBM + ISF treatment group that maintained the highest serum PRRS viral concentrations 
(i.e., lowest Ct values) at both 3 and 6 DPI. In a previous study from our laboratory, 
concentration of SBM (17.5% vs. 29.0%) in the diet had no influence on Ct values until 14 DPI 
with pigs fed higher concentrations of SBM having lower serum PRRS viral concentrations 
(Rochell et al., 2015). Importantly, the methods used to detect serum PRRSV viral antigen differ 
between the studies discussed above; studies by Greiner et al. utilized a cytopathic effect assay, 
an indirect viral detection assay involving serial dilutions of serum and viral clearing results of 
the assay to calculate the virus concentration (Reed and Muench, 1938; Greiner et al., 2000; 
Greiner et al., 2001a; Greiner et al., 2001b). Rochell et al. (2015) utilized detection of PRRS 
viral mRNA via real-time PCR, a direct viral detection assay and the same assay utilized in our 
present study.  
Understanding the differences in effects on serum PRRS viral concentrations across 
previous studies and ours is difficult, mainly due to lack of in vivo studies evaluating antiviral 
properties of ISF. In vitro, genistein in particular exhibits high inhibitory activity against viruses. 
Against human rotavirus, viral infectivity of cultured macrophages (MA-104 cell line) exposed 
to genistein or a mixture of ISF was reduced by 33% to 72%. Mixtures where genistein was 
absent lost these reductions of viral infectivity, demonstrating its importance for mediating viral 
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infections (Andres et al., 2007). Against herpes simplex virus types-1 and -2 (HSV-1 and HSV-
2), genistein moderately inhibited cytopathic effects (CPE), which are structural changes to the 
host cell that occur when they become infected by a virus resulting in subsequent cell death (Lyu 
et al., 2005). As stated above, measuring CPE was how Greiner et al. detected the presence of 
PRRS virus in serum and observed significant reductions with genistein supplementation 
utilizing that assay. Therefore, reasoning for why Rochell et al. (2015) and our study did not see 
similar reductions in serum PRRS viral concentrations may likely be due to our use of real-time 
PCR vs. a CPE assay, which may be influenced by the presence of free, bio-activated genistein 
in circulating serum collected for the assay instead of direct effects on the virus itself in vivo. 
Differences in PRRSV strain and severity of established infection (i.e., presence or absence of 
co-infection and strain virulence factors) may have also affected the ability of ISF to influence 
the response to PRRSV infections across these studies.  
Regarding inflammatory cytokines as an indicator of infection status, previous studies 
involving PRRSV and ISF mainly focused on IFN-γ, a key pro-inflammatory cytokine released 
during viral infections. Concentrations of IFN-γ in the current study were well-aligned with what 
have been observed previously in our laboratory (Rochell et al., 2015), yet we observed here an 
unremarkable IFN-γ response to dietary ISF supplementation. In the study conducted by Greiner 
et al. (2000), PRRSV infection alone caused an increase in serum IFN-γ concentrations, peaking 
at 4 DPI. These researchers suggested that the increase was due to IFN-γ production by cytotoxic 
T-cells and natural killer cells in response to the virus in order to support clearance of PRRSV by 
tissue resident macrophages. Subsequent PRRSV-challenge studies by the same group suggested 
a quadratic reduction of serum IFN-γ concentrations in response to genistein supplementation 
(Greiner et al., 2001a). Alternatively, daidzein supplementation at 200 or 800 ppm (but not 
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400 ppm) caused increased serum IFN-γ concentrations at peak viremia (4 DPI) (Greiner et al., 
2001b). Researchers speculated that the reductions for genistein alone may be related to its 
influence on intracellular signaling pathways. Such pathways on which ISF may elicit an 
inhibitory action are mainly initiated by tyrosine-specific kinases, which are also targets for a 
variety of virus types though this is not the case for PRRSV. However, inhibition of these 
kinases is likely a primary mechanism for reducing viral infectivity by ISF (Akiyama et al., 
1987). In addition to tyrosine kinase mediation, genistein administered at low concentrations 
(0.5–5 µM) may stimulate natural killer cell activity in vitro, which could increase the rate of 
pathogen clearance (Zhang et al., 1999). Within our study, minimal effects on IFN-γ 
concentrations were observed, suggesting that ISF at the concentrations provided in study only 
mildly influenced cellular pathways involved in IFN-γ production. 
Under the influence of inflammatory cytokines, erythrocyte and leukocyte production and 
systemic concentrations are also affected by disease status. By 14 DPI, PRRSV-infection 
decreased RBC counts and elicited reductions in associated parameters (e.g., HGB, HCT, MCV, 
and MCH). There is evidence that PRRSV-infection and virulence factors associated with 
specific strains contribute to the onset of anemia with varying severity (Halbur et al., 2002). 
Although previous research suggests that diets containing higher concentrations of SBM had 
improved hematocrit values and tendency for greater hemoglobin concentrations, both of which 
are used as clinical indicators of anemia severity, our findings do not suggest that soy source or 
ISF supplementation plays a factor in those pathways (Rochell et al., 2015). Regarding 
differential WBC counts, PRRSV-infection caused leukopenia detectable starting at 6 DPI, 
which is consistent with previous PRRSV studies (Halbur et al., 2002; Toepfer-Berg et al., 2004; 
Liu et al., 2013). For our study, ISF supplementation within soy source decreased relative band 
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neutrophil (i.e., immature neutrophil) populations during the acute phase of infection. This could 
suggest that ISF reduces the stimulation of aggressive pro-inflammatory pathways in the early 
immune response to PRRSV, which may confer benefits to the overall health and recovery of 
the pig.  
Regarding other measures of inflammatory status, immunophenotyping results by flow 
cytometry indicated that PRRSV in the presence of a Mh co-infection resulted in shifts of 
peripheral effector T-cell populations. Effector T-cells have specific and complementary effector 
functions that aid in the clearance of pathogens, but alterations of proportions of these cells may 
indicate disruptions in immune system function. In the human medical field, the ratio of effector 
helper T-cell and cytotoxic T-cell populations has been utilized as a measure of immune system 
status and presence of immunosuppression. Although not well characterized among healthy 
individuals, the ratio of helper T-cells to cytotoxic T-cells (CD4:CD8 or helper/suppressor to 
cytotoxic) typically ranges between 1.5 and 2.0 with a higher ratio value indicating better 
immune system status. An inverse of this ratio can result by targeted cell death of helper T-cells, 
population expansion of cytotoxic T-cells, or a combination thereof (Mcbride and Striker, 2017). 
In humans, this ratio tends to decrease as they age, a phenomenon referred to as 
“immunosenesence,” and humans of older age groups with inverted CD4:CD8 ratios had higher 
mortality rates than those with normal ratios (Wikby et al., 2005).  
For the pigs in this study, PRRSV-infection appeared to inverse the CD4:CD8 ratio by 
increasing the proportion of cytotoxic T-cells in the periphery. For PRRSV-infected pigs fed the 
Control diet, infection resulted in a reduction of the CD4:CD8 ratio by half (2.15 vs. 1.06 for 
PRRSV-infected vs. non-infected animals receiving the Control diet, respectively). Within our 
PRRSV-infected pigs and independent of soy source, consumption of ISF increased the 
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CD4:CD8 T-cell ratio from 0.99 to 1.35 (Figure 3.3). We also observed an increased proportion 
of peripheral helper T-cells, which partially restored the CD4:CD8 ratio to be closer to that 
observed in non-infected control animals. Although there is a lack of information on whether this 
relationship between helper and cytotoxic T-cells is also observed in swine, it could suggest that 
increased efforts to better understand implications of altered ratios of these effector cell 
populations on susceptibility to disease in growing pigs may be beneficial. 
Implications 
When isolating the impact of ISF on disease-challenged pigs, they appear to be non-
beneficial regarding growth performance. However, adaptive immune responses appear to be 
altered beneficially when disease-challenged growing pigs consume ISF, which may elicit 
benefits during the recovery period in terms of compensatory growth. For these reasons, studying 














Tables and Figures 
 
Table 3.1. Experimental treatments1 
Treatment Dietary treatment Infection status2 
Control Soy protein concentrate Uninfected 
Control Soy protein concentrate PRRSV-infected 
Control + ISF Soy protein concentrate + ISF PRRSV-infected 
ETSBM3 ETSBM PRRSV-infected 
ETSBM3 + ISF ETSBM + ISF PRRSV-infected 
1Abbreviations: ISF, soy isoflavones; PRRSV, porcine reproductive and respiratory syndrome virus, Mh, Mycoplasma hyopneumoniae. 
2All pigs were naturally co-infected with Mh prior to the start of the study at the source farm. 
3Enzyme-treated soybean meal (ETSBM) manufactured to contain a gentle soya-yeast (10% yeast components) supplement for piglet feed with a 





























Table 3.2. Analyzed isoflavone, saponin, and amino acid concentrations of experimental ingredients (as-fed 
basis)1 
 Ingredient 
Item  SPC2 ETSBM3 ISF4 
Isoflavones, mg/kg    
 Total genistein 0.00 908 177,317 
 Total daidzein 0.00 1,314 201,902 
 Total glycitein 0.00 196 22,983 
 Total isoflavones 0.00 2,417 402,203 
Total saponins, mg/kg 1,313 3,656 - 
Total AA4    
Indispensable AA4, g/kg    
Arginine 4.89 3.91 0.12 
Histidine 1.71 1.36 0.04 
Isoleucine 3.29 2.54 0.06 
Leucine 5.28 4.14 0.07 
Lysine 4.30 3.29 0.06 
Methionine 0.92 0.73 0.02 
Phenylalanine 3.44 2.74 0.20 
Threonine 2.55 2.09 0.05 
Tryptophan 0.96 0.75 0.33 
Valine 3.41 2.65 0.06 
Dispensable AA4, g/kg    
Alanine 2.84 2.34 0.07 
Aspartic acid 7.43 5.97 0.20 
Cysteine 0.89 0.72 0.07 
Glutamic acid 12.41 9.80 0.34 
Glycine 2.83 2.28 0.08 
Proline 3.50 2.76 0.12 
Serine 2.92 2.46 0.04 
Tyrosine 2.32 1.95 0.17 
1Abbreviations: SPC, soy protein concentrate; ETSBM, enzyme-treated soybean meal; ISF, isoflavones; AA, amino acids. 
2SPC manufactured by traditional process to remove soluble sugars and reduce anti-nutritional factors; ADM Foods & Wellness, Decatur, IL. 
3 ETSBM manufactured to contain a gentle soya-yeast (10% yeast components) supplement for piglet feed with a low content of anti-nutritional factors 
(trypsin inhibitors, antigens, and flatulent oligosaccharides); Hamlet Protein, Findlay, OH. 
4 ISF provided by Novasoy 400, which has a guaranteed 40% minimum total isoflavone concentration (referred to as suppl. ISF in subsequent tables); ADM, 
Decatur, IL. Diets were formulated to contain ISF concentrations similar to those observed in typical weaning commercial diets containing SBM. 
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Table 3.3. Ingredient and calculated composition of experimental diets (as-fed basis)1 
Soy source SPC  ETSBM 
Item Suppl. ISF No Yes  No Yes 
Ingredient, %      
 Corn 62.52 62.11  59.25 58.91 
 HP300 0.00 0.00  20.80 20.80 
 Arcon AF 17.50 17.50  0.00 0.00 
 Dried whey 12.00 12.00  12.00 12.00 
 Poultry by-product meal2 4.00 4.00  4.00 4.00 
 Choice white grease 1.50 1.50  1.50 1.50 
 Ground limestone 0.60 0.60  0.60 0.60 
 Monocalcium phosphate 0.20 0.20  0.20 0.20 
 Sodium chloride 0.40 0.40  0.40 0.40 
 Vitamin and mineral premix3 0.30 0.30  0.30 0.30 
 Choline chloride 0.07 0.07  0.07 0.07 
 L-Lys HCl 0.43 0.43  0.49 0.49 
 DL-Met 0.18 0.18  0.16 0.16 
 L-Trp 0.07 0.07  0.05 0.05 
 L-Thr 0.20 0.20  0.18 0.18 
 L-Val 0.03 0.03  0.00 0.00 
 Novasoy400 0.00 0.41  0.00 0.34 
      
Calculated composition      
 ME, kcal/kg4 3,472 3,458  3,465 3,453 
 CP, %4 21.29 21.26  21.28 21.25 
 SID AA, %4      
 Lysine 1.34 1.34  1.34 1.34 
 Methionine + Cysteine 0.73 0.73  0.74 0.74 
 Tryptophan 0.26 0.26  0.26 0.26 
 Threonine 0.86 0.86  0.86 0.86 
 Valine 0.88 0.88  0.88 0.88 
 Isoflavones, mg/kg      
 Total genistein 2 690  135 702 
 Total daidzein 1 723  105 701 
 Total glycitein 0 87  25 97 
 Total isoflavones 3 1,500  265 1,500 
 Total saponins, mg/kg 664 1,013  840 1,128 
1All pigs received allotted treatment diet upon starting -7 DPI. Abbreviations: DPI, day post-inoculation; ISF, isoflavones; SID, standardized ileal 
digestible, AA, amino acids. 
2Low ash pet-food-grade poultry by-product meal, American Proteins, Inc., Hanceville, AL 
3Vitamin-mineral premix (JBS United, Sheradin, IN) included the following per kilogram of complete diet: Vitamin A (retinyl acetate), 11,128 IU; 
Vitamin D3 (cholecalciferol), 2,204 IU; Vitamin E (dl-α tocopheryl acetate), 66 IU; Vitamin K (menadione nicotinamide bisulfite), 1.42 mg; 
Thiamine (thiamine mononitrate), 0.24 mg; Riboflavin, 6.58 mg; Pyridoxine (pyridoxine hydrochloride), 0.24 mg; Vitamin B12, 0.03 mg; d-
Pantothenic acid (d-calcium pantothenate), 23.5 mg; Niacin (nicotinamide and nicotinic acid), 44 mg; Folic acid, 1.58 mg; Biotin, 0.44 mg; Cu 
(copper sulfate), 10 mg; Fe (iron sulfate), 125 mg; I (potassium iodate), 1.26 mg; Mn (manganese sulfate), 60 mg; Se (sodium selenite), 0.3 mg; and 
Zn (zinc oxide), 100 mg. 
4Metablizable energy and standardized ileal digestible (SID) amino acid values were calculated using NRC (2012). Analyzed crude protein 








Table 3.4. Analyzed composition of experimental diets (as-fed basis)1 
Soy source SPC  ETSBM 
Item Suppl. ISF No Yes  No Yes 
Dry matter, % 90.66 90.19  90.26 90.03 
Organic matter, % 94.60 94.42  94.30 94.19 
Crude protein2, % 21.29 21.26  21.28 21.25 
Lactose, % 8.75 8.75  8.75 8.75 
Total dietary fiber, % 11.89 11.83  11.83 11.79 
Isoflavones, mg/kg      
 Total genistein 52.0 757  291 947 
 Total daidzein 0.00 625  358 969 
 Total glycitein 34.0 69.0  48.0 125 
 Total isoflavones 87.0 1,451  697 2,041 
Total saponins, mg/kg 1,336 1,316  1,382 1,252 
Total AA      
Indispensable AA, g/kg       
Arginine 12.8 12.6  12.0 12.4 
Histidine 5.00 5.00  4.80 4.90 
Isoleucine 9.10 9.00  8.80 9.20 
Leucine 17.5 17.3  16.9 17.2 
Lysine 14.8 14.4  14.2 14.8 
Methionine 4.80 4.70  4.20 4.50 
Phenylalanine 9.70 9.50  9.40 9.70 
Threonine 9.90 9.60  9.10 9.70 
Tryptophan 3.10 3.00  2.80 3.00 
Valine 10.4 10.4  9.80 10.2 
Dispensable AA, g/kg      
Alanine 10.6 10.4  10.0 10.4 
Aspartic acid 19.7 19.5  18.7 19.5 
Cysteine 3.00 3.00  2.90 2.90 
Glutamic acid 35.4 35.3  34.3 34.9 
Glycine 9.80 9.40  8.90 9.50 
Proline 12.2 11.9  11.4 11.9 
Serine 8.70 8.70  8.30 8.50 
Tyrosine 6.50 6.40  6.10 6.50 
1All pigs received allotted treatment diet upon starting -7 DPI. Abbreviations: DPI, day post-inoculation; ISF, isoflavones, AA, amino acids. 





Table 3.5. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) infection on growth performance of weanling pigs1  
 
     P-value 
 Uninfected  PRRSV-infected    Main effects3 Interaction 
Item Control2  Control2 
Control 
+ ISF2 ETSBM2 
ETSBM 






Soy Source × 
ISF 
BW, kg             
 initial 5.72  5.74 5.57 5.73 5.70  0.43 0.872 0.887 0.814 0.992 
 final 12.12  8.65* 7.89 9.28 8.91  0.45 < 0.0001 0.057 0.196 0.151 
-7 to 0 DPI4             
 ADG, g/d 161  127 160 155 173  20.9 0.287 0.321 0.214 0.727 
 ADFI, g/d5 677  632* 654 604 649  21.6 0.042 0.453 0.137 0.621 
 G:F, g/kg5 264  214 240 259 275  35.1 0.300 0.272 0.559 0.878 
0 to 6 DPI             
 ADG, g/d 275  103* 83.2 126 107  35.2 0.0001 0.362 0.441 0.965 
 ADFI, g/d5 1,236  1,381 1,188 1,128 1,403  257.0 0.295 0.885 0.756 0.084 
 G:F, g/kg5 248  75.5* 99.2 120 93.6  37.1 < 0.0001 0.551 0.977 0.443 
6 to 14 DPI             
 ADG, g/d 460  190* 156 270 219  46.7 0.0002 0.099 0.317 0.838 
 ADFI, g/d5 728  489 423 549 450  149.8 0.080 0.633 0.442 0.845 
 G:F, g/kg5 526  437 268 484 173  99.5 0.384 0.803 0.020 0.463 
0 to 14 DPI4             
 ADG, g/d 380  137* 103 219 165  39.5 < 0.0001 0.015 0.125 0.712 
 ADFI, g/d5 775  648 558 629 601  186.6 0.229 0.888 0.485 0.708 
 G:F, g/kg5 566  250* 171 378 361  59.8 0.0001 0.009 0.413 0.598 
*Difference (P < 0.05) between uninfected and infected groups fed the control diet.  
1Values represent least square means of 6 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = days post-inoculation; ISF = isoflavones. 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 
3Main effect of day post-inoculation (DPI); no 2- or 3-way interactive effects involving DPI were significant, so they were not included in the statistical model. 
4Feed intake data and G:F values for -7-0 DPI from the first cohort of pigs (n=28) were omitted due to a mechanical error with the feeders that led to incorrect feed intake measurements.  












Table 3.6. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) infection on daily rectal temperatures (ºC) of 
weanling pigs1 
 
     P-value 
 Uninfected  PRRSV-infected    Main effects3 Interaction 










Soy Source × 
ISF 
0 39.36  39.86* 39.91 39.69 39.65  0.28 0.036 0.228 0.971 0.681 
3 39.48  40.07* 39.92 40.35 40.11  0.27 0.012 0.197 0.266 0.400 
6 39.65  40.12 40.42 40.47 40.18  0.27 0.051 0.748 0.965 0.399 
8 39.58  40.36* 40.69 40.50 40.62  0.27 0.001 0.848 0.205 0.562 
12 40.01  40.24 40.68 40.50 40.49  0.27 0.340 0.855 0.247 0.417 
14 39.88  40.29 40.21 40.29 40.40  0.27 0.091 0.630 0.949 0.922 
*Difference (P < 0.05) between uninfected and infected groups fed the control diet.  
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = days post-inoculation; ISF = isoflavones. 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 
3Main effect of day post-inoculation (DPI); no 2- or 3-way interactive effects involving DPI were significant, so they were not included in the statistical model.  
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Table 3.7. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) infection on serum viral load and presence of anti-
PRRSV antibodies in weanling pigs1  
 
     P-value 
 Uninfected  PRRSV-infected    Main effects3 Interaction 












Ct Value4             
 0 DPI ND  ND ND ND ND  1.52 0.812 0.968 0.968 0.999 
 3 DPI ND  15.57*b 16.44b 18.81b 12.10a  1.41 < 0.001 0.592 0.005 0.0001 
 6 DPI ND  14.12* 15.39 15.37 12.66  1.41 < 0.001 0.522 0.430 0.166 
 14 DPI ND  18.75* 19.09 19.51 18.69  1.45 < 0.001 0.860 0.795 0.948 
             
ELISA S/P Ratio5             
 6 DPI --  0.087 0.070 0.040 0.045  0.10 -- 0.661 0.935 0.974 
 14 DPI --  1.565
 1.736 1.475 1.440  0.171 -- 0.027 0.412 0.080 
*Difference (P < 0.05) between uninfected and infected groups fed the control diet. abMeans without common superscript letter do differ (P < 0.05).  
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = days post-inoculation; ISF = isoflavones; ELISA = enzyme-linked immunosorbent assay. 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 
3Main effect of day post-inoculation (DPI); no 2- or 3-way interactive effects involving DPI were significant, so they were not included in the statistical model. 
4Cycle threshold (Ct) values represent the mean number of PCR cycles required to detect the presence of PRRSV mRNA. A higher Ct value indicates less PRRSV RNA in the serum. No PRRSV DNA was detected in the serum of 
any uninfected pigs. 









Table 3.8. Effects of dietary soy isoflavone levels and porcine reproductive and respiratory virus (PRRSV) infection on red blood cell measures in weanling pigs1 
 
     P-value 
 Uninfected  PRRSV-infected    Main effects3 Interaction 












RBC, × 106 cells/µL             
0 DPI 6.53  6.66 6.84 6.49 6.81  0.180 0.624 0.456 0.099 0.305 
3 DPI 6.20  6.00 6.14 5.90 6.29  0.180 0.419 0.862 0.066 0.234 
6 DPI 5.97  6.05 6.17 5.87 6.00  0.175 0.778 0.220 0.375 0.502 
14 DPI 5.85  5.31* 5.58 5.25 5.43  0.187 0.050 0.519 0.129 0.436 
HGB, g/dL             
0 DPI 12.3  11.9 12.5 12.2 12.5  0.341 0.552 0.750 0.190 0.588 
3 DPI 11.5  10.6 11.1 10.8 11.4  0.341 0.119 0.472 0.070 0.268 
6 DPI 10.9  10.4 10.9 10.5 10.8  0.326 0.386 0.888 0.205 0.633 
14 DPI 11.0  9.0* 9.5 9.1 9.5  0.358 0.002 0.874 0.156 0.540 
HCT, %             
0 DPI 35.1  37.4 39.1 37.9 39.1  0.976 0.294 0.882 0.172 0.591 
3 DPI 35.7  33.4 34.9 33.8 35.6  0.976 0.272 0.537 0.081 0.314 
6 DPI 34.0  32.9 34.4 33.1 33.7  0.930 0.635 0.722 0.301 0.708 
14 DPI 34.7  28.5* 30.3 28.8 30.0  1.03 0.010 0.893 0.116 0.442 
MCV, fl             
0 DPI 58.6  56.2 57.2 58.5 57.5  1.91 0.281 0.257 0.937 0.579 
3 DPI 57.9  55.7 56.9 57.3 56.7  1.75 0.300 0.500 0.801 0.742 
6 DPI 57.4  54.6 55.8 56.4 56.1  1.72 0.209 0.346 0.712 0.706 
14 DPI 59.6  53.7* 54.2 55.0 55.3  1.79 0.013 0.292 0.700 0.719 
*Difference (P < 0.05) between uninfected and infected groups fed the control diet. abMeans without common superscript letter do differ (P < 0.05).  
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = days post-inoculation; ISF = isoflavones; RBC = red blood cells; HGB = hemoglobin; HCT = packed 
cell volume; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 





Table 3.8. Continued1 
 
     P-value 
 Uninfected  PRRSV-infected    Main effects3 Interaction 












MCH, pg             
0 DPI 18.6  17.9 18.3 18.8 18.4  0.662 0.331 0.224 0.961 0.498 
3 DPI 18.4  17.7 18.1 18.3 18.1  0.650 0.374 0.451 0.698 0.717 
6 DPI 18.2  17.3 17.7 17.9 18.0  0.650 0.219 0.283 0.510 0.632 
14 DPI 18.8  17.0* 17.1 17.4 17.5  0.675 0.037 0.312 0.775 0.762 
MCHC, g/dL             
0 DPI 31.8  31.6 32.0 32.0 32.0  0.734 0.721 0.842 0.871 0.988 
3 DPI 31.7  31.6b 31.9b 31.9b 29.3a  0.734 0.943 0.092 0.096 0.024 
6 DPI 31.7  31.5 31.8 31.6 32.0  0.700 0.561 0.836 0.655 0.968 
14 DPI 31.5  31.6 31.6 31.6 31.7  0.774 0.662 0.920 0.991 0.999 
*Difference (P < 0.05) between uninfected and infected groups fed the control diet. abMeans without common superscript letter do differ (P < 0.05).  
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = days post-inoculation; ISF = isoflavones; RBC = red blood cells; HGB = hemoglobin; HCT = 
packed cell volume; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 










Table 3.9. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) infection on differential leukocyte counts and relative 
population proportions in weanling pigs1 
 
     P-value 
 Uninfected  PRRSV-infected    Main effects3 Interaction 










Soy Source × 
ISF 
WBC, × 103 cells/µL             
0 DPI 15.2  13.3 13.4 14.8 17.2  3.39 0.359 0.447 0.719 0.826 
3 DPI 16.1  12.2 9.83 14.2 13.7  3.39 0.061 0.360 0.670 0.789 
6 DPI 16.4  11.8*a 12.7a 24.4b 14.5a  3.24 0.031 0.026 0.153 0.018 
14 DPI 16.6  23.1* 24.5 23.2 23.5  3.57 0.006 0.929 0.787 0.990 
NEU, % of WBC             
0 DPI 49.1  45.3 38.9 47.5 40.5  4.64 0.522 0.671 0.137 0.492 
3 DPI 46.3  56.5 57.1 57.8 55.1  4.64 0.076 0.938 0.811 0.977 
6 DPI 38.7  51.5* 54.2 59.1 47.4  4.42 0.030 0.345 0.301 0.281 
14 DPI 35.7  49.9* 43.2 46.9 39.4  4.89 0.027 0.466 0.134 0.340 
BAND, % of WBC             
0 DPI 0.00  0.135 0.00 0.550 0.333  2.06 0.858 0.810 0.924 0.995 
3 DPI 1.10  6.00* 1.10 6.63 3.18  2.06 0.038 0.412 0.012 0.073 
6 DPI 0.304  6.11* 2.45 5.25 5.27  1.99 0.016 0.542 0.267 0.422 
14 DPI 0.087  1.27 4.44 1.77 3.63  2.14 0.648 0.922 0.157 0.546 
LYM, % of WBC             
0 DPI 47.1  45.7 51.3 45.3 51.7  4.44 0.780 0.973 0.149 0.546 
3 DPI 47.1  31.1* 35.8 31.0 37.5  4.43 0.002 0.851 0.179 0.588 
6 DPI 52.9  32.2* 32.8 27.7 38.1  4.24 0.0001 0.905 0.176 0.348 
14 DPI 51.7  39.5* 41.9 45.0 47.7  4.67 0.032 0.219 0.592 0.588 
*Difference (P < 0.05) between uninfected and infected groups fed the control diet. abMeans without common superscript letter do differ (P < 0.05).  
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = days post-inoculation; ISF = isoflavones; WBC = white blood cells; NEU = neutrophils; BAND = 
immature neutrophils aka. band cells; LYM = lymphocytes; MONO = monocytes; EOSIN = eosinophils; BASO = basophils.  
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 




Table 3.9. Continued1 
 
     P-value 
 Uninfected  PRRSV-infected    Main effects3 Interaction 












MONO, % of WBC             
0 DPI 2.77  7.09* 7.19 5.56 6.00  1.22 0.016 0.229 0.842 0.379 
3 DPI 4.47  3.25 2.10 2.98 2.62  1.22 0.472 0.911 0.508 0.905 
6 DPI 6.06  6.50 7.53 5.42 5.62  1.17 0.804 0.181 0.594 0.530 
14 DPI 4.73  4.81 5.86 3.70 5.07  1.28 0.963 0.454 0.307 0.679 
EOSIN, % of WBC             
0 DPI 1.19  1.63 2.11 1.14 1.42  0.979 0.644 0.446 0.591 0.830 
3 DPI 0.993  2.25ab 3.80b 1.04a 1.31a  0.979 0.171 0.013 0.218 0.047 
6 DPI 1.79  3.06 2.49 2.25 3.40  0.951 0.176 0.934 0.677 0.669 
14 DPI 2.95  4.07 4.15 2.19 3.61  1.01 0.272 0.119 0.358 0.280 
BASO, % of WBC             
0 DPI 0.200  0.100 0.207 0.00 0.083  0.240 0.826 0.631 0.682 0.942 
3 DPI 0.100  0.917 0.300 0.364 0.182  0.240 0.064 0.144 0.083 0.095 
6 DPI 0.200  0.636 0.455 0.250 0.182  0.636 0.327 0.147 0.581 0.482 
14 DPI 0.500  0.400 0.261 0.294 0.558  0.252 0.836 0.695 0.798 0.814 
*Difference (P < 0.05) between uninfected and infected groups fed the control diet. abMeans without common superscript letter do differ (P < 0.05).  
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = days post-inoculation; ISF = isoflavones; WBC = white blood cells; NEU = neutrophils; BAND = 
immature neutrophils aka. band cells; LYM = lymphocytes; MONO = monocytes; EOSIN = eosinophils; BASO = basophils. 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 







Table 3.10. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) infection on serum cytokine concentrations (pg/mL) 
in weanling pigs1 
 
     P-value 
 Uninfected  PRRSV-infected    Main effects3 Interaction 












TNF-α             
0 DPI 128  33.2 38.7 39.6 50.0  181 0.088 0.953 0.958 0.999 
3 DPI 72.7  89.7 120 85.1 104  92.9 0.665 0.897 0.786 0.992 
6 DPI 58.7  75.1 140 59.9 73.4  98.8 0.676 0.634 0.666 0.929 
14 DPI 52.2  152* 113 187 353  92.9 0.017 0.094 0.429 0.160 
IFN-α             
0 DPI 18.6  101 202 16.4 134  164 0.722 0.645 0.509 0.882 
3 DPI 19.3  1,132*a 1,483ab 1,643bc 2,156c  232 < 0.001 0.005 0.039 0.005 
6 DPI 142  501 428 529 396  147 0.118 0.990 0.465 0.900 
14 DPI 5.31  44.6 17.1 21.6 50.2  190 0.930 0.976 0.998 0.999 
IFN-γ             
0 DPI BDL  BDL BDL BDL BDL  -- -- -- -- -- 
3 DPI BDL  39.4a 3.39b 4.96b 3.10b  10.1 -- 0.069 0.048 0.026 
6 DPI BDL  12.2 8.91 12.2 10.0  9.31 -- 0.950 0.746 0.989 
14 DPI 2.88  2.58 2.00 2.04 9.62  14.2 0.996 0.772 0.775 0.963 
IL-10             
0 DPI BDL  BDL 12.8 BDL BDL  39.6 -- -- -- -- 
3 DPI BDL  26.2 23.7 33.8 24.9  19.8 -- 0.755 0.810 0.977 
6 DPI BDL  27.1 42.1 33.5 31.3  22.9 -- 0.914 0.759 0.959 
14 DPI BDL  BDL 33.6 BDL 154  28.0 -- -- -- -- 
*Difference (P < 0.05) between uninfected and infected groups fed the control diet. abMeans without common superscript letter do differ (P < 0.05).  
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = days post-inoculation; ISF = isoflavones; TNF-α = tumor necrosis factor-α; IFN-α = interferon-α; 
IFN-γ = interferon-γ; IL-10 = interleukin 10; BDL = below detectable limits. 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 




Table 3.11. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) infection on peripheral blood T cell 
immunophenotypes of weanling pigs1 
 
    
  P-value 
 Uninfected  PRRSV-infected    Main effects3 Interaction 
Item Control2  Control2 
Control 
+ ISF2 ETSBM2 
ETSBM 








T-Cell, %  
(CD3+)4 
55.30  53.21 53.01 53.89 59.02  6.66 0.610 0.393 0.539 0.434 
Helper T-Cell, %  
(CD3+CD4+)5 
22.03  20.18 23.09 18.03 26.41  2.13 0.463 0.783 0.011 0.202 
Cytotoxic T-Cell, %  
(CD3+CD8+)5 
12.44  22.78* 22.43 22.71 19.20  3.21 0.003 0.527 0.459 0.506 
Dual-Positive T-Cell, % 
(CD3+CD4+CD8+)5 
4.30  6.66* 6.32 6.15 5.13  1.19 0.022 0.287 0.406 0.603 
Dual-Positive T-Cell 
Expressing IFN-γ, % 
(CD3+CD4+CD8+IFNγ+)5 
90.10  79.72* 79.25 77.94 83.41  4.06 0.001 0.594 0.292 0.253 
             
Dual-Positive T-Cell 
Expressing IFN-γ MFI 
(CD3+CD4+CD8+IFNγ+)6 
764.1  501.0* 515.4 490.6 577.3  88.5 0.002 0.511 0.212 0.397 
             
CD4:CD8 Ratio 2.15  1.06
* 1.17 0.918 1.53  0.176 0.001 0.535 0.049 0.159 
*Difference (P < 0.05) between uninfected and infected groups fed the control diet.  
1Values represent least square means of 10 to 12 pigs with collection of blood occurring at 12 DPI. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = days post-inoculation; ISF = isoflavones. 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 
3Main effect of day post-inoculation (DPI); no 2- or 3-way interactive effects involving DPI were significant, so they were not included in the statistical model. 
4Percent of total lymphocytes that are positive for cell-surface marker CD3. 
5Percent of CD3-positive lymphocytes that are also positive for cell-surface markers CD4, CD8, CD4/CD8, or CD4/CD8 and intercellular IFN-γ 
6Median fluorescence intensity (MFI) is a measure of the fluorescence intensity in a fluorescence channel being measured. It provides an alternative measurement to percent positive for comparison of cell populations between 




































Figure 3.1. Main effect of isoflavone supplementation on the concentration of PRRSV antigen in serum, main 
effects of both soy source and isoflavone supplementation on serum interferon-α cytokine concentrations, and main 
effects of isoflavone supplementation on serum interferon-γ cytokine concentrations. PRRSV = porcine reproductive 
and respiratory syndrome virus; ISF = isoflavones; SPC = soy protein concentrate; ETSBM = enzyme-treated 
soybean meal; DPI = days post-inoculation; IFN-α = interferon-α; IFN-γ = interferon-γ. Values represent least 
square means of 20 to 24 pigs, and error bars indicate standard error of the mean. Cycle threshold (Ct) values 
represent the mean number of PCR cycles required to detect the presence of PRRSV mRNA. A higher Ct value 
indicates less PRRSV DNA in the serum. An asterisk (*) denotes a difference (P < 0.05) due to soy protein source 

























Figure 3.2. Main effect of isoflavone supplementation on the relative concentrations of band neutrophils in whole blood and main effect of soy source on total 
while blood cell counts in peripheral whole blood. ISF = isoflavones; SPC = soy protein concentrate; ETSBM = enzyme-treated soybean meal; DPI = days post-
inoculation; WBC = white blood cells. Values represent least square means of 20 to 24 pigs, and error bars indicate standard error of the mean. An asterisk (*) 





































Figure 3.3. Main effects of isoflavone supplementation on the proportion of Helper T-cells (CD3+/CD4+) and Helper:Cytotoxic T-cell ratios (CD4:CD8) in 
peripheral whole blood. ISF = isoflavones. Values represent least square means of 20 to 24 pigs, and error bars indicate standard error of the mean. An asterisk 
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CHAPTER 4: DIETARY SOY ISOFLAVONES REDUCE PATHOGEN-RELATED 
MORTALITY IN GROWING PIGS UNDER PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRAL CHALLENGE6 
Abstract 
 Porcine reproductive and respiratory syndrome virus (PRRSV) is an economically-important 
disease and ingestion of soy isoflavones (ISF) may benefit PRRSV-infected pigs due to 
demonstrated anti-inflammatory and anti-viral properties. The objective of this experiment was 
to recreate immunological effects previously observed in young pigs infected with PRRSV 
receiving ISF and determine how those effects influence growth performance during the entire 
growth period from weaning to market. In total, 96 weaned barrows were group-housed in a 
BSL-2 containment facility and allotted to 1 of 3 experimental treatments that were maintained 
throughout the study: non-infected pigs received an ISF-devoid control diet (NEG, n=24), and 
infected pigs received either the control diet (POS, n=36) or that supplemented with total ISF in 
excess of 1,600 mg/kg (ISF, n=36). Following a 7-day adaptation, weanling pigs were inoculated 
intranasally with either a sham-control (PBS) or live PRRSV (1×105 TCID50/mL, strain 
NADC20). After inoculation, individual blood samples (n=8-12/treatment) were routinely 
collected to monitor viral clearance and hematological parameters, including serum neutralizing 
anti-PRRSV antibody production. Pen-based oral fluids were used to monitor PRRSV clearance 
at later growth stages. A 1- or 2-way ANOVA was performed to compare experimental 
treatments depending on whether the outcome was repeatedly measured. In general, PRRSV 
infection decreased performance during early growth phases, resulting in 5.4% lower final BW 
 
6
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isoflavones reduce pathogen-related mortality in growing pigs under porcine reproductive and respiratory syndrome 




for POS vs. NEG pigs (P < 0.05). Dietary ISF elicited inconsistent effects on growth 
performance, increased (P < 0.05) neutrophil cell counts and the relative proportion of memory 
T-cells, and decreased (P < 0.05) the time to full PRRSV clearance from oral fluids. Dietary ISF 
also elicited a more robust anti-PRRSV neutralizing antibody production as compared with POS 
pigs. Additionally, and most notably, POS pigs experienced ~50% greater infection-related 
mortality rate vs. ISF pigs (P < 0.05), which may have significant economic implications for 
producers. Overall, dietary ISF ingestion supported immune responses and reduced mortality in 
PRRSV-infected pigs when fed to growing pigs though the biological mechanism of these effects 
remains unclear. 
Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) continues to be one of the 
leading pathogens causing high economic impact in modern swine production (Holtkamp et al., 
2013). Due to its prevalence and lack of highly effective vaccine options (Loving et al., 2015), 
nutritional intervention or management strategies are of high interest for PRRSV mitigation due 
to relatively low cost and ease of implementation. It has been demonstrated that increasing the 
level of soybean meal in diets fed to pigs under immune stress reduces adverse effects of illness 
and may improve growth performance (Boyd et al., 2010; Rochell et al., 2015). However, those 
studies were unable to determine if improved growth performance was due to differences in 
dietary bioavailable amino acid content or the presence of other dietary components. Isoflavones 
(ISF) are flavonoid compounds that are enriched in soybeans and possess anti-inflammatory and 
anti-oxidative properties (Smith and Dilger, 2018). More specifically, under PRRSV-challenge, 
dietary ISF have been shown to beneficially alter adaptive immune responses in weaned pigs by 
improving cytotoxic-to-helper T-cell ratios, which may elicit performance benefits during the 
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recovery period (Smith et al., 2019). The objective of this experiment was to recreate 
immunological effects previously observed in young pigs infected with PRRSV receiving ISF 
and determine how those immunomodulatory effects influence growth performance during the 
entire growth period from weaning to market. Our hypothesis was that pigs infected with 
PRRSV receiving ISF would recover from PRRSV-infection faster and thus exhibit better 
growth performance over the whole growth period. 
Materials and Methods 
The protocol for this experiment was approved by the Institutional Animal Care and Use 
Committee and the Institutional Biosafety Committee of the University of Illinois at Urbana-
Champaign. 
Animal Husbandry and Experimental Design 
Ninety-six weanling pigs (96 barrows; 6.77 ± 0.94 kg initial body weight, BW) were 
obtained from a PPRS-negative, non-PRRS vaccinated commercial herd (1050 Cambro genetics; 
Carthage Veterinary Service, Ltd.) and group-housed at the Innovative Swine Solutions 
Veterinary Research Facility (ISS-VRF), a Biosafety Level 2 production containment facility in 
Champaign, IL. Pigs remained at this facility and allowed to grow to market weight 
(approximately 27 weeks of age, 118-129 kg average BW) before being transported to the Meat 
Science Laboratory at the University of Illinois for slaughter. The ISS-VRF consisted of 4 
individual production rooms (30' x 14') with 4 pens (up to 6 pigs per pen) available to house pigs 
in each room. Each room was equipped with a high-efficiency particulate air filtration system, 
plastic slotted flooring appropriate for market-sized pigs, and each pen provided appropriate 
floor space for pigs taken to market weight. Lighting and ambient temperature was maintained as 
appropriate for life stage. 
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Upon entry to the facility, pigs were weighed and uniformly allotted to 1 of 3 
experimental treatments [n = 24 for non-PRRSV-infected controls (NEG), n = 36 each for 
PRRSV-infected controls (POS) and PRRSV-infected receiving soy isoflavones (ISF)] by 
completely randomized design based on initial body weight. All replicates of the NEG treatment 
(6 pigs per replicate, 4 replicates total) were housed in a single room to account for biosecurity 
while replicates for POS and ISF treatments (6 pigs per replicate, 6 replicates total) were equally 
represented in the remaining three rooms at ISS-VRF. Two levels of supplemental ISF (none vs. 
≥1,600 mg/kg Novasoy400; ADM, Decatur, IL) constituted the total of two dietary treatments 
(Table 4.1). The ISF provided to the ISF treatment are reflective of those typical for a 
commercially relevant corn-soybean meal diet fed to pigs with approximately 20% soybean meal 
inclusion. Both diets contained soy protein concentrate (SPC) as a protein source, which is 
practically devoid of soy isoflavones. Experimental diets were formulated to be isocaloric and, 
with the exceptions of corn and the isoflavone-enriched product, were identical in ingredient 
composition. Experimental diets were fed over 7 feeding phases including nursery phases 1 and 
2 (N1-N2) and finisher phases 1-5 (F1-F5). Isoflavone and saponin concentrations of ingredients 
and experimental diets were quantified via HPLC at the USDA-ARS National Center for 
Agricultural Utilization Research (Peoria, IL) according to procedures of Berhow et al. (2006). 
Crude protein was determined by measuring total nitrogen (TruMac N, Leco Corp., St. Joseph, 
MI) as standardized with EDTA and amino acid concentrations were determined at the 
University of Missouri Agricultural Experiment Station (Columbia, MO; Table 4.2) according to 
AOAC (2002) official methods [920.39 and 982.30 E(a, b, c), for crude protein and amino acid 
concentrations, respectively]. Gross energy of the experimental diets was determined using an 
adiabatic bomb calorimeter (Parr Instruments, Moline, IL), and DM (method 934.01, AOAC 
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International, 2002) and OM were performed by determining percent ash (method 942.05, 
AOAC International, 2002) and subtracting from 100. Diets were analyzed for total dietary fiber 
according to Prosky et al. (1994), but no separation of soluble and insoluble fractions was made. 
Diets were formulated on a standardized ileal digestible (SID) amino acid basis with identical 
concentrations across all diets (Tables 4.2 and 4.3). All diet formulations met or exceeded NRC 
(2012) nutrient recommendations for each life stage. It should be noted that after the delivery of 
finisher diet 3 (F3), we became aware that both diets contained less than the recommended 
amount of phosphorus for the first 5 feeding phases. This error impacted the Ca-to-P ratio, but 
this deficit was corrected in the finisher 4 (F4) and 5 (F5) diets. Analyzed nutrient composition 
for each diet are presented in Tables 4.4 and 4.5. 
Following a 1-week adaptation period to experimental diets [days post-inoculation (DPI) 
-7 to 0], blood was collected from 2 pigs per pen to establish 0 DPI baseline measurements and 
to ensure that a representative number of pigs were confirmed PRRSV-negative at experiment 
initiation. Immediately following blood collection, all pigs were administered via intranasal 
inoculation either 2 mL of a 2% fetal bovine serum + phosphate-buffered saline solution (sham-
control) or 1.0×105 50% tissue culture infective dose of PRRS virus (strain NADC20, courtesy 
of Dr. Federico Zuckermann, University of Illinois, Urbana, IL).  
Growth Performance  
Growth performance was recorded on a pen basis. Individual pig and pen feeder weights 
were captured weekly from -7 to 48 DPI, every other week from 48 to 118 DPI, and every third 
week from 118 to 161 DPI to accommodate increased heat stress associated with late summer 
weather during the end of the experiment for calculation of average daily gain (ADG), average 
daily feed intake (ADFI), and feed efficiency (gain-to-feed, G:F). Growth performance data are 
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reported in reference to our inoculation schedule (e.g., -7 to 0 DPI). Mortality was also recorded 
throughout the experiment and growth performance measurements were adjusted to reflect 
mortalities within individual replicate pens. 
Rectal Temperatures 
Individual pig served as the experimental unit for rectal temperatures. Rectal 
temperatures were recorded using a commercial-grade livestock probe thermometer (GLA M700 
Thermometer, GLA Agricultural Electronics, San Luis Obispo, CA) and collected from up to 3 
pigs per pen (48 pigs total, same pigs collected when possible) at 0, 3, 6, 10, and 13 DPI. If blood 
collection was occurring on the same day as rectal temperature collection, the rectal temperature 
was captured prior to bleeding. 
Whole Blood and Sera Collection and Measurements  
Individual pig served as the experimental unit for all whole blood and serum outcomes. 
Blood samples (up to 8 mL total) were collected from the jugular vein of up to 2 pigs per pen 
into Vacutainer blood collection tubes (BD, Franklin Lakes, NJ) at 0, 3, 6, 13, 20, 27, and 34 DPI 
using a 21 gauge needle. Whole blood samples collected on 0, 3, 6, and 13 DPI were collected 
into tubes containing EDTA as an anti-coagulant, placed on ice, and submitted to the University 
of Illinois College of Veterinary Medicine Clinical Pathology Lab for complete blood cell counts 
and differential analyses using a multi-parameter, automated hematology analyzer (CELL-DYN 
3700, Abbott Laboratories, Abbott Park, IL). Additional whole blood was collected on 13 and 20 
DPI for a T-cell immunophenotyping protocol performed in-house via flow cytometry (protocol 
described below). Serum samples collected on 0, 3, 6, and 13 DPI were collected into serum 
tubes, allowed to clot at room temperature, and centrifuged at 1,300 × g for 15 min at 20ºC 
before storage in 0.5 mL aliquots at -80ºC pending subsequent analyses. One aliquot per pig was 
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submitted to the Veterinary Diagnostic Laboratory for detection of PRRS viral antigen via 
quantitative real-time polymerase chain reaction (qRT-PCR) using Z-PRRSV Multiplex 
reagents (Tetracore, Rockville, MD) as described in Smith et al. 2019. Additional serum aliquots 
were separated and saved for the following assays: 1) submission to the Clinical Pathology Lab 
for a general health serum chemistry panel measured at 0, 3, 6, and 13 DPI and 2) submission to 
the University of South Dakota Animal Disease Research and Diagnostic Laboratory for 
detection of PRRSV-neutralizing antibodies measured at 20, 27, and 34 DPI.  
T-Cell Immunophenotyping 
Whole blood collected on 13 and 20 DPI was used for isolation of peripheral blood 
mononuclear cells (PBMC) for a T-cell immunophenotyping procedure using flow cytometry. In 
brief, PBMC were isolated by placing individual whole blood samples over a density gradient 
[SepMate 15 (IVD) and Lymphoprep, StemCell Technologies, Cambridge, MA] and 
centrifuging at 1,200 × g for 25 minutes at 20°C. Isolated PBMC were then washed with 
phosphate buffer saline containing 2% fetal bovine serum before being counted using the Moxi Z 
Mini Automated Cell Counter (ORFLO Technologies, Ketchum, ID). Individual samples were 
prepared with 1.0 × 106 cells and labeled with external fluorescent antibodies against cell surface 
markers CD3 (FITC Mouse Anti-Pig CD3ε, BD Pharmingen, San Jose, CA), CD4 (Alexa Fluor 
647 Mouse Anti-Pig CD4a, BD Pharmingen, San Jose, CA), and CD8 (PE Mouse Anti-Pig 
CD8b (BD Pharmingen, San Jose, CA). Following application of external antibodies for 45 
minutes at 4°C, cells were fixed using 4% paraformaldehyde solution for 20 minutes at 4°C. 
Prepared, labeled cells were evaluated at the University of Illinois Flow Cytometry Facility using 
a BD LSR II Flow Cytometry Analyzer (BD Biosciences, San Jose, CA) and flow cytometer 
outputs were analyzed using FCS Express 5 Plus (De Novo Software, Glendale, CA). 
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To summarize our analysis and gating procedures, recorded cellular events were plotted 
by density using forward and side scatter areas on the y- and x-axes, respectively, to exclude 
dead cells and cellular debris and allow for the selection of lymphocyte cells based on size. A 
single gate was applied to the lymphocyte population, the content of which was then plotted by 
density using forward scatter width and side scatter on the y- and x-axes, respectively, to allow 
for the gating and analysis of single cell events within our lymphocyte population only. Utilizing 
single cellular events within our lymphocyte population, single-stain control samples were used 
to set our detection thresholds for each individual fluorochrome and creation of a CD3+ gate. 
Gated on CD3+ lymphocytes, a final density plot using our CD8+ and CD4+ fluorochrome 
channels on the y- and x-axes, respectively, was created and our individual fluorochrome 
detection levels were used to apply quadrants to the density plot. Statistics from each quadrant 
were then used for our individual effector T-cell proportions (e.g., Helper T-cells, CD3+/CD4+). 
Oral Fluid Analyses  
 Oral fluids were collected weekly on a pen basis starting at 39 DPI through 123 DPI or 
until a single pen had 2 consecutive negative test results in a row. Ropes were hung at the front 
of each pen in two locations and pigs were allowed to chew on the ropes for 15 to 20 minutes or 
until the ropes were saturated with salvia. Saliva was manually expressed from the ropes into a 
clean plastic bag and transferred to 15 mL conical tubes for submission to the University of 
Illinois College of Veterinary Medicine Veterinary Diagnostic Laboratory for detection of PRRS 
viral antigen via qRT-PCR. Samples that could not be submitted the same day were stored 






Statistical analysis was dependent on whether outcomes were measured at a single time-
point or at multiple time-points for the same subject. For calculations of ADG, ADFI, G:F, and 
oral fluid samples, individual pens holding up to 6 pigs served as the experimental unit. For body 
weight, all immune and clinical outcomes, and mortality, individual pig was considered the 
experimental unit, with 12 to 18 individual pigs utilized for each of the three experimental 
treatments for immune and clinical outcomes. A total of two different diets were fed to PRRSV-
infected pigs, while a single group of uninfected pigs received only the control diet. Thus, the 1- 
or 2-way analyses of variance (ANOVA) described below were performed to evaluate effects 
between diets treatments.  
For all single time-point outcomes, a 1-way ANOVA was conducted using the MIXED 
procedure of SAS Enterprise Guide (version 6.1) (SAS Institute, Inc., Cary, NC). For repeated 
measures, a 2-way ANOVA including a time effect was conducted for all outcomes involving 
samples collected from the same subject at multiple time-points. When appropriate, means 
separation was conducted. Least-square means and the standard error of the mean estimates were 
derived from the 1- and 2-way ANOVA. In all cases, outliers were identified as having an 
absolute Studentized residual value of 3 or greater and statistical significance was considered at 
P ≤ 0.05. 
Results 
Growth Performance 
Results for growth performance can be found in Figure 4.1 and Table 4.6. Between 
NEG and POS treatments, PRRSV-infection resulted in decreased individual body weight 
starting at 13 DPI (P < 0.05) through to the end of the live-phase of the experiment (161 DPI). 
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Regarding growth performance metrics, PRRSV-infection decreased ADG during growth 
periods 0 to 6 DPI, 6 to 13 DPI, and 13 to 20 DPI (P < 0.05) and decreased ADFI during growth 
periods 6 to 13 DPI and 13 to 20 DPI (P < 0.05). However, PRRSV-infected pigs relative to non-
infected controls only exhibited reductions in feed efficiency during the 0 to 6 DPI growth period 
(P < 0.05) and again much later during the 104 to 118 DPI growth period (P < 0.05).  
 Between POS and ISF treatments, there were differences observed for individual body 
weights (P < 0.0001). Ingestion of supplemental ISF resulted in decreased body weights during 
the later portion of the growth period (104, 118 and 161 DPI) (P < 0.001), but no differences 
were observed during the acute infection or early recovery phases and the difference at 161 DPI 
was not maintained when pigs were weighed a few days later prior to slaughter at the University 
of Illinois Meat Science Laboratory. Regarding growth performance metrics, ISF 
supplementation increased ADFI during the 0 to 6 DPI growth period (P < 0.05) and the 90 to 
104 DPI growth periods, but decreased ADFI during the 76 to 90 DPI (P < 0.05). Moreover, ISF 
supplementation decreased growth efficiency, as measured by G:F, during the 90 to 104 DPI 
growth period (P < 0.05), but increased growth efficiency during the 104 to 118 DPI growth 
period (P < 0.05). Across the entire growth period, however, all effects of ISF supplementation 
on growth performance were transient and inconsistent with the exception of individual body 
weight. 
Rectal Temperatures 
Results for rectal temperature can be found in Table 4.7. Between NEG and POS 
treatments, PRRSV-infection increased rectal temperatures significantly by 6 DPI (P < 0.05) 
with rectal temperatures of infected pigs returning to the normal range by 13 DPI, indicating 
successful establishment of infection. Between POS and ISF treatments, there were observed 
95 
 
differences in rectal temperatures (P < 0.05), with ISF supplementation causing increased rectal 
temperatures at 0 DPI and decreased rectal temperatures at 6 DPI (P < 0.05).  
Complete and Differential Blood Cell Counts 
 For the sake of clarity, results for the erythrogram and leukogram analyses are presented 
and discussed separately. 
Erythrogram Results 
Compared with the NEG treatment, PRRSV-infection resulted in decreased red blood cell 
(RBC) counts, decreased hemoglobin concentrations, and decreased hematocrit on 6 and 13 DPI 
(Figure 4.2) and decreased mean cellular hemoglobin concentrations (MCHC) on 6 DPI (P < 
0.05). These findings are indicative of an active infection, with many immune challenges 
resulting in decreased RBC synthesis and release into circulation. Between POS and ISF 
treatments, ISF supplementation resulted in decreased RBC counts and hematocrit at 13 DPI (P 
< 0.05). Full panel results for the erythrogram analysis can be found in Table 4.8. 
Leukogram Results 
Between NEG and POS treatments, PRRSV-infection resulted in decreased white blood 
cell (WBC) counts on 3, 6, and 13 DPI, increased proportions of circulating neutrophils at 6 and 
13 DPI, and decreased proportions of circulating lymphocytes at 6 and 13 DPI (P < 0.05) 
(Figure 4.3), which is in agreement with our immunophenotyping data (see below). When 
looking at the total counts for neutrophils, however, we observed that the POS and ISF 
treatments actually had fewer circulating neutrophils at 3 DPI compared with non-infected 
controls (P < 0.05), which was maintained for the POS treatment at 6 DPI. These numbers 
increased for our POS treatment by 13 DPI, but supplemental ISF resulted in greater numbers of 
circulating neutrophils to levels similar to or greater than that of our negative controls at 6 and 13 
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DPI. Total lymphocyte counts were consistent with the calculated proportions observed. The 
neutrophilia was unexpected for a viral infection model, however, due to the high incidence of 
secondary bacterial infections observed for this experiment it could be considered a reasonable 
finding. More interestingly, the difference in total neutrophil counts across the acute infection 
period could be worth noting in the context of these bacterial insults following PRRSV-infection. 
Full panel results for the leukogram analysis can be found in Table 4.9. 
Serum Viral Load, Anti-PRRSV Antibody Titers, and Neutralizing Anti-PRRSV Antibody 
Titers 
Results for serum PRRS viral RNA concentrations can be found in Table 4.10. Between 
NEG and POS treatments, PRRSV-infection resulted in viremia detectable by serum PRRS viral 
RNA by qRT-PCR at 3, 6, and 13 DPI. Non-infected control pigs remained PRRSV-negative for 
serum PRRS viral RNA throughout the course of the experiment. Between POS and ISF 
treatments, there was no difference observed for serum PRRS viral RNA concentrations at any 
time-point measured (P > 0.05). 
Results for PRRSV neutralizing antibody titers can be found in Figure 4.4. Across all 
time-points measured, the NEG treatment tested negative for PRRSV neutralizing antibodies 
(i.e., titer of <1:4). At 20 DPI, 8 out of 11 POS pigs collected had negative titers, 2 had titers of 
1:4, and 1 had a titer of 1:8. Within the ISF treatment, 8 out of 12 pigs collected had negative 
titers and 4 had titers of 1:4. At 27 DPI, 3 of the 12 POS pigs collected had negative titers, 1 had 
a titer of 1:4, 4 had titers of 1:8, 1 had a titer of 1:16, 2 had titers of 1:32, and 1 had a titer of 
1:128. Within the ISF treatment, none of the 12 pigs collected tested negative, 5 had titers of 1:4, 
4 had titers of 1:8, 1 had a titer of 1:16, and 2 had titers of 1:32. At 34 DPI, none of the 11 POS 
pigs collected tested negative, 1 pig had a titer of 1:4, 2 had titers of 1:8, 4 had titers of 1:16, 3 
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had titers of 1:32, and 1 had a titer of 1:64. Within the ISF treatment, none of the 12 pigs 
collected tested negative, 2 had titers of 1:8, 6 had titers of 1:16, and 4 had titers of 1:32. When 
looking specifically at pigs that had clinically protective titers (i.e., ≥ 1:8), 9% (1/11) of pigs 
collected in the POS treatment had protective titers at 20 DPI vs. 0% (0/12) in the ISF treatment. 
At 27 DPI, 72% (8/11) of pigs collected in the POS treatment had protective titers vs. 58% (7/12) 
in the ISF treatment. At 34 DPI, 83% (10/12) in the POS treatment had protective titers vs. 100% 
(12/12) in the ISF treatment.  
PRRSV Oral Fluid Clearance 
Results for PRRSV clearance in oral fluids by treatment can be found in Figure 4.5. 
Monitoring of PRRSV clearance in oral fluids on a pen basis began on 39 DPI and was 
continued on a weekly basis through 123 DPI. The NEG treatment remained negative for oral 
PRRSV antigen by qRT-PCR throughout the course of the experiment. The POS treatment 
peaked with 100% of pens being oral-fluid-positive at 60 DPI and experienced an initial wave of 
clearance at 74 DPI. The ISF treatment peaked later at 67 DPI and experienced an initial wave of 
clearance at 81 DPI. Both POS and ISF treatments had replicate pens that reentered an infectious 
stage and cycled between 0 to 33% positive until 102 DPI, with a greater number of ISF replicate 
pens maintaining their negative status compared with the POS treatment. The ISF treatment 
reached final clearance at 102 DPI, while the POS treatment did not reach final clearance until 
123 DPI. 
Secondary Bacterial Infections and Mortality Prevalence 
 Some level of infection-related mortality can be expected among young pigs infected 
with PRRSV. However, starting at approximately 10 to 12 DPI, there was an observable increase 
in infection-related mortalities observed in our POS and ISF treatment groups, above expected 
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values for this model. Based on clinical presentation and rapid onset of symptoms, the 
veterinarian overseeing ISS-VRF suspected that our PRRSV-infected pigs were suffering from 
secondary bacterial co-infection (likely Streptococcus suis [Strep. suis], though a differential 
diagnosis of Haemophilis parasuis was also suggested) (Gottschalk, 2020; Segales, 2020). Due 
to the large number of infected pigs impacted by this secondary infection and the increasing 
number of mortality cases, researchers opted to treat all pigs on study (including uninfected pigs 
in the NEG treatment) with a three-day course of enrofloxacin (Baytril 100, Bayer Healthcare 
LLC, Shawnee Mission, KS) starting at 21 DPI in attempt to slow infection-related losses.  
Results for mortality rate and extent by treatment can be found in Figure 4.6. Of the 
original 96 pigs allotted, a total of 27 (28%) died prior to the completion of the experiment. Of 
those 27, 3 were categorized as non-infection/pathogen related deaths: one NEG pig that tested 
as a false positive for PRRSV serum antigen at 6 DPI, one NEG pig that developed severe 
kyphosis, and one ISF pig that developed an inguinal hernia. With those excluded, the POS 
treatment experienced 47% mortality while the ISF treatment experienced only 25% mortality. 
The initial rate of mortality appeared similar between POS and ISF treatments between 7 and 21 
DPI, but the rate slowed for the ISF treatment beyond that point. Recall that all pigs were treated 
with antibiotics at 21 DPI in attempt to control increased losses attributed to a severe secondary 
infection with Strep. suis. The POS treatment continued to experience infection-related 
mortalities as late as 77 DPI, while the ISF treatment experienced their last infection-related 
mortality at 44 DPI.  
T-Cell Immunophenotyping Results 
Results for T-cell immunophenotyping can be found in Table 4.11. Between NEG and 
POS treatments, PRRSV-infection caused a transient leukopenia (i.e., decrease in total 
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lymphocytes), with increased proportions of circulating mature T-cells (CD3+), decreased 
proportions of cytotoxic T-cells (CD3+/CD8+), and decreased proportions of memory T-cells 
(CD3+/CD4+/CD8+) (P < 0.05) on 13 DPI. Proportions of all impacted T-cell 
immunophenotype parameters in POS animals returned to values comparable to uninfected 
controls by 20 DPI. Interestingly, ISF increased the relative proportion of memory T-cells over 
the NEG treatment at 20 DPI. Regarding the helper:cytotoxic T-cell ratio (a measure of immune 
system functionality), PRRSV-infected treatments exhibited an increased ratio, which is typically 
a predictor of an appropriate immune response, with the ISF treatment having the greatest ratio 
value (P < 0.05).  
Serum Chemistry Results 
Results for serum chemistry clinical analyses can be found in Table 4.12. The majority of 
differences seen in analyte concentrations across the acute infection period (0 to 13 DPI) appear 
to be due to PRRSV-infection alone with differences mainly observed during the 6 and 13 DPI 
time-points (P < 0.05). Regarding measures of protein status, POS and ISF treatments exhibited 
increased creatine concentrations, decreased creatine phosphokinase (CK) activity, and 
decreased total blood proteins (but increased globulin proteins at 13 DPI), which together can 
indicate disruptions in protein metabolism and skeletal muscle deposition, with the exception of 
globulin proteins which mainly indicate an active immune response. Regarding serum mineral 
and electrolyte concentrations, POS and ISF treatments exhibited decreased calcium, potassium, 
and sodium concentrations and increased chloride concentrations across the acute infection 
period compared with the NEG treatment. PRRSV-infection also reduced blood glucose levels 
fairly dramatically across the acute infection period, which is expected due to the increase 
demand for glucose during infection and decreased feed intake. Finally, PRRSV-infection 
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resulted in several changes observed for liver enzyme serum concentrations (i.e., decreased 
alkaline phosphatase concentrations, decreased glutamate dehydrogenase concentrations, 
increased aminotransferase concentrations) across infected treatments. 
There were only a few analytes at specific time-points during the acute infection period 
that were influenced by dietary ISF. At 6 DPI, pigs in the ISF treatment group had lower blood 
glucose levels than the NEG and POS treatments, but did not differ from the POS treatment at 
any other time-point measured (P < 0.05). At 13 DPI, pigs in the ISF treatment group had similar 
sodium concentrations to those in the NEG treatment (P < 0.05). Additionally, at 13 DPI pigs in 
the ISF treatment had greater (P < 0.05) total CO2 serum concentrations than the NEG treatment, 
with the POS treatment exhibiting intermediate concentrations.  
Discussion 
 Isoflavones are bioactive components that are found in high concentrations in soybeans 
and soybean-derived feedstuffs and have been shown to have antiviral activity (Wang and 
Murphy, 1996). This activity has been demonstrated against PRRSV specifically in live animal 
studies previously (Greiner et al., 2001a; Greiner et al., 2001b; Rochell et al. 2015; Smith et al., 
2019). The purpose of this study was to help elucidate a time-dependent biological mechanism 
by which ISF exert immunomodulatory effects over the entire infection period with PRRSV, 
both acute and recovery phases, which was not fully captured by these previous experiments. 
 Induction of PRRSV infection had the greatest impact on growth performance. PRRSV-
infected pigs had lower body weights as early at 13 DPI and final finishing weights 
approximately 7% lighter than that of non-infected controls. Isoflavones only had transient 
impacts on growth performance with no consistent trend over the growth period. Previously, the 
isolated isoflavones genistein and daidzein were independently found to improve ADG during 
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the early post-inoculation period (Greiner et al., 2001a; Greiner et al., 2001b), but those same 
effects have not been consistently observed in situations where a mixture of isoflavones to mimic 
naturally occurring soy ISF ratios is fed. In PRRSV-challenged pigs, those receiving higher 
concentrations of SBM did not experience a decrease in average daily gain, a hallmark of 
PRRSV infection, however researchers could not conclude if that improvement was due to 
increased crude protein in the diet or bioactive compounds such as isoflavones (Rochell et al., 
2015). However, in another PRRSV-challenge study evaluating the effects of dietary SBM on 
amino acid digestibility and losses, researchers found that a 3-time increase in dietary SBM, 
which would have significantly increased the ISF content in experimental diets, did not affect 
growth performance in infected pigs (Schweer et al., 2018). Most recently in our laboratory, 
PRRSV-infected weaned pigs infected with the same strain of PRRSV virus utilized for this 
study exhibited greater feed efficiency when receiving supplemental ISF between 6 to 14 DPI, 
but ISF did not impact any other growth metrics over the 2-week infection period (Smith et al., 
2019). It should be noted that the PRRSV strains used in some those studies are different than 
what was utilized in our study. In that context, findings from the current study and previous 
research suggest that soy isoflavones may have some influence on growth performance under 
PRRSV-challenge, but that influence is not consistent over the entire infection period. 
Additionally, differences in virulence of individual PRRSV strains and the severity of clinical 
disease they cause (Johnson et al., 2004) may be a factor in the capacity of which isoflavones are 
able to influence growth performance in pathogenically-stressed pigs and partially explain 
differences observed between PRRSV-challenge studies. Regardless, while there does not seem 
to be a clear explanation for why the final on-site live body weights for our ISF treatment were 
approximately 3% lower compared with the POS treatment, this appears to be a transient effect 
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since no differences were detected between the two dietary treatments at time of slaughter later 
the same week. 
Shifting the focus from growth performance to immune response and recovery outcomes, 
regarding rectal temperatures as an indicator of ongoing infection, pigs in the ISF treatment had 
increased rectal temperatures at 0 DPI but decreased rectal temperatures at 6 DPI compared with 
the POS treatment. Reasoning for the increased baseline, pre-inoculation rectal temperatures of 
ISF supplemented pigs is unclear, however, due to fact that both the POS and ISF treatments are 
within the normal physiological rectal temperature range for pigs of that age (38.6°C-39.5°C), 
the biological relevance of that difference may be considered weak. The half-degree difference 
between POS and ISF treatments at 6 DPI, however, is physiologically relevant, with ISF 
supplementation reducing rectal temperatures of infected pigs to temperatures similar to those 
observed in the negative control animals. 
Regarding erythrocyte measures, starting at 6 DPI we observed a decline in total RBC 
counts and hematocrit in both infected treatments, which has been observed previously in 
PRRSV-challenge models (Halbur et al., 2002). By 13 DPI, the ISF treatment had the lowest 
RBC counts and hematocrit values, with the POS treatment exhibiting intermediate levels 
between the ISF and negative control treatment. While within normal clinical ranges, the levels 
of the ISF treatment group were nearing or exceeding lower cutoff values for those measures 
(Friendship & Henry, 1992). It is thought that a potential cause of anemia during infection may 
be mediated by systemic pro-inflammatory cytokines, which can induce erythroid hypoplasia due 
to increased demand for granulocyte production from myeloid progenitor cells (Halbur et al., 
2002). If true, then one explanation for why ISF consumption elicited a more severe anemia 
could be that pigs receiving ISF experienced a heavily neutrophilic response. Such a case has 
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been observed with higher levels of systemic inflammation, earlier during the infection period, 
thus creating a stronger suppression on erythrocyte differentiation (Duncan et al., 1994). This is 
particularly interesting in the context of our PRRSV-challenge since PRRSV is considered to be 
immunosuppressive, especially during the early acute infection period, and the fact that pigs on 
study suffered severe secondary bacterial infections.  
Upon initial exposure to a viral insult, tissue-resident innate immune cells such as 
macrophages and dendritic cells typically produce the anti-viral, pro-inflammatory type I 
interferons, interferon-α and interferon-β (IFN-α, IFN-β) (Loving et al., 2015; Bogdan, 2000). 
Targeting pulmonary alveolar macrophages specifically, PRRSV dampens this type-I interferon 
response, with peak IFN-α titers being minimally 1,000-fold lower than that observed during 
other common swine respiratory viruses (e.g. swine influenza virus, SIV, and porcine respiratory 
circovirus, PRCV). It also appears to reduce the production of other key pro-inflammatory 
cytokines such as TNF-α (van Reeth et al., 1999). Suppression of these signaling pathways 
results in poor viral clearance and a transient leukopenia and lymphopenia (Shimizu et al., 1996; 
Albina et al., 1998; Bogdan, 2000). We observed this in PRRSV-infected pigs, where decreased 
WBC and lymphocyte counts were observed starting as early as 3 DPI. However, suppression of 
type-I interferon signaling and recruitment of adaptive immune cells does not explain differences 
in neutrophil counts between our two infected treatments, as granulocytes are not typically 
associated with PRRSV infection. However, previous PRRSV models have observed transient 
increases in total granulocyte percentages during early infection which is in line with our 
findings (Hernandez et al., 2018). Regardless, some of this response may be explained by the 
estrogenic activity of ISF and the role of estrogen receptors on immune cells, which may have 
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impacted the susceptibility of our ISF treatment to secondary bacterial infections (Smith and 
Dilger, 2018; Straub, 2007; Yakimchuk et al., 2013). 
Due to their structural similarity to 17β-estradiol (E2), isoflavones have the capacity to 
interact with estrogen receptors throughout the body as a weak E2 analog. There are two main 
types of estrogen receptors, estrogen receptor-α (ER-α) and estrogen receptor-β (ER-β); of the 
two, soy ISF preferentially bind ER-β (Andres et al., 2009). Additionally, while more typically 
thought to express anti-inflammatory effects, certain cell responses mediated by ER-β are more 
appropriately categorized as pro-inflammatory. ER-β can be found throughout the body, but is 
notably found on peripheral leukocytes, tissue macrophages, and pulmonary epithelial tissues. 
One pro-inflammatory response by ER-β activity is increased apoptotic activity. In response to 
local inflammation or pathogenic insult, the expression of ER-β increases on immune cells which 
in turn increases pro-apoptotic pathway activation (Straub, 2007; Yakimchuk et al., 2013). It is 
possible that the presence of circulating ISF in pigs fed ISF may have resulted in increased 
apoptosis of PRRSV-infected alveolar macrophages, potentially preventing spread of PRRSV to 
uninfected alveolar macrophages and affording them greater functionality during a secondary 
bacterial insult at the level of the lung. Since it is likely that the pigs utilized in the experiment 
were exposed and asymptomatically harboring pathogenic bacteria prior to their arrival and 
inoculation with PRRSV, dietary ISF may have afforded ISF pigs increased protection against 
bacterial insult in the face of a PRRSV infection, allowing local immune cells to recruit an 
appropriate neutrophil response earlier than pigs in the POS treatment. Additionally, human 
studies suggest that increased levels of E2 increases total numbers of neutrophils in circulation 
and may contribute to greater phagocytic activity in those cells; being an E2 analog, ISF may be 
directly contributing to the rise in neutrophil counts of our ISF treatment (Bouman et al., 2005). 
105 
 
We provide this purported mechanism but were unable to collect lung tissue from infected pigs 
during acute infection to assess local cytokine levels or expression or cellular damage, so we 
cannot confirm whether secondary bacterial infections started in the respiratory tract. We can 
confirm that systemic serum cytokine concentrations did not differ between infected treatments 
(results not shown).  
Within the broad clinical picture, the impact of ISF on immune cell numbers and 
mobilization may be what set the stage for recovery and greater survival by our ISF treatment. 
By having some influence on the kinetics of the immune response to a secondary bacterial 
infection, pigs receiving ISF were able to begin the recovery process from PRRSV more 
completely than our POS treatment. This was reflected in a few of our immune measures 
captured. First, our ISF treatment elicited a greater proportion of memory T-cells by 20 DPI, 
which are typically a group of adaptive immune cells that are relatively inactive in a PRRSV 
infection, but are recognized as important cells for the development of immunological memory 
(Lanzavecchia and Sallusto, 2005; Fu et al., 2012). Additionally, though it is in contrast to 
previous findings by our lab (Smith et al., 2019) and not necessarily characteristic a PRRSV 
infection, we found PRRSV-infected treatments exhibited an increased helper:cytotoxic T-cell 
ratios, with the ISF treatment having the greatest ratio value across all treatments. However, 
immune responses to secondary bacterial infections may have played a role in influencing this 
outcome. Second, while it did not seem to increase the rate of neutralizing antibody production, 
more pigs in the ISF treatment demonstrated protective titers by our last collection point (34 
DPI) compared with the POS treatment, which was approximately 10 days following antibiotic 
administration. Though sampled from a small number of animals, these results suggest that ISF 
promote greater immune protection across an infected population, which is a key factor for 
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PRRSV clearance and recovery. Third, and interestingly, while a majority of replicate pens in the 
POS treatment started to test negative by oral fluids two weeks before the ISF treatment, half of 
the POS replicates continued to cycle back into positive status 5 weeks beyond when a majority 
of ISF replicate pens tested oral fluid negative for the first time. These findings together suggest 
that once the ISF treatment started to enter the recovery phase from PRRSV, they did so more 
completely and were able to reach true clearance 7 weeks earlier (with the exception of one 
replicate pen) than the POS treatment.  
While reaching PRRSV clearance earlier in the growth period is of obvious interest to 
swine producers, what ISF really afforded the PRRSV-challenge pigs within this experiment was 
fewer infection-related losses. The ISF treatment experienced approximately 25% mortality over 
the entire growth period compared with the POS treatment with nearly 50% mortality. These 
mortality patterns suggest that under PRRSV-challenge with a severe secondary bacterial 
infection that ISF may contribute to reduced overall mortality rates of infected pigs. As a side 
note, we concluded that based on our mortality patterns it appears that the incorrectly formulated 
Calcium: Phosphorus ratio in the initial finisher phase diets did not contribute strongly to overall 
mortality as all experimental treatments were affected and we observed an appropriate level of 
mortality in the uninfected, control-fed group throughout the experiment. Even in the absence of 
any calculated production losses, we conclude that this finding may have significant financial 
implications for pork productions when nearly twice as many pigs were able to make it through 
their entire growth period when they received ISF compared with those that did not when faced 
with a severe pathogenic challenge. 
Unfortunately, it is still not clear exactly how ISF worked biologically within this model. 
While we have suggested that it may be possible that ISF acted via estrogen-signaling pathways 
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to impact early immune responses that later impacted recovery from PRRSV complicated with 
secondary bacterial infections, it is important to note that ISF are a weak estrogen analog, so 
their activity against pathogens is likely not through those pathways exclusively (Andres et al., 
2009; Smith and Dilger, 2018). Additionally, we must keep in mind that this was a nutritional 
intervention and ISF are heavily metabolized by both host and microbial enzymes in the 
gastrointestinal tract. More research is warranted to elucidate whether these effects were due to 
direct activity by circulating isoflavones or if shifts in microbial populations could also be 
contributing. Finally, these findings were observed under severe pathogen challenge when an 
isoflavone mixture was added back to the diet at levels normally found in traditional commercial 
swine diets. Moving forward, there is there is also a need to identify whether higher isoflavone 
concentrations or a less severe pathogenic challenges would generate more or similar protection 
against infection-related losses when pigs are faced with PRRSV in a commercial setting.  
Implications 
  Under PRRSV-challenge complicated by severe secondary bacterial infections, dietary 
soy isoflavones reduced pathogen-associated mortality by approximately 50% over the course of 
the entire growth period from weaning to market. While having minimal to no impact on growth 
performance, isoflavones appeared to alter the kinetics of early acute immune responses, 
impacting the timeline for PRRSV recovery and clearance. This has significant implications for 
pork producers, however more research is required to further clarify the mechanism of action for 
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Table 4.1. Experimental treatments1 
Treatment Dietary Treatment Infection Status 
NEG Control diet Uninfected 
POS Control diet PRRSV-Infected 
ISF Control diet + ISF2 PRRSV-Infected 
1Abbreviations: PRRSV, porcine reproductive and respiratory syndrome virus; ISF, isoflavones. 







































Table 4.2. Ingredient and calculated composition of experimental diets (as-fed basis), nursery phases1 
Item 
Nursery Phase 1 Nursery Phase 2 
CON CON+ISF CON CON+ISF 
Ingredients, g/kg     
Corn 629.05 624.55 606.20 601.70 
Soy protein concentrate2 175.00 175.00 200.00 200.00 
Dried whey 120.00 120.00 -- -- 
DDGS -- -- 150.00 150.00 
Fish meal3 40.00 40.00 -- -- 
Fat, choice white grease 10.00 10.00 10.00 10.00 
Limestone 12.00 12.00 18.00 18.00 
Salt 5.00 5.00 6.50 6.50 
Vitamin-mineral premix4 1.00 1.00 2.25 2.25 
Choline chloride, 60% 0.70 0.70 0.70 0.70 
Isoflavone mixture5 0.00 4.50 0.00 4.50 
L-Lys HCl 4.50 4.50 4.25 4.25 
DL-Met 1.25 1.25 0.85 0.85 
L-Thr 1.00 1.00 0.75 0.75 
L-Trp 0.50 0.50 0.50 0.50 
     
Calculated Composition6     
ME, kcal/kg 3,470 3,455 3,449 3,434 
Crude protein, g/kg 212.4 212.0 227.6 227.2 
SID AA, g/kg     
Lysine 14.2 14.2 13.5 13.5 
Methionine + Cysteine 7.4 7.4 11.4 11.4 
Tryptophan  2.5 2.5 2.4 2.4 
Threonine 8.0 8.0 7.4 7.4 
Valine 8.9 8.9 9.1 9.0 
Isoflavones, mg/kg     
Genistein 2.0 752 2.0 753 
Daidzein 1.0 789 1.0 789 
Glycitein 0.0 95 0.0 95 
Total isoflavones 3.0 1,636 3.0 1,637 
Total saponins, mg/kg 664 1,045 759 1,140 
1All pigs received allotted treatment diet upon starting -7 DPI. Abbreviations: DPI, days post-inoculation; ISF, isoflavones; SID, standardized ileal digestible, AA, 
amino acids. 
2Arcon AF, ADM, Decatur, IL. 
3Special SelectTM Menhaden Fish Meal, Omega Protein, Houston, TX. 
4Vitamin-mineral premix (JBS United, Sheridin, IN) included the following per kilogram of complete diet: Vitamin A (retinyl acetate), 11,128 IU; Vitamin D3 
(cholecalciferol), 2,204 IU; Vitamin E (dl-α tocopheryl acetate), 66 IU; Vitamin K (menadione nicotinamide bisulfite), 1.42 mg; Thiamine (thiamine mononitrate), 
0.24 mg; Riboflavin, 6.58 mg; Pyridoxine (pyridoxine hydrochloride), 0.24 mg; Vitamin B12, 0.03 mg; d-Pantothenic acid (d-calcium pantothenate), 23.5 mg; 
Niacin (nicotinamide and nicotinic acid), 44 mg; Folic acid, 1.58 mg; Biotin, 0.44 mg; Cu (copper sulfate), 10 mg; Fe (iron sulfate), 125 mg; I (potassium iodate), 
1.26 mg; Mn (manganese sulfate), 60 mg; Se (sodium selenite), 0.3 mg; and Zn (zinc oxide), 100 mg. 
5Novasoy400, ADM, Decatur, IL. 
6Metablizable energy and standardized ileal digestible (SID) amino acid values were calculated using NRC (2012). Analyzed crude protein determined as CP = total 







Table 4.3. Ingredient and calculated composition of experimental diets (as-fed basis), grow-finish phases1 
Item 
















Ingredients, g/kg           
Corn 535.75 531.25 664.15 659.65 815.40 810.90 826.45 821.95 884.35 879.85 
Soy protein concentrate2 125.00 125.00 100.00 100.00 100.00 100.00 90.00 90.00 85.00 85.00 
DDGS 300.00 300.00 200.00 200.00 50.00 50.00 50.00 50.00 --  -- 
Fat, choice white grease 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 
Limestone 15.50 15.50 15.50 15.50 14.00 14.00 9.00 9.00 8.00 8.00 
Dicalcium phosphate  -- -- -- -- -- -- 8.00 8.00 7.00 7.00 
Salt 5.00 5.00 4.00 4.00 4.00 4.00 2.00 2.00 2.00 2.00 
Vitamin-mineral premix3  2.50 2.50 1.50 1.50 1.00 1.00 0.75 0.75 0.75 0.75 
Choline chloride, 60% 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 
Isoflavones4  0.00 4.50 0.00 4.50 0.00 4.50 0.00 4.50 0.00 4.50 
L-Lys HCl 4.50 4.50 3.25 3.25 3.25 3.25 2.30 2.30 1.50 1.50 
DL-Met 0.50 0.50 0.10 0.10 0.25 0.25  -- -- -- -- 
L-Thr 0.25 0.25 0.50 0.50 1.00 1.00 0.50 0.50 0.50 0.50 
L-Trp 0.30 0.30 0.30 0.30 0.40 0.40 0.30 0.30 0.20 0.20 
           
Calculated Composition4           
ME, kcal/kg 3,434 3,419 3,425 3,410 3,428 3,412 3,418 3,403 3,419 3,404 
Crude protein, g/kg 213.6 213.2 179.0 178.6 150.8 150.5 143.6 143.2 130.5 130.1 
SID AA, g/kg           
Lysine 11.6 11.5 9.1 9.1 8.7 8.7 7.4 7.4 6.3 6.3 
Methionine + Cysteine 10.1 10.1 8.3 8.3 7.4 7.4 6.8 6.8 6.4 6.3 
Tryptophan  1.9 1.9 1.6 1.6 1.6 1.6 1.4 1.4 1.2 1.2 
Threonine 6.2 6.2 5.5 5.5 5.3 5.3 4.6 4.6 4.2 4.2 
Valine 8.2 8.2 6.9 6.9 5.9 5.9 5.6 5.6 5.2 5.1 
Isoflavones, mg/kg           
Genistein 1.0 752 1.0 752 1.0 752 1.0 751 1.0 751 
Daidzein 1.0 788 1.0 788 1.0 788 1.0 788 1.0 788 
Glycitein 0.0 95 0.0 95 0.0 95 0.0 95 0.0 95 
Total isoflavones 2.0 1,635 2.0 1,635 2.0 1,635 2.0 1,635 1.0 1,635 
Total saponins, mg/kg 474 855 380 760 380 760 342 722 323 703 
1All pigs received allotted treatment diet upon starting -7 DPI. Abbreviations: DPI, days post-inoculation; ISF, isoflavones; SID, standardized ileal digestible, AA, amino acids. 
2Special SelectTM Menhaden Fish Meal, Omega Protein, Houston, TX. 
3Vitamin-mineral premix (JBS United, Sheradin, IN) included the following per kilogram of complete diet: Vitamin A (retinyl acetate), 11,128 IU; Vitamin D3 (cholecalciferol), 2,204 IU; Vitamin E (dl-α tocopheryl acetate), 66 IU; 
Vitamin K (menadione nicotinamide bisulfite), 1.42 mg; Thiamine (thiamine mononitrate), 0.24 mg; Riboflavin, 6.58 mg; Pyridoxine (pyridoxine hydrochloride), 0.24 mg; Vitamin B12, 0.03 mg; d-Pantothenic acid (d-calcium 
pantothenate), 23.5 mg; Niacin (nicotinamide and nicotinic acid), 44 mg; Folic acid, 1.58 mg; Biotin, 0.44 mg; Cu (copper sulfate), 10 mg; Fe (iron sulfate), 125 mg; I (potassium iodate), 1.26 mg; Mn (manganese sulfate), 60 mg; 
Se (sodium selenite), 0.3 mg; and Zn (zinc oxide), 100 mg. 








































Table 4.4. Analyzed composition of experimental diets (as-fed basis), nursery phases1 
 Nursery Phase 1  Nursery Phase 2 
Item  CON CON+ISF  CON CON+ISF 
Dry matter, g/kg 909.2 911.2  903.2 900.1 
Organic matter, g/kg 932.9 936.3  946.2 937.9 
Crude protein2, g/kg 218.3 220.3  240.3 238.2 
Total dietary fiber, g/kg 99.9 117.5  156.3 156.4 
Isoflavones, mg/kg      
 Genistein 37.9 988  87.1 1.129 
 Daidzein 18.5 661  22.2 785 
 Glycitein 0.0 49.5  0.0 61 
 Total isoflavones 56.4 1,699  108 1,975 
Total saponins, mg/kg 193 560  442 764 
Total AA, g/kg 213.0 214.6  230.4 234.1 
Indispensable AA, g/kg       
Arginine 12.8 12.9  9.70 14.4 
Histidine 5.40 5.50  6.20 6.30 
Isoleucine 10.0 10.1  10.6 10.7 
Leucine 18.5 18.7  21.3 21.7 
Lysine 15.1 15.5  15.3 15.5 
Methionine 4.80 4.70  4.50 4.60 
Phenylalanine 10.1 10.3  11.6 11.9 
Threonine 9.10 9.30  9.20 9.40 
Tryptophan 3.10 3.10  3.20 3.00 
Valine 11.0 10.9  11.8 12.0 
Dispensable AA, g/kg       
Alanine 11.1 11.2  12.3 12.5 
Aspartic acid 21.0 21.0  21.8 22.3 
Cysteine 3.30 3.30  3.90 3.80 
Glutamic acid 37.2 37.3  40.8 41.5 
Glycine 9.70 9.70  9.80 9.90 
Proline 12.5 12.5  14.6 14.8 
Serine 8.50 8.60  9.30 9.70 
Tyrosine 6.70 6.90  7.90 8.00 
1All pigs received allotted treatment diet upon starting -7 DPI. Abbreviations: AA, amino acids; DPI, days post-inoculation; ISF, 
isoflavones, AA, amino acids. 
2Analyzed CP = total N × 6.25. 
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Table 4.5. Analyzed composition of experimental diets (as-fed basis), grow-finish phases1 
 
















Dry matter, g/kg -- 888.4 881.0 879.2 864.0 840.4 867.8 867.0 874.5 866.6 
Organic matter, g/kg -- 950.1 954.2 955.3 960.8 973.1 955.0 961.0 970.5 968.5 
Crude protein3, g/kg -- 202.4 171.6 156.1 136.9 133.0 135.5 139.1 114.1 114.1 
Total dietary fiber, g/kg  180.3 163.2 161.6 131.1 143.2 133.9 128.1 137.5 119.9 
Isoflavones, mg/kg           
Genistein -- 1,375 84.8 1,173 66.0 1,163 48.1 1,010 64.8 753 
Daidzein -- 1,064 20.2 923 17.5 928 10.3 809 14.1 605 
Glycitein -- 89.4 0.0 75.0 0.0 76.7 0.0 66.7 0.0 49.9 
Total isoflavones -- 2,528 105 2,172 83.5 2,172 58.4 1,886 78.9 1,407 
Total saponins, mg/kg -- 938 345 852 406 832 250 665 265 571 
Total AA, g/kg -- 187.9 172.0 164.5 141.1 132.8 142.8 132.2 123.1 119.1 
Indispensable AA, g/kg            
Arginine -- 10.1 9.70 9.10 8.20 7.50 8.30 7.50 7.10 6.70 
Histidine -- 5.10 4.80 4.60 3.80 3.60 3.90 3.60 3.40 3.20 
Isoleucine -- 8.20 7.50 7.00 6.20 5.70 6.30 5.80 5.40 5.20 
Leucine -- 19.3 17.2 16.8 14.0 13.1 13.9 13.3 12.0 11.8 
Lysine -- 12.3 10.3 10.0 8.60 8.60 8.90 7.80 7.20 7.10 
Methionine -- 3.50 3.20 2.90 2.50 2.30 2.50 2.20 2.00 1.90 
Phenylalanine -- 9.40 8.50 8.20 7.10 6.60 7.20 6.60 6.20 5.90 
Threonine -- 7.30 6.90 6.60 5.80 5.60 5.60 5.30 5.00 4.80 
Tryptophan -- 2.10 2.00 1.80 1.60 1.50 1.50 5.40 1.30 1.40 
Valine -- 9.60 9.00 8.50 7.30 6.60 7.30 6.70 6.20 5.90 
Dispensable AA, g/kg           
Alanine -- 11.3 10.4 10.1 8.20 7.80 8.20 7.80 7.10 7.00 
Aspartic acid -- 16.2 14.9 14.1 12.5 11.6 13.0 11.5 11.1 10.6 
Cysteine -- 3.30 3.20 3.00 2.50 2.30 2.60 2.40 2.20 2.10 
Glutamic acid -- 32.4 29.6 28.3 25.6 23.6 25.6 23.7 22.3 21.4 
Glycine -- 7.90 7.50 7.10 5.90 5.50 6.00 5.60 5.10 4.90 
Proline -- 13.6 12.5 12.0 9.30 9.00 9.40 8.90 8.50 8.30 
Serine -- 8.20 7.00 6.90 5.70 5.70 5.90 5.40 5.10 4.90 
Tyrosine -- 6.20 5.60 5.40 4.40 4.00 4.50 4.30 3.70 3.70 
1All pigs received allotted treatment diet upon starting -7 DPI. Abbreviations: AA, amino acids; DPI, days post-inoculation; ISF, isoflavones, AA, amino acids. 
2Missing sample, unable to analyze. 
3Analyzed CP = total N × 6.25. 
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Table 4.6. Effects of soy isoflavones and Porcine Reproductive and Respiratory Virus (PRRSV) 
infection on growth performance of pigs from weaning to market weight1,2 
Growth Period 
Uninfected PRRSV-infected   Model 
NEG POS ISF  SEM P-value 
Active infection       
-7 to 0 DPI       
ADG, g/d 112 91.2 98.8  18.0 0.694 
ADFI, g/pig/d 435 427 409  38.9 0.862 
G:F, g/kg 265 230 248  52.5 0.875 
0 to 6 DPI       
ADG, g/d 265b 107a 128a  43.0 0.010 
ADFI, g/pig/d 434a 537b 854c  52.8 < 0.001 
G:F, g/kg 574b 207a 142a  69.0 0.003 
6 to 13 DPI       
ADG, g/d 320b 85.3a 43.3a  62.8 0.022 
ADFI, g/pig/d 568b 383a 503a  48.8 0.036 
G:F, g/kg 565 298 273  84.8 0.101 
13 to 20 DPI       
ADG, g/d 416b 258a 238a  42.9 0.019 
ADFI, g/pig/d 856b 440a 390a  88.0 0.005 
G:F, g/kg 508 650 797  21.0 0.582 
20 to 27 DPI       
ADG, g/d 491 419 421  58.7 0.594 
ADFI, g/pig/d 761 791 691  129 0.747 
G:F, g/kg 625 567 623  96.9 0.833 
27 to 34 DPI       
ADG, g/d 627b 404a 455a  61.4 0.024 
ADFI, g/pig/d 1,013 863 943  151 0.683 
G:F, g/kg 622 518 500  10.7 0.658 
Recovery       
34 to 90 DPI       
ADG, g/d 707 692 648  28.3 0.174 
ADFI, g/pig/d 1,569 1,460 1,336  81.2 0.106 
G:F, g/kg 450 477 487  16.6 0.278 
After viral clearance       
90 to 161 DPI       
ADG, g/d 925 959 967  37.8 0.649 
ADFI, g/pig/d 2,591 2,843 2,644  167 0.216 
G:F, g/kg 360 342 370  18.8 0.306 
abcMeans without a common superscript letter differ (P < 0.05). 
1Values represent least square means of 17 to 36 pigs across 4-6 replicates per treatment. Pigs were removed from analysis for ADG, ADFI, and G:F 
if their body weight measurement was deemed as a statistical outlier. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI, 
day post-inoculation, ADG, average daily gain, ADFI, average daily feed intake, G:F, feed efficiency.  
2Growth performance was calculated on a pen basis, with each pen representing one experimental replicate containing 1 to 6 pigs per pen. In the 
event a replicate pen experienced net weight loss over a growth period, they were excluded from the calculation of average feed efficiency of their 













Table 4.7. Effects of soy isoflavones and Porcine Reproductive and Respiratory Virus 
(PRRSV) infection on rectal temperature (°C) of pigs1 
Day Uninfected PRRSV-infected   Model 
Post-Inoculation NEG POS ISF  SEM P-value 
DPI 0 39.5b 39.4b 39.0a  0.164 0.042 
DPI 3 39.3 39.7 39.5  0.164 0.144 
DPI 6 39.3a 40.0b 39.5a  0.164 0.005 
DPI 10 39.2 39.6 39.3  0.164 0.141 
DPI 13 39.3 39.6 39.6  0.164 0.344 
abMeans without a common superscript letter differ (P < 0.05). 









































Table 4.8. Effects of soy isoflavones and Porcine Reproductive and Respiratory Virus (PRRSV) infection on the 
erythrogram of weanling pigs1 
 Uninfected PRRSV-infected    
Item NEG POS ISF  SEM Model P-value 
RBC, × 106 cells/µL       
DPI 0 6.55 6.53 6.68  0.169 0.670 
DPI 3 6.22 5.86 5.71  0.169 0.056 
DPI 6 6.14b 5.71a 5.51a  0.158 0.004 
DPI 13 6.03c 5.23b 4.73a  0.149 < 0.001 
Hemoglobin, g/dL       
DPI 0 12.45 12.67 12.69  0.306 0.805 
DPI 3 11.70 11.10 10.87  0.306 0.098 
DPI 6 11.59b 10.64a 10.28a  0.285 0.001 
DPI 13 11.04b 9.53a 9.07a  0.267 < 0.001 
Hematocrit, %       
DPI 0 39.83 40.59 40.77  0.965 0.718 
DPI 3 36.65 34.90 34.55  0.965 0.193 
DPI 6 35.89b 33.73a 32.93a  0.898 0.023 
DPI 13 34.78c 29.29b 26.79a  0.845 < 0.001 
MCV, fl       
DPI 0 60.58 62.11 61.05  1.01 0.507 
DPI 3 58.77 59.64 60.34  1.01 0.479 
DPI 6 58.21 59.19 59.83  0.930 0.388 
DPI 13 57.50 55.67 56.65  0.870 0.260 
MCH, pg       
DPI 0 18.95 19.37 18.99  0.414 0.689 
DPI 3 18.78 18.95 18.99  0.414 0.924 
DPI 6 18.77 18.63 18.69  0.384 0.961 
DPI 13 18.24 18.13 18.21  0.359 0.971 
MCHC, g/dL       
DPI 0 31.26 31.19 31.11  0.246 0.882 
DPI 3 31.93 31.77 31.46  0.246 0.284 
DPI 6 32.23 31.47 31.24  0.229 0.003 
DPI 13 31.72a 32.14b 32.28b  0.228 0.159 
abcMeans without a common superscript letter differ (P < 0.05). 
1Values represent least square means of 6 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI, day post-inoculation; RBC, red 



















Table 4.9. Effects of soy isoflavones and Porcine Reproductive and Respiratory Virus (PRRSV) infection on the 
leukogram of weanling pigs1 
 Uninfected PRRSV-infected   Model 
Item NEG POS ISF  SEM P-value 
WBC, × 103 cells/µL       
DPI 0 13.77 14.73 14.45  1.90 0.930 
DPI 3 19.96b 13.22a 10.71a  1.90 0.001 
DPI 6 21.29b 12.58a 15.82a  1.76 0.001 
DPI 13 23.08b 17.43a 19.44a  1.65 0.034 
Neutrophils, % of WBC       
DPI 0 39.54 41.93 44.59  5.17 0.729 
DPI 3 51.03 58.97 62.92  5.17 0.196 
DPI 6 43.98a 50.55a 63.67b  4.80 0.003 
DPI 13 26.55a 50.58b 61.09c  4.80 < 0.001 
Band Cells, % of WBC       
DPI 0 0.04 0.46 0.07  1.65 0.976 
DPI 3 0.95 1.37 2.93  1.65 0.595 
DPI 6 1.01 0.90 2.28  1.53 0.690 
DPI 13 0.28 3.17 0.15  1.43 0.144 
Lymphocytes, % of WBC       
DPI 0 48.65 47.85 42.39  4.97 0.514 
DPI 3 40.49 35.83 26.80  4.97 0.079 
DPI 6 47.41b 40.18b 23.17a  4.61 < 0.001 
DPI 13 64.41b 35.75a 29.48a  4.61 < 0.001 
Monocytes, % of WBC       
DPI 0 11.09 8.66 11.68  1.63 0.265 
DPI 3 5.44 2.75 6.71  1.63 0.067 
DPI 6 5.44 5.90 6.17  1.52 0.924 
DPI 13 5.74 7.08 6.85  1.43 0.728 
Eosinophils, % of WBC       
DPI 0 0.67 1.00 1.00  0.586 0.887 
DPI 3 1.67 0.82 0.67  0.586 0.383 
DPI 6 2.00 1.90 1.73  0.542 0.919 
DPI 13 2.38 2.00 1.56  0.507 0.501 
Basophils, % of WBC       
DPI 0 0.16 0.14 0.30  0.280 0.867 
DPI 3 0.33 0.18 0.00  0.280 0.636 
DPI 6 0.27 0.51 0.33  0.260 0.745 
DPI 13 0.37 1.00 0.80  0.244 0.132 
Neutrophil Count, × 103 cells/µL       
DPI 0 5.47 6.24 6.52  1.21 0.786 
DPI 3 10.52b 7.67a 6.49a  1.21 0.036 
DPI 6 9.11b 5.75a 9.53b  1.12 0.009 
DPI 13 6.27a 9.52b 11.72b  1.12 0.002 
Band Cell Count, × 103 cells/µL       
DPI 0 0.00 0.09 0.01  0.554 0.991 
DPI 3 0.22 0.17 0.32  0.554 0.970 
DPI 6 0.22 0.10 0.30  0.513 0.941 
DPI 13 0.07 1.15 0.06  0.480 0.108 
abcMeans without a common superscript letter differ (P < 0.05). 








Table 4.9. Continued1 
 Uninfected PRRSV-infected   Model 
Item NEG POS ISF  SEM P-value 
Lymphocyte Count, × 103 cells/µL       
DPI 0 6.77 6.94 6.00  0.983 0.694 
DPI 3 7.91b 4.78a 3.06a  0.983 0.001 
DPI 6 10.36b 4.32a 3.56a  0.910 < 0.0001 
DPI 13 14.80b 6.35a 6.20a  0.910 < 0.0001 
Monocyte Count, × 103 cells/µL       
DPI 0 1.53 1.28 1.71  0.334 0.548 
DPI 3 1.03 0.44 0.80  0.334 0.230 
DPI 6 1.20 0.73 0.99  0.311 0.478 
DPI 13 1.34 1.39 1.36  0.292 0.993 
Eosinophil Count, × 103 cells/µL       
DPI 0 0.08 0.13 0.14  0.106 0.892 
DPI 3 0.28 0.12 0.09  0.106 0.351 
DPI 6 0.48 0.23 0.27  0.098 0.139 
DPI 13 0.57 0.34 0.34  0.091 0.104 
Basophil Count, × 103 cells/µL       
DPI 0 0.02 0.03 0.05  0.043 0.817 
DPI 3 0.05 0.03 0.00  0.043 0.600 
DPI 6 0.04 0.05 0.06  0.040 0.934 
DPI 13 0.06 0.17 0.10  0.037 0.061 
abcMeans without a common superscript letter differ (P < 0.05). 





























Table 4.10. Effects of soy isoflavones and Porcine Reproductive and Respiratory Virus 
(PRRSV) infection on serum viral RNA (Ct value) in weanling pigs1 
Day Uninfected PRRSV-infected   Model 
Post-Inoculation NEG POS ISF  SEM P-value2 
DPI 0 ND ND ND  0.957 1.000 
DPI 3 ND 14.50 13.65  0.998 0.358 
DPI 6 ND 13.98 15.50  0.998 0.621 
DPI 13 ND 17.12 18.71  0.923 0.629 
1Values represent least square means of 12 to 18 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI, 
day post-inoculation; ND, non-detectable; Ct, cycle threshold. 









































Table 4.11. Effects of soy isoflavones and Porcine Reproductive and Respiratory Virus (PRRSV) infection on 
peripheral blood T-cell immunophenotypes of weanling pig1 
 Uninfected PRRSV-infected   Model 
Cellular Outcome, % NEG POS ISF  SEM P-value 
Total Lymphocytes       
DPI 13 42.3b 20.9a 17.2a  4.25 < 0.001 
DPI 20 50.2 45.1 41.0  4.25 0.234 
Mature T-cells3       
DPI 13 42.0a 49.7b 51.5b  3.08 0.034 
DPI 20 51.1 45.6 51.4  3.08 0.156 
Helper T-cells4       
DPI 13 24.9 28.5 32.4  2.55 0.069 
DPI 20 21.8 20.6 23.5  2.55 0.591 
Cytotoxic T-cells5       
DPI 13 32.5b 23.8a 23.3a  3.15 0.050 
DPI 20 37.0 34.7 33.1  3.15 0.625 
Memory T-cells6       
DPI 13 11.3b 7.05a 7.31a  1.27 0.023 
DPI 20 9.03a 11.5ab 13.2b  1.27 0.046 
Helper:Cytotoxic T-cell Ratio7       
DPI 13 0.83a 1.19a 1.53b  0.143 0.001 
DPI 20 0.64 0.66 0.77  0.143 0.726 
abMeans without a common superscript letter differ (P < 0.05). 
1Values represent least square means of 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI, day post-inoculation 
3Percent of total lymphocytes that are positive for cell-surface marker CD3 
4Percent of CD3-positive lymphocytes that are also positive for cell-surface markers CD4, CD8, or CD4/CD8 
5Percent of CD3-positive lymphocytes that are also positive for cell-surface markers CD8 
6Percent of CD3-positive lymphocytes that are also positive for cell-surface markers CD4/CD8 



























Table 4.12. Effects of soy isoflavones and Porcine Reproductive and Respiratory Virus (PRRSV) infection on 
serum chemistry parameters of weanling pigs1 
 Uninfected PRRSV-infected   Model 
Item NEG POS ISF  SEM P-value 
Creatinine, mg/dL       
DPI 0 1.06 1.02 0.99  0.068 0.658 
DPI 3 0.84 0.92 0.86  0.062 0.517 
DPI 6 0.74a 0.91b 0.90b  0.058 0.035 
DPI 13 0.65 0.73 0.69  0.055 0.537 
BUN, mg/dL       
DPI 0 9.37 9.86 11.6  1.43 0.335 
DPI 3 10.9 12.2 11.7  1.31 0.717 
DPI 6 10.2 11.4 11.4  1.22 0.686 
DPI 13 12.5 14.7 13.7  1.14 0.349 
Total Protein, g/dL       
DPI 0 4.71 4.71 4.53  0.143 0.386 
DPI 3 4.68b 4.25a 4.24a  0.130 0.017 
DPI 6 4.74b 4.29a 4.18a  0.121 0.003 
DPI 13 4.79 4.98 4.82  0.113 0.362 
Albumin, g/dL       
DPI 0 2.98 3.04 2.95  0.129 0.774 
DPI 3 2.93 2.74 2.58  0.118 0.071 
DPI 6 2.94b 2.52a 2.40a  0.109 0.002 
DPI 13 2.81b 2.18a 2.19a  0.102 < 0.001 
Globulin, g/dL       
DPI 0 1.74 1.67 1.58  0.096 0.368 
DPI 3 1.76 1.52 1.66  0.088 0.073 
DPI 6 1.81 1.77 1.78  0.082 0.927 
DPI 13 1.98a 2.79b 2.63b  0.077 < 0.001 
Albumin:Globulin Ratio       
DPI 0 1.80 1.84 1.93  0.124 0.693 
DPI 3 1.68 1.83 1.56  0.114 0.098 
DPI 6 1.66 1.44 1.37  0.101 0.135 
DPI 13 1.43b 0.82a 0.84a  0.099 < 0.001 
Calcium, mg/dL       
DPI 0 11.8 12.2 11.9  0.693 0.861 
DPI 3 14.1b 11.2a 10.6a  0.634 0.0001 
DPI 6 14.3b 11.1a 10.1a  0.588 < 0.001 
DPI 13 12.7b 10.7a 11.1a  0.551 0.023 
Phosphorus, mg/dL       
DPI 0 4.54 4.21 4.19  0.316 0.626 
DPI 3 4.20 3.94 3.95  0.290 0.742 
DPI 6 4.40 3.80 3.89  0.269 0.194 
DPI 13 4.06 4.30 4.38  0.252 0.607 
Sodium, mmol/L       
DPI 0 139 140 139  1.29 0.829 
DPI 3 137 139 140  1.18 0.183 
DPI 6 136 137 136  1.09 0.705 
DPI 13 137b 133a 135b  1.02 0.003 
abMeans without a common superscript letter differ (P < 0.05). 








Table 4.12. Continued1 
 Uninfected PRRSV-infected   Model 
Item NEG POS ISF  SEM P-value 
Potassium, mmol/L       
DPI 0 4.89 5.35 5.33  0.261 0.273 
DPI 3 4.90 4.64 4.91  0.241 0.482 
DPI 6 5.52b 4.95a 4.80a  0.226 0.040 
DPI 13 6.20 6.13 6.09  0.213 0.907 
Sodium:Potassium Ratio       
DPI 0 28.5 26.6 26.4  1.26 0.349 
DPI 3 28.1 30.4 28.9  1.27 0.212 
DPI 6 24.8a 27.8b 28.2b  1.09 0.032 
DPI 13 22.4 22.0 22.3  1.03 0.939 
Chloride, mmol/L       
DPI 0 97.8 99.2 100.0  0.953 0.183 
DPI 3 95.8a 99.1b 98.6b  0.873 0.009 
DPI 6 96.4a 99.0b 98.6b  0.810 0.037 
DPI 13 100.2b 96.9a 96.2a  0.759 < 0.001 
Glucose, mg/dL       
DPI 0 109 114 116  5.30 0.507 
DPI 3 108b 94.6a 90.9a  4.84 0.024 
DPI 6 99.4b 93.4b 83.7a  4.48 0.048 
DPI 13 96.3b 74.0a 77.6a  4.19 < 0.001 
Alkaline Phosphatase, U/L       
DPI 0 287 327 251  50.5 0.329 
DPI 3 312 386 270  46.4 0.064 
DPI 6 392b 277a 189a  43.1 0.004 
DPI 13 495b 139a 92.8a  40.4 < 0.001 
Aminotransferase, U/L       
DPI 0 39.7 33.2 25.1  9.78 0.410 
DPI 3 51.0 61.6 53.7  9.03 0.536 
DPI 6 40.8a 66.5b 68.9b  8.45 0.018 
DPI 13 65.5 83.6 76.5  7.97 0.191 
Gamma-Glutamyl Transferase, U/L       
DPI 0 34.1 34.8 41.2  4.98 0.286 
DPI 3 37.9 38.1 41.0  4.63 0.791 
DPI 6 44.5 42.0 46.4  4.35 0.631 
DPI 13 43.5 49.8 50.0  4.13 0.366 
Total Bilirubin, mg/dL       
DPI 0 0.173 0.157 0.183  0.078 0.947 
DPI 3 0.123a 0.371b 0.359b  0.071 0.012 
DPI 6 0.136 0.225 0.271  0.066 0.329 
DPI 13 0.130 0.144 0.108  0.062 0.889 
Creatine Phosphokinase, U/L       
DPI 0 652 473 270  264 0.478 
DPI 3 1,116 556 428  241 0.077 
DPI 6 716 561 425  223 0.654 
DPI 13 1,083b 841ab 381a  209 0.034 
abMeans without a common superscript letter differ (P < 0.05). 









Table 4.12. Continued1 
 Uninfected PRRSV-infected   Model 
Item NEG POS ISF  SEM P-value 
Cholesterol, mg/dL       
DPI 0 62.6 63.9 61.4  5.46 0.906 
DPI 3 65.0 59.3 55.4  4.99 0.337 
DPI 6 76.4 84.8 73.4  4.62 0.118 
DPI 13 75.1b 58.3a 56.6a  4.32 0.003 
Glutamate Dehydrogenase, U/L       
DPI 0 3.80b 2.89a 2.18a  0.348 0.001 
DPI 3 1.95 1.95 1.80  0.318 0.900 
DPI 6 1.63 2.01 2.31  0.294 0.260 
DPI 13 2.30 2.25 1.89  0.275 0.440 
Total CO2, mmol/L       
DPI 0 25.0 25.7 24.7  1.33 0.775 
DPI 3 28.9 27.5 28.0  1.23 0.722 
DPI 6 26.6 26.4 25.3  1.13 0.663 
DPI 13 23.9a 25.6ab 27.4b  1.05 0.045 
Magnesium, mg/dL       
DPI 0 1.85 1.83 1.83  0.119 0.986 
DPI 3 1.83 1.67 1.74  0.109 0.461 
DPI 6 1.83 1.67 1.72  0.101 0.400 
DPI 13 2.06 1.90 1.98  0.095 0.427 
Triglycerides, mg/dL       
DPI 0 41.4 44.6 38.6  7.36 0.713 
DPI 3 34.7 29.0 25.5  6.77 0.554 
DPI 6 44.5 51.2 49.0  6.31 0.681 
DPI 13 65.0 51.0 51.4  5.93 0.121 
Anion Gap       
DPI 0 20.7 20.2 20.8  1.54 0.920 
DPI 3 17.6 17.1 18.4  1.41 0.689 
DPI 6 18.9 16.7 16.6  1.31 0.335 
DPI 13 19.5 16.7 17.7  1.23 0.207 
abMeans without a common superscript letter differ (P < 0.05). 































Figure 4.1. Average body weights of pigs by treatment over the course of the entire growth period. Means assigned differing numbers of asterisks (*) are 


























Figure 4.2. Erythrogram results for red blood 
cell counts of whole blood, hemoglobin 
concentrations of whole blood, and percent 
hematocrit of whole blood collected on 0, 3, 
6, and 13 days post-inoculation by treatment. 
Means assigned differing numbers of 
asterisks (*) are different at P < 0.05. 
Abbreviations: PRRSV, porcine reproductive 
and respiratory syndrome virus; ISF, 
isoflavones; Treatment ID: NEG, control diet 
+ uninfected; POS, control diet + PRRSV-


















































Figure 4.3. Leukogram results for white 
blood cell counts, raw neutrophil cell counts, 
and raw lymphocyte cell counts of whole 
blood collected on 0, 3, 6, and 13 days post-
inoculation by treatment. Means assigned 
differing numbers of asterisks (*) are 
different at P < 0.05. Abbreviations: PRRSV, 
porcine reproductive and respiratory 
syndrome virus; ISF, isoflavones; Treatment 
ID: NEG, control diet + uninfected; POS, 
control diet + PRRSV-infection; ISF, control 
















































Figures 4.4. Counts of 
individual pigs within treatment 
with detectable anti-PRRSV 
neutralizing antibody titers and 
associated titer result at 20, 27, 
and 34 DPI. Antibody titers were 
measured in 12 pigs per 
treatment and the same 
individual pigs were used for 
sample collection when possible. 
NEG treatment was omitted 
from these figures as they never 
tested positive for anti-PRRSV 
antibodies across all the time 
points measured. Abbreviations: 
PRRSV, porcine reproductive 
and respiratory syndrome virus; 




























Figure 4.5. Visual representation of PRRSV status on pen basis by PRRS viral antigen via qRT-PCR in group-based oral fluids from 39 DPI onward. Oral fluids 
were collected from up to 6 pens per treatment and collection was discontinued for an individual pen following 2 consecutive weeks of negative test results. The 
NEG treatment was omitted from this figure as no NEG pens tested positive for PRRS viral RNA over the course of the experiment. Values represent Ct value of 
submitted samples. A Ct value ≤ 38.0 was considered a positive result and a Ct value of 38.0-45.0 is considered suspect. Abbreviations: PRRSV, porcine 


























Figure 4.6. Percent mortality within treatment across the entire experiment depicted in reference to the inoculation schedule. Percent mortality is out of 24 pigs 
total for the NEG treatment and 36 pigs total for both POS and ISF treatments. Abbreviations: PRRSV, porcine reproductive and respiratory syndrome virus; 
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CHAPTER 5: ALTERATIONS OF FECAL MICROBIOME CHARACTERISTICS BY 
DIETARY SOY ISOFLAVONE INGESTION IN GROWING PIGS INFECTED WITH 
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS 
Abstract 
 Porcine reproductive and respiratory syndrome virus (PRRSV) is an economically important 
disease and ingestion of soy isoflavones (ISF) may benefit PRRSV-infected pigs due to 
demonstrated anti-inflammatory and anti-viral properties. The objective of this study was to 
quantify long-term effects of ISF consumption on fecal microbiome characteristics under disease 
challenge. In total, 96 weaned barrows were group-housed in a Biosafety Level-2 containment 
facility and allotted to 1 of 3 experimental treatments that were maintained throughout the study: 
non-infected pigs receiving an ISF-devoid control diet (NEG, n=24), and infected pigs receiving 
either the control diet (POS, n=36) or that supplemented with total ISF in excess of 1,600 mg/kg 
(ISF, n=36). Following a 7-day adaptation, pigs were inoculated intranasally with either a sham-
control (PBS) or live PRRSV (1×105 TCID50/mL, strain NADC20). Fecal samples were 
collected from 48 individual pigs at pre-infection (-2 days post-inoculation, DPI), peak-infection 
(10 DPI), post-infection (144 DPI) time-points. Extracted DNA was used to quantify fecal 
microbiota profiles via 16S bacterial rRNA sequencing. Differences in bacterial communities 
among diet groups were evaluated with principal co-ordinate analysis (PCoA) and permutational 
multivariate analysis of variance (PERMANOVA) using UniFrac distance matrices. Both 
unweighted and weighted UniFrac distances using QIIME 2. All other data were analyzed by 
one-way ANOVA performed on square root transformations using R. Across all time-points, 
only minimal differences were observed due to ISF alone. The most notable difference observed 
was decreased relative abundance of Actinobacteria at 144 DPI between non-infected and 
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infected treatments (P < 0.05), which is consistent with various dysbioses observed in other 
disease models. Our findings indicate that differences present were mainly due to PRRSV-
infection alone and not strongly influenced by diet, which implies previously observed 
performance benefits conferred by dietary ISF are not likely due to changes in microbiome 
composition. 
Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) continues to be one of the 
leading pathogens with high economic impact in modern swine production (Holtkamp et al., 
2013). Due to its prevalence and a lack of highly effective vaccines (Loving et al., 2015), 
nutritional intervention or management strategies are of high interest for PRRSV mitigation due 
to relatively low cost and ease of implementation. Previously it has been demonstrated that 
increased levels of soybean meal in diets fed to pigs under immune stress reduces adverse effects 
of illness and may improve growth performance (Boyd et al., 2010; Rochell et al., 2015). 
However, it remains unclear if improved growth performance in those studies were due to 
differences in dietary bioavailable amino acid content or the presence of other dietary 
components. Among these components, soy isoflavones (ISF) are naturally occurring flavonoid 
compounds that possess anti-inflammatory and anti-oxidative properties (Smith and Dilger, 
2018). Under PRRSV-challenge, weaned pigs that received dietary ISF have previously 
exhibited improved immune responses to PRRSV by improved growth performance, reduce viral 
load, and improved adaptive immune cell responses by measurements of effector T-cell 
proportions during peak infection periods (Greiner et al., 2001; Smith et al., 2019). More 
recently, when ISF were fed to growing pigs infected with PRRSV over the entire growth period 
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from weaning to market, dietary ISF improved PRRSV clearance during recovery and reduced 
pathogen-related mortality by approximately 50% (Smith et al., 2020).  
In light of these effects on the response to PRRSV-infection in an in vivo model, it is 
unclear if dietary ISF and their metabolites are producing these effects directly following 
absorption into the body or if these effects are due to alterations of the gastrointestinal 
microbiome. While it is fairly well accepted that the gastrointestinal microbiome can influence 
systemic immune system function through the “gut-lung axis” (Collado et al., 2018), there is also 
evidence that soy ISF can influence the composition of the gastrointestinal microbiome (Nakatsu 
et al., 2014; Huang et al., 2016; Paul et al., 2017; Vázquez et al., 2017; Kolátorová et al., 2018). 
These alterations may impact modulation of immune function and thus systemic response to 
infections. For those reasons, the objective of this experiment was to evaluate how consumption 
of soy ISF by PRRSV-infected pigs affected the longitudinal composition of the gastrointestinal 
microbiota throughout the entire growth period. Our hypothesis was that both PRRSV-infection 
status and consumption of ISF would result in detectable differences in global microbiome 
composition in growing pigs. 
Materials and Methods 
The protocol for this experiment was approved by the Institutional Animal Care and Use 
Committee and the Institutional Biosafety Committee of the University of Illinois at Urbana-
Champaign. 
Animal Husbandry and Experimental Design 
This experiment is a continuation of the one described in Chapter 4 of this dissertation 
and utilized the same animals for sample collection. In total, ninety-six weanling pigs (96 
barrows; 6.77 ± 0.94 kg initial body weight) were obtained from a PPRSV-negative, non-PRRSV 
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vaccinated commercial herd (1050 Cambro genetics; Carthage Veterinary Service, Ltd.) and 
group-housed at the Innovative Swine Solutions Veterinary Research Facility (ISS-VRF), a 
Biosafety Level 2 production containment facility in Champaign, IL. Pigs were managed at this 
facility through market weight (approximately 27 weeks of age, 118-129 kg average body 
weight) and then transported to the Meat Science Laboratory at the University of Illinois for 
slaughter. The ISS-VRF consisted of 4 individual production rooms (9.1 m x 4.3 m) with 4 pens 
(up to 6 pigs per pen) available to house pigs in each room. Each room was equipped with a 
high-efficiency particulate air filtration system, plastic slotted flooring appropriate for market-
sized pigs, and each pen provided appropriate floor space for pigs taken to market weight. 
Lighting and ambient temperature was maintained as appropriate for life stage. 
Upon entry to the facility, pigs were weighed and uniformly allotted to 1 of 3 
experimental treatments [n = 24 for non-PRRSV-infected controls (NEG), n = 36 each for 
PRRSV-infected controls (POS) and PRRSV-infected receiving soy isoflavones (ISF)] by 
completely randomized design based on initial body weight. All replicates of the NEG treatment 
(6 pigs per replicate, 4 replicates total) were housed in a single room to account for biosecurity 
while replicates for POS and ISF treatments (6 pigs per replicate, 6 replicates total) were equally 
represented in the remaining three rooms at ISS-VRF. Two levels of supplemental ISF (none vs. 
≥1,600 mg/kg Novasoy400; ADM, Decatur, IL) constituted the total of two dietary treatments 
(Table 5.1). The ISF concentrations used in the ISF treatment were reflective of those typical for 
a commercially relevant corn-soybean meal diet fed to pigs with approximately 20% soybean 
meal inclusion (USDA-ARS, 2016). Both diets contained soy protein concentrate (SPC) as a 
protein source, as this ingredient is practically devoid of soy ISF. Experimental diets were 
formulated to be isocaloric and, with the exceptions of corn and the isoflavone-enriched product, 
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were identical in ingredient and nutrient composition. Experimental diets were fed over 7 feeding 
phases including nursery phases 1 and 2 (N1-N2) and finisher phases 1-5 (F1-F5). For additional 
information regarding experimental diet formulations and nutrient composition, please refer to 
Chapter 4 of this dissertation.  
Following a 1-week adaptation period to experimental diets [days post-inoculation (DPI) 
-7 to 0], blood was collected from 2 pigs per pen to establish 0 DPI baseline measurements and 
to ensure that a representative number of pigs were confirmed PRRSV-negative at experiment 
initiation. Immediately following blood collection, pigs were administered via intranasal 
inoculation either 2 mL of a 2% fetal bovine serum + phosphate-buffered saline solution (sham-
control) or 1.0×105 50% tissue culture infective dose of PRRS virus (strain NADC20, courtesy 
of Dr. Federico Zuckermann, University of Illinois, Urbana, IL).  
Fecal Sample Collection 
Individual pigs served as the experimental unit for all fecal microbiota outcomes 
described herein. Fecal samples were collected manually by trained personnel with a clean fecal 
loop from up to 3 pigs per pen (12-18 pigs/treatment, same pigs collected at each time-point 
when possible) on -2, 10, and 144 DPI to represent baseline, peak infection, and post-PRRSV 
clearance time-points. Samples were stored at -80°C pending DNA extraction. 
Fecal Bacterial DNA Extraction and Analyses 
For DNA extraction, 180-220 mg of feces from individual samples was homogenized 
using MP Biomedicals Lysing Matrix E 2 mL tubes (MP Biomedicals, Santa Ana, CA). DNA 
was extracted from homogenized samples using the QIAamp FastDNA Stool Mini Kit (Qiagen, 
Valencia, CA) per manufacturer instructions and concentrations of isolated DNA were quantified 
using a Nanodrop 1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). Quality 
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of the DNA was checked on a 1% agarose gel following staining with ethidium bromide. When 
at sufficiently high quality, individual samples were then diluted to 20 ng/µL using 
RNAse/DNAse-free water and 15 µL of diluted DNA was transferred to a 96-well plate for 
submission to the University of Illinois High-Throughput Sequencing and Genotyping Unit at the 
Roy J. Carver Biotechnology Center for polymerase chain reaction amplification and sequencing 
of 16S bacterial rRNA genes for microbial profiling. 
Statistical Analyses 
Differences in bacterial communities among diet groups were evaluated with principal 
co-ordinate analysis (PCoA) and permutational multivariate analysis of variance 
(PERMANOVA) using UniFrac distance matrices. Based on both unweighted and weighted 
UniFrac distances using QIIME 2 (2019.4) (Caporaso et al., 2011). All other data were analyzed 
by one-way ANOVA performed on square root transformations using R (version 3.5.4, Vienna, 
Austria) and sliced by DPI. Please note that due to greater loss in mortality than expected (Smith 
et al., 2020), several animals were not able to be sampled at each time-point. Thus, we chose to 
analyze the microbial data individually at each time-point, rather than across time-points. Post-
hoc mean separation with a Tukey adjustment was performed if the ANOVA resulted in a P-
value < 0.05. Mean separation was performed by main effect of treatment and significance was 
accepted at P ≤ 0.05. Only bacterial phyla and genera with at least one mean with relative 
abundance >0.3% and > 1.0%, respectively, were interpreted and summarized in data tables. 
Data are presented as least-squares means with pooled standard errors of the mean (SEM). For 
relative abundance microbiota outcomes, data are presented as raw least-square means plus 




For the sake of clarity, measures of alpha diversity (i.e., species richness or number of 
distinguishable taxa within an individual sample) and beta diversity (i.e., difference between 
global microbial communities or differences in taxonomic abundance profiles between individual 
samples) are discussed separately, with beta diversity being discussed first. Please note that some 
of the bacterial genera detected through our analyses are newly identified and have not yet been 
fully classified, so they may be identified by higher taxonomic level names, particularly at the 
family level. In those cases, the bacterial genera names are preceded by the letter “F” in 
parentheses, indicating that it is associated with a specific taxonomic family.  
Beta and Alpha Diversity Measures 
 Beta diversity was evaluated by PCoA and PERMANOVA using both unweighted and 
weighted UniFrac distances matrices and are represented by experimental time-point in Figure 
5.1. During the pre-infection period (-2 DPI), PERMANOVA analysis revealed that overall 
bacterial composition in fecal samples did not differ between treatments (P > 0.05). However, at 
peak infection (10 DPI), PERMANOVA analysis revealed that overall bacterial composition in 
fecal samples differed (unweighted, P = 0.012; weighted, P = 0.02) between non-infected (NEG) 
and infected treatments (POS and ISF); the two infected treatments did not differ from each 
other. By the post-infection period, PERMANOVA analysis revealed that overall bacterial 
composition in fecal samples differed, but only for unweighted UniFrac measures (unweighted, 
P = 0.003; weighted, P = 0.172).  
 Alpha diversity was evaluated using operational taxonomic units (OTU) at the phyla and 
genera level. Differences in relative abundance of bacteria at these taxonomic levels is discussed 
in the following section. Visualization of variation in phyla relative abundance among individual 
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samples across sampling time-points can be found in Figure 5.2. Additionally, heat maps 
depicting the differences in relative abundance of both common (> 1.0%) and rare (< 1.0%) 
genera among treatments across sampling time-points can be found in Figures 5.3 and 5.4, 
respectively.  
Relative Abundance of Bacteria at the Phyla and Genera Level 
At the pre-infection period (-2 DPI), 8 phyla and 30 genera were detected at or above our 
interpretation thresholds (0.3% and 1.0%, respectively). There were no differences in relative 
abundance at the phyla level between treatments at the pre-infection time-point (Table 5.2). At 
the genera level, the NEG treatment had a greater (P < 0.05) relative abundance of Roseburia 
bacteria than POS and ISF treatments (Table 5.3).  
At peak infection (10 DPI), 6 phyla and 26 genera were detected at or above our 
interpretation thresholds. At the phyla level, the ISF treatment had greater (P < 0.05) relative 
abundance of Proteobacteria bacteria compared with the NEG treatment, but did not differ from 
the POS treatment (Table 5.4). At the genera level, there were 5 differences detected among 
experimental treatments (Table 5.5). The NEG treatment had greater (P < 0.05) relative 
abundance of Prevotella 9 compared with POS and ISF treatments and greater (P < 0.05) relative 
abundance of (F) Prevotellaceae Unassigned and Anaerovibrio compared with the ISF treatment 
only, with the POS treatment exhibiting intermediated relative abundances for those genera. The 
ISF treatment had greater (P < 0.05) relative abundance of Prevotellaceae NK3B31 group 
compared with the NEG treatment, with the POS treatment exhibiting an intermediate relative 
abundance. Alternatively, the ISF treatment had lower (P < 0.05) relative abundance of Dialister 




At the post-infection time-point (144 DPI), 7 phyla and 27 genera were detected at or 
above our interpretation thresholds. At the phyla level, there was a difference observed for 
Actinobacteria, with the NEG treatment expressing greater (P < 0.05) relative abundance 
compared with POS and ISF treatments, though the total relative abundance of this phylum 
across treatments was low (Table 5.6). At the genera level, there were 7 differences detected 
among experimental treatments (Table 5.7). The NEG treatment had greater (P < 0.05) relative 
abundance of CAG-873 and Prevotellaceae UCG-004 compared with both the POS and ISF 
treatments. Both the NEG and POS treatment had greater (P < 0.05) relative abundance of 
Clostridium sensu stricto 1 compared with the ISF treatment. The NEG treatment had greater (P 
< 0.05) relative abundance of Ruminococcaceae UCG-002 and Lachnospiraceae XPB1014 
group compared with the POS treatment, with the ISF treatment exhibiting an intermediate 
relative. The ISF treatment had greater (P < 0.05) relative abundance of (F) Lachnospiraceae 
Unassigned and Ruminococcaceae UCG-014 compared with the NEG treatment, with the POS 
treatment exhibiting an intermediate relative abundances.  
Discussion 
  In the live-animal phase of this study (Smith et al., 2020), ISF consumption over the 
entire growth period resulted in earlier complete viral clearance and an approximately 50% 
reduction in pathogen-related mortalities in pigs infected with PRRSV, though there were no 
growth performance benefits observed. Those results suggest that when included at levels that 
are typical for standard commercial swine diets, soy ISF may support the immune response to 
PRRSV, particularly in the presence of severe secondary bacterial infections. While it is 
understood that ISF can interact directly with cell signaling cascades utilized by the immune 
system (Smith and Dilger, 2018), within the context of this live-animal model it was unclear 
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whether such beneficial health effects were due to direct action of ISF in circulation or if changes 
to the gastrointestinal microbiome may be contributing to these systemic effects.   
 Regarding the role of the gastrointestinal microbiome in immune function, the “gut-lung 
axis” is a well-documented phenomena that represents the bi-directional communication between 
microbial populations of the gastrointestinal and respiratory tracts (Collado et al., 2018). In 
general, the gastrointestinal microbiome has been shown to play a role in the development of 
innate immunity (e.g., maintenance of homeostasis, epithelial function at mucosal surfaces), T-
cell differentiation, modulation of local and systemic inflammation, and regulate homeostasis of 
the adaptive immune response (Kau et al., 2011; Hooper et al., 2012; Hauptmann and Schaible, 
2016; Niederwerder, 2017). These effects are not only driven by the composition of microbial 
populations in the gastrointestinal tract (GIT), but also through the production of different 
metabolites through fermentation dependent on predominant species present. These metabolites, 
most notably short-chain fatty acids, have been shown to not only have local effects on mucosal 
immune and barrier function in the intestinal tract, but also influence the development of 
peripheral immune cells such as dendritic cells and B-cells, thus impacting their overall function 
(Collado et al., 2018). When considering immune function at the level of the respiratory tract, it 
has been suggested that the GIT and respiratory tract share a common mucosal response, which 
involves effects of the gastrointestinal microbiome on mucosal immunity driving immune 
responses at distal mucosal sites (Mcghee and Fujihashi, 2012; Hauptmann and Schaible, 2016; 
Date et al., 2017). In practice, several dysbioses (i.e., microbial imbalances or maladaptation on 
or inside the body) in the gastrointestinal microbiota have been associated with lung disorders 
and respiratory infections in humans, including viral pathogens such as influenza virus (Collado 
et al., 2018). Within respiratory viral pathogen disease models, microbiome composition and 
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diversity has been shown to be directly associated with clinical outcomes, including disease 
progression, airway inflammation, immune response, and morbidity (Niederwerder, 2017; Ober 
et al., 2017).  
 This relationship between respiratory infections and gastrointestinal dysbioses are also 
observed in swine respiratory disease models (Niederwerder et al., 2016; Niederwerder, 2017; 
Ober et al., 2017; Niederwerder et al., 2018). Considering disease models utilizing PRRSV, 
microbial composition has been linked to differences in pig performance following pathogenic 
challenge. In a PRRSV and porcine circovirus type 2 (PCV2) co-infection model in weanling 
pigs, researchers found that pigs with the best clinical outcomes had greater fecal microbial 
diversity than pigs with the worst clinical outcomes. In the worst clinical outcomes group, pigs 
experienced delayed peak PRRSV-infection with prolonged and increased viremia, higher peak 
PCV2 viremia levels (non-significant), and increased serum concentrations of Bacillus cereus, 
suggesting these animals experienced a more severe systemic infection and compromised 
mucosal integrity. Regarding microbiome differences observed, in addition to differences in 
overall measures of microbiome diversity, pigs in the worst clinical outcomes group notably had 
no Escherichia coli detected in their fecal samples, which has been found to influence feed 
efficiency and growth performance in growing pigs (Niederwerder et al., 2016). Continuation of 
the same research found that even early microbiome properties (i.e., composition and diversity 
prior to disease challenge) influenced performance outcomes of PRRSV/PCV2 co-infected pigs, 
suggesting that the effects of the gastrointestinal microbiome on immune function extends 
beyond current GIT conditions. Following subclinical infection, there was a clear divergence 
between high and low growth rate groups during the mid-to-late infection period, with pigs in the 
high growth rate group exhibiting reduced viral replication rates and decreased lung lesion 
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severity. Like previous findings from this group, pigs in the high growth rate group had 
increased fecal microbial diversity (Ober et al., 2017). In general, a common finding across these 
studies and other respiratory disease models is increased global microbial diversity at the level of 
the gastrointestinal tract being associated with improved clinical outcomes in infected 
individuals. 
 Within our own experiment, we observed differences in beta diversity or global microbial 
diversity at peak-infection and post-infection time-points (10 and 144 DPI) between 
experimental treatments. These differences were most notable at our peak-infection time-point, 
with significance achieved for both weighted and unweighted UniFrac distance matrices, and 
appear to mainly be due to PRRSV-infection as infected treatments did not differ from one 
another. At the post-infection time point, there was an effect of treatment on beta diversity with 
the NEG treatment differing from our infected treatments, but only for unweighted UniFrac 
distance matrices. These differences are in line with the PRRSV co-infection models described 
above, but suggest that at the inclusion level utilized for this experiment ISF do not result in 
dramatic shifts of global microbial diversity in the GIT.  
 While we observed differences that appeared to be due to PRRSV alone, alpha diversity 
or relative abundance at both the phyla and genera levels were not strongly influenced ISF 
supplementation. Regardless, a vast majority of differences in relative abundance occurred so at 
post-inoculation time-points. At the peak-infection time-point, we detected a single difference at 
the phyla level between the NEG and ISF treatment for Proteobacteria with the ISF treatment 
showing greater relative abundance. Interestingly, increased abundance of Proteobacteria has 
been associated with improved clinical outcomes under swine pathogen challenge (Niederwerder 
et al., 2016; Smith et al., 2020). However because the ISF treatment did not differ from the POS 
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treatment it is unclear whether this increased relative abundance contributed to any of the 
performance differences observed in the live animal phase of this experiment. At the genera 
level, reduced relative abundance of Prevotella 9, (F) Prevotellaceae Unassigned, and 
Anaerovibrio genera appear to be mainly driven by PRRSV-infection. Among these findings, the 
difference in Prevotella 9 abundance is most notable due to its reduction from nearly 20% in 
non-infected control pigs to less than 10% in infected pigs. However, knowing the specific 
function of this Prevotella genera is difficult due to genetic and overall microbiota differences in 
the host. Prevotella, while having been identified as potentially beneficial microbes, are also 
linked to inflammatory conditions such as colitis and arthritis under immune suppressive states 
(Dillon et al. 2016). Based on those findings, we would have expected a relationship for 
Prevotella abundance with a PRRSV-infection model opposite to what was observed. 
Additionally, previous nutrition studies in humans suggest that effects of single diet ingredients 
on Prevotella are not easily predicted (Kovatcheva-Datchary et al. 2015). Regarding dietary 
supplementation, ISF increased the relative abundance of the Prevotellaceae NK3B31 group and 
decreased the relative abundance of Dialister compared with the NEG treatment. Of these two 
genera quantified in intestinal dysbioses models, Prevotellaceae species has been found to be a 
driver of chronic inflammation at the level of the GIT. In the context of our model, one could 
argue that ISF in the presence of a PRRSV-infection support the growth of this particular 
bacteria species (Palm et al., 2015).  
Moving to the post-infection time-point, we detected a single difference at the phyla level 
for relative abundance of Actinobacteria between our NEG treatment and our infected 
treatments, with PRRSV-infection appearing to decrease the relative abundance of this bacteria. 
Reduction in the relative abundance of Actinobacteria has been linked to various dysbioses for 
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which changes typically represent a loss of microbial richness that may directly impact amino 
acid synthesis, cell junction integrity, and inflammatory responses (Rinninella et al., 2019). At 
the genera level, reduced relative abundance of the CAG-873 and Prevotellaceae UCG-004 
genera appeared to be driven by PRRSV-infection alone. The reduction in Prevotellaceae UCG-
004 specifically here is unexpected as other Prevotellaceae genera measured in this experiment 
demonstrated the opposite relationship. Regarding ISF supplementation, ISF appeared to 
increase the relative abundance of (F) Lachnospiraceae Unassigned and Ruminococcaceae 
UCG-014 genera relative to the NEG treatment and decreased the relative abundance of 
Clostridium sensu stricto 1 genera relative to both the NEG and POS treatments. Alternatively, 
the ISF treatment exhibited intermediate relative abundance of Ruminococcaceae UCG-002 and 
Lachnospiraceae XPB1014 group genera compared with the NEG and POS treatments. In 
previous PRRSV-challenge studies, pigs demonstrating improved performance exhibited 
increased species diversity in the Ruminococcaceae family, which was previously associated 
with improved growth performance (Ober et al., 2017). In the context of our model, it may be 
that ISF in the presence of a PRRSV-infection supports the growth of certain Ruminococcaceae 
bacteria within the GIT, though it is difficult to speculate what the specific role these individual 
genera play in the global response to PRRSV-infection. Increased relative abundance of 
Lachnospiraceae bacteria have been associated with gastrointestinal dysbioses, specifically 
irritable bowel syndrome in humans (Rinninella et al., 2019), though within our model there 
appear to be inconsistent effects of ISF supplementation on its presence under PRRSV-
challenge. 
Though a number of differences in relative abundance were detected within our model 
based on our interpretation criteria, interpretation of these findings must be done conservatively. 
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It is important to note that the majority of differences detected at the genera level and involved 
bacterial genera that on average had a relative abundance of less than 3% (range: 0.16% to 
18.5% across all treatments). Additionally, many of these genera are either newly identified or 
not well described regarding their role in swine specifically. Due to that limitation and the 
relatively low abundance of these bacteria, it is difficult to make conclusions on their specific 
role in the clinical response to PRRSV-infection within our model.  
While our model did result in changes to global microbial diversity, the magnitude of 
those differences appear to be less than previously observed in PRRSV-challenge models 
(Niederwerder et al., 2016; Ober et al., 2017). This is particularly noticeable when referencing 
visualizations of phyla and genera relative abundance across our experimental time-points 
(Figures 5.2-5.4); differences between experimental treatments are not particularly robust, 
especially when considering pre- and post-infection time-points. That could be due to differences 
in how global diversity was measured between our experiment and previous models or simply 
unaccounted for differences in viral strain properties and influence on the GIT. Additionally, 
while we can appreciate that there are noticeable visual differences in relative abundance 
distributions across experimental time-points (e.g., phyla relative abundance at -2 DPI vs. 144 
DPI), we analyzed each experimental time-point individually, which prevented us from taking 
the effect of time into account on individual microbiome composition. 
Implications 
  In conclusion, there were few differences detected at either the phyla or genera level 
between treatments regardless of time point. Of the differences observed, the reduction in the 
relative abundance of Actinobacteria phylum during the post-infection period (144 DPI) may be 
of interest due to its association with dysbioses within other disease models. Our observations 
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suggest that most of the differences present were likely due to PRRSV infection alone and not 
strongly influenced by diet, which implies that the performance benefits conferred by dietary 
isoflavones in our live animal phase, such as reduced mortality, were not likely due to changes in 
microbiome composition or function. 
Implications 
In conclusion, there were few differences detected at either the phyla or genera level between 
treatments regardless of time point. Of the differences observed, some have been previously 
associated with gastrointestinal dysbioses and differences in pig performance under respiratory 
disease challenge. Our observations suggest that most of the differences present were likely due 
be driven by PRRSV-infection and not strongly influenced or inconsistently influenced by diet, 
which implies that the performance benefits observed within infected treatments conferred by 
dietary isoflavones in the companion study, such as reduced mortality, were not likely due to 














Tables and Figures 
Table 5.1. Experimental treatments1 
Treatment Dietary Treatment Infection Status 
NEG Control diet Uninfected 
POS Control diet PRRSV-Infected 
ISF Control diet + ISF2 PRRSV-Infected 
1Abbreviations: PRRSV, porcine reproductive and respiratory syndrome virus; ISF, isoflavones. 







Table 5.2. Percent relative abundance of bacterial phyla detected in fecal samples at -2 DPI1,2 
 Treatment  
Bacterial phyla3 NEG POS ISF P-value 
Bacteroidetes 47.9 ± 3.54 49.9 ± 1.96 48.1 ± 3.40 0.791 
Deferribacteres 0.93 ± 0.57 0.76 ± 0.46 0.82 ± 0.42 0.822 
Epsilonbacteraeota 9.93 ± 2.74 6.52 ± 1.42 7.20 ± 2.14 0.628 
Firmicutes 34.1 ± 3.64 35.7 ± 1.66 34.3 ± 3.08 0.793 
Fusobacteria 1.04 ± 0.48 1.45 ± 1.06 1.81 ± 0.85 0.918 
Kiritimatiellaeota 0.47 ± 0.47 0.02 ± 0.01 0.07 ± 0.04 0.696 
Proteobacteria 3.66 ± 0.86 2.30 ± 0.33 4.39 ± 1.11 0.198 
Spirochaetes 1.42 ± 0.38 2.58 ± 0.63 2.80 ± 0.99 0.561 
1Abbreviations: DPI: days post-inoculation; PRRSV: porcine reproductive and respiratory syndrome virus; ISF = isoflavones; NEG: Control diet + uninfected; POS: 
Control diet + PRRSV-infection; ISF: Control diet + ISF + PRRSV-infection.  
2Data are expressed as least-square mean ± standard error of the mean (SEM) for each treatment group.  





















Table 5.3. Relative abundance of bacterial genera detected in fecal samples at -2 DPI1,2 
 Treatment  
Bacterial genus by phyla3 NEG POS ISF P-value 
Bacteroidetes     
Alloprevotella 6.55 ± 1.75 8.05 ± 1.58 6.14 ± 1.69 0.606 
Bacteroides 0.84 ± 0.47 0.97 ± 0.33 1.60 ± 0.55 0.581 
dgA-11 gut group 0.80 ± 0.36 0.54 ± 0.14 1.16 ± 0.32 0.310 
(F) Muribaculaceae Porphyromonadaceae Unassigned 2.71 ± 0.61 4.59 ± 1.39 7.90 ± 2.49 0.354 
(F) Muribaculaceae Unassigned 2.20 ± 0.64 1.51 ± 0.29 1.46 ± 0.32 0.493 
Parabacteroides 1.49 ± 0.27 1.38 ± 0.26 1.53 ± 0.28 0.961 
Prevotella 1 1.48 ± 0.29 2.48 ± 0.42 2.32 ± 0.63 0.415 
Prevotella 2 4.08 ± 0.84 3.22 ± 0.53 2.44 ± 0.60 0.192 
Prevotella 9 13.9 ± 3.83 9.30 ± 1.36 7.16 ± 1.18 0.241 
Prevotellaceae NK3B31 group 2.60 ± 0.52 2.40 ± 0.36 2.05 ± 0.32 0.614 
Prevotellaceae UCG-003 3.70 ± 1.01 5.60 ± 0.80 3.92 ± 1.06 0.136 
Rikenellaceae RC9 gut group 3.53 ± 0.39 4.94 ± 0.72 5.17 ± 0.87 0.340 
Firmicutes     
Agathobacter 2.85 ± 1.18 2.17 ± 0.50 1.04 ± 0.29 0.108 
Anaerovibrio 2.22 ± 0.92 1.19 ± 0.26 1.02 ± 0.49 0.242 
(F) Eubacterium coprostanoligenes group 0.56 ± 0.10 1.17 ± 0.24 1.65 ± 0.64 0.343 
Faecalibacterium 2.16 ± 0.70 1.79 ± 0.35 1.31 ± 0.23 0.548 
Lachnospiraceae NK4A136 group 2.02 ± 0.63 2.67 ± 0.79 1.48 ± 0.62 0.349 
(F) Lachnospiraceae Unassigned 2.72 ± 0.53 2.90 ± 0.45 2.20 ± 0.43 0.408 
Lactobacillus 4.37 ± 1.81 3.81 ± 0.90 3.39 ± 1.20 0.644 
Megasphaera 2.69 ± 2.10 0.19 ± 0.13 2.94 ± 2.12 0.196 
Phascolarctobacterium 1.15 ± 0.35 1.79 ± 0.34 1.63 ± 0.40 0.532 
Roseburia 1.35 ± 0.41b 0.59 ± 0.11a 0.58 ± 0.15a 0.039 
Ruminococcaceae UCG-002 1.05 ± 0.25 1.74 ± 0.32 1.95 ± 0.47 0.411 
(F) Veillonellaceae Unassigned 0.54 ± 0.25 1.83 ± 0.73 1.87 ± 1.23 0.665 
Fusobacteria     
Fusobacterium 1.04 ± 0.48 1.45 ± 1.06 1.81 ± 0.85 0.910 
Proteobacteria     
Campylobacter 9.48 ± 2.64 6.30 ± 1.43 6.00 ± 1.88 0.546 
Desulfovibrio 0.84 ± 0.14 1.10 ± 0.15 1.09 ± 0.23 0.645 
Helicobacter 0.46 ± 0.18 0.23 ± 0.11 1.21 ± 0.77 0.324 
Succinivibrio 1.07 ± 0.59 0.40 ± 0.22 2.05 ± 0.84 0.109 
Spirochaetes     
Treponema 2 1.30 ± 0.35 2.51 ± 0.63 2.66 ± 0.99 0.568 
abMeans without a common superscript letter differ (P < 0.05). 
1Abbreviations: DPI: days post-inoculation; PRRSV: porcine reproductive and respiratory syndrome virus; ISF = isoflavones; NEG: Control diet + uninfected; POS: 
Control diet + PRRSV-infection; ISF: Control diet + ISF + PRRSV-infection.  
2Data are expressed as least-square mean ± standard error of the mean (SEM) for each treatment group.  
3Only genera with at least one mean with > 1.0% relative abundance were considered for interpretation. Bacterial genera names preceded by (F) indicates that genera 









Table 5.4. Percent relative abundance of bacterial phyla detected in fecal samples at 10 DPI1,2 
 Treatment  
Bacterial phyla3 NEG POS ISF P-value 
Bacteroidetes 50.1 ± 2.32 46.4 ± 2.7 42.4 ± 2.64 0.123 
Elusimicrobia 0.41 ± 0.40 0.16 ± 0.10 0.09 ± 0.05 0.934 
Epsilonbacteraeota 1.65 ± 0.42 3.62 ± 1.38 2.48 ± 0.72 0.536 
Firmicutes 41.1 ± 2.76 36.8 ± 2.25 38.7 ± 3.00 0.533 
Proteobacteria 5.15 ± 1.23b 10.4 ± 2.22ab 10.7 ± 1.71a 0.045 
Spirochaetes 1.07 ± 0.48 1.72 ± 0.47 4.66 ± 1.57 0.070 
abMeans without a common superscript letter differ (P < 0.05). 
1Abbreviations: DPI: days post-inoculation; PRRSV: porcine reproductive and respiratory syndrome virus; ISF = isoflavones; NEG: Control diet + uninfected; POS: 
Control diet + PRRSV-infection; ISF: Control diet + ISF + PRRSV-infection.  
2Data are expressed as least-square mean ± standard error of the mean (SEM) for each treatment group.  





























Table 5.5. Relative abundance of bacterial genera detected in fecal samples at 10 DPI1,2 
 Treatment  
Bacterial genus by phyla3 NEG POS ISF P-value 
Bacteroidetes     
Alloprevotella 4.46 ± 0.77 4.18 ± 0.81 3.32 ± 0.87 0.399 
dgA-11 gut group 0.58 ± 0.30 0.79 ± 0.22 1.07 ± 0.46 0.563 
(F) Muribaculaceae Porphyromonadaceae 
Unassigned 
2.46 ± 0.39 5.98 ± 3.15 3.31 ± 0.73 0.593 
(F) Muribaculaceae Unassigned 0.53 ± 0.16 1.08 ± 0.35 0.65 ± 0.15 0.243 
Prevotella 1 2.52 ± 1.20 2.26 ± 0.57 2.52 ± 0.43 0.914 
Prevotella 2 2.80 ± 0.32 2.30 ± 0.39 1.78 ± 0.21 0.100 
Prevotella 9 18.4 ± 3.19a 9.56 ± 1.75b 7.63 ± 1.15b 0.002 
Prevotellaceae NK3B31 group 1.71 ± 0.35b 3.64 ± 0.63ab 3.97 ± 0.61a 0.040 
Prevotellaceae UCG-003 3.31 ± 0.91 4.28 ± 0.72 4.97 ± 0.86 0.408 
(F) Prevotellaceae Unassigned 2.68 ± 0.37a 1.71 ± 0.28a 0.79 ± 0.15b < 0.0001 
Rikenellaceae RC9 gut group 7.25 ± 1.10 7.09 ± 2.72 7.79 ± 1.86 0.804 
Firmicutes     
Acidaminococcus 1.14 ± 0.39 0.69 ± 0.27 1.49 ± 0.83 0.723 
Agathobacter 1.48 ± 0.32 3.55 ± 1.75 1.78 ± 0.51 0.574 
Anaerovibrio 1.25 ± 0.27a 0.65 ± 0.21ab 0.42 ± 0.14b 0.011 
Dialister 2.83 ± 0.90a 1.40 ± 0.40ab 0.52 ± 0.13b 0.011 
Faecalibacterium 1.53 ± 0.50 0.76 ± 0.18 0.62 ± 0.10 0.099 
Lachnospiraceae NK4A136 group 1.23 ± 0.22 3.15 ± 0.88 2.82 ± 0.58 0.111 
(F) Lachnospiraceae Unassigned 1.91 ± 0.48 2.37 ± 0.69 2.67 ± 1.07 0.869 
Lactobacillus 5.72 ± 1.48 3.42 ± 0.65 3.78 ± 0.74 0.604 
Megasphaera 4.14 ± 1.19 5.85 ± 1.85 5.21 ± 1.94 0.865 
Roseburia 0.41 ± 0.16 0.78 ± 0.27 1.38 ± 0.59 0.246 
Ruminococcaceae UCG-002 2.71 ± 0.37 1.51 ± 0.21 2.31 ± 0.51 0.173 
(F) Veillonellaceae Unassigned 2.05 ± 0.45 1.43 ± 0.47 1.94 ± 0.44 0.319 
Proteobacteria     
Campylobacter 1.58 ± 0.39 3.52 ± 1.37 2.31 ± 0.72 0.546 
Succinivibrio 3.28 ± 1.27 7.81 ± 2.25 7.82 ± 1.88 0.155 
Spirochaetes     
Treponema 2 1.04 ± 0.48 1.67 ± 0.46 4.64 ± 1.57 0.060 
abMeans without a common superscript letter differ (P < 0.05). 
1Abbreviations: DPI: days post-inoculation; PRRSV: porcine reproductive and respiratory syndrome virus; ISF = isoflavones; NEG: Control diet + uninfected; POS: 
Control diet + PRRSV-infection; ISF: Control diet + ISF + PRRSV-infection.  
2Data are expressed as least-square mean ± standard error of the mean (SEM) for each treatment group.  
3Only genera with at least one mean with > 1.0% relative abundance were considered for interpretation. Bacterial genera names preceded by (F) indicates that genera 
are associated with a specific taxonomic family and has not yet been further classified.  
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Table 5.6. Percent relative abundance of bacterial phyla detected in fecal samples at 144 DPI1,2 
 Treatment  
Bacterial phyla3 NEG POS ISF P-value 
Actinobacteria 0.43 ± 0.11a 0.20 ± 0.03b 0.24 ± 0.05ab 0.049 
Bacteroidetes 30.6 ± 1.88 29.2 ± 1.09 29.3 ± 1.30 0.787 
Elusimicrobia 0.05 ± 0.02 0.20 ± 0.05 0.49 ± 0.23 0.109 
Firmicutes 30.1 ± 2.37 27.9 ± 1.27 30.1 ± 1.67 0.593 
Kiritimatiellaeota 0.86 ± 0.18 1.33 ± 0.19 1.26 ± 0.18 0.129 
Proteobacteria 25.3 ± 2.73 23.7 ± 2.44 18.7 ± 1.96 0.185 
Spirochaetes 12.2 ± 2.69 16.9 ± 2.79 19.0 ± 3.14 0.346 
abMeans without a common superscript letter differ (P < 0.05). 
1Abbreviations: DPI: days post-inoculation; PRRSV: porcine reproductive and respiratory syndrome virus; ISF = isoflavones; NEG: Control diet + uninfected; 
POS: Control diet + PRRSV-infection; ISF: Control diet + ISF + PRRSV-infection.  
2Data are expressed as least-square mean ± standard error of the mean (SEM) for each treatment group.  





















Table 5.7. Relative abundance of bacterial genera detected in fecal samples at 144 DPI1,2 
 Treatment  
Bacterial genus by phyla3 NEG POS ISF P-value 
Bacteroidetes     
Bacteroides 1.09 ± 0.21 0.79 ± 0.17 0.99 ± 0.21 0.445 
CAG-873 2.98 ± 1.49a 0.33 ± 0.12b 0.16 ± 0.05b < 0.0001 
dgA-11 gut group 0.88 ± 0.26 1.29 ± 0.45 1.53 ± 0.44 0.576 
(F) Muribaculaceae Porphyromonadaceae 
Unassigned 
1.30 ± 0.40 1.38 ± 0.38 1.12 ± 0.30 0.871 
(F) Muribaculaceae Unassigned 3.20 ± 0.40 2.93 ± 0.66 2.41 ± 0.37 0.372 
Parabacteroides 1.10 ± 0.15 0.75 ± 0.09 1.16 ± 0.16 0.149 
Prevotella 1 0.68 ± 0.15 1.09 ± 0.19 1.59 ± 0.53 0.141 
Prevotellaceae NK3B31 group 5.63 ± 1.19 5.66 ± 0.54 6.66 ± 0.82 0.599 
Prevotellaceae UCG-001 3.35 ± 0.63 5.44 ± 0.94 4.24 ± 0.64 0.306 
Prevotellaceae UCG-004 1.13 ± 0.22a 0.59 ± 0.05b 0.55 ± 0.06b 0.002 
Rikenellaceae RC9 gut group 4.70 ± 0.47 4.33 ± 0.73 3.57 ± 0.42 0.337 
Firmicutes     
Christensenellaceae R-7 group 3.43 ± 0.83 2.62 ± 0.50 2.10 ± 0.27 0.363 
(F) Christensenellaceae Unassigned 0.79 ± 0.27 1.87 ± 0.31 2.15 ± 0.61 0.085 
Clostridium sensu stricto 1 1.26 ± 0.24a 1.15 ± 0.21a 0.64 ± 0.09b 0.038 
Family XIII AD3011 group 1.03 ± 0.18 1.63 ± 0.44 1.55 ± 0.28 0.471 
Lachnospiraceae NK4A136 group 2.59 ± 0.64 1.75 ± 0.46 1.35 ± 0.30 0.155 
(F) Lachnospiraceae Unassigned 1.60 ± 0.32b 2.87 ± 0.51ab 3.17 ± 0.50a 0.044 
Lachnospiraceae XPB1014 group 2.07 ± 0.42a 1.05 ± 0.23b 1.12 ± 0.22ab 0.039 
Ruminococcaceae NK4A214 group 2.19 ± 0.23 2.08 ± 0.31 1.78 ± 0.15 0.470 
Ruminococcaceae UCG-002 1.54 ± 0.31a 0.83 ± 0.15b 0.92 ± 0.12ab 0.039 
Ruminococcaceae UCG-005 2.09 ± 0.40 1.49 ± 0.20 1.58 ± 0.17 0.266 
Ruminococcaceae UCG-014 0.45 ± 0.10b 0.79 ± 0.11ab 1.12 ± 0.25a 0.043 
Ruminococcus 1 1.21 ± 0.36 1.01 ± 0.12 1.21 ± 0.17 0.782 
(F) Veillonellaceae Unassigned 1.93 ± 0.64 1.07 ± 0.28 1.93 ± 0.45 0.170 
Proteobacteria     
Succinivibrio 21.8 ± 3.06 18.3 ± 2.26 12.7 ± 1.99 0.060 
Succinivibrionaceae UCG-001 2.77 ± 1.68 4.40 ± 1.35 4.20 ± 1.05 0.481 
Spirochaetes     
Treponema 2 12.2 ± 2.68 16.9 ± 2.78 19.0 ± 3.14 0.348 
1Abbreviations: DPI: days post-inoculation; PRRSV: porcine reproductive and respiratory syndrome virus; ISF = isoflavones; NEG: Control diet + uninfected; POS: 
Control diet + PRRSV-infection; ISF: Control diet + ISF + PRRSV-infection.  
2Data are expressed as least-square mean ± standard error of the mean (SEM) for each treatment group.  
3Only genera with at least one mean with > 1.0% relative abundance were considered for interpretation. Bacterial genera names preceded by (F) indicates that genera 


























Figure 5.1. Principal co-ordinate analysis of unweighted and weighted UniFrac distances generated from fecal samples collected from individual pigs (n = 12-18 
per treatment) at -2, 10, and 144 days post-inoculation. Treatment ID: NEG, control diet + uninfected; POS, control diet + PRRSV-infection; ISF, control diet + 




































Figure 5.2. Percent relative abundance of bacterial phyla detected in fecal samples collected from individual pigs (n = 12-18 per treatment) at -2, 10, and 144 
days post-inoculation. Treatment ID: NEG, control diet + uninfected; POS, control diet + PRRSV-infection; ISF, control diet + ISF + PRRSV-infection. 




















































Figure 5.3. Heat map depicting differences in relative abundance of common genera (> 1.0% relative abundance) 
between experimental treatments at -2, 10, and 144 days post-inoculation. Treatment ID: NEG, control diet + 
uninfected; POS, control diet + PRRSV-infection; ISF, control diet + ISF + PRRSV-infection. Abbreviations: DPI, 


























































Figure 5.4. Heat map depicting differences in relative abundance of rare genera (< 1.0% relative abundance) 
between experimental treatments at -2, 10, and 144 days post-inoculation. Treatment ID: NEG, control diet + 
uninfected; POS, control diet + PRRSV-infection; ISF, control diet + ISF + PRRSV-infection. Abbreviations: DPI, 
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CHAPTER 6: GENERAL CONCLUSIONS 
The overall focus of this dissertation was to determine if dietary soy isoflavones provide 
performance benefits to growing pigs faced with a pathogenic challenge and identify potential 
biological mechanisms. Three experimental aims and objectives were addressed, and their 
conclusions are summarized below. 
 Regarding the first experiment, intervention of an acute porcine reproductive and 
respiratory syndrome viral (PRRSV) infection in weanling pigs resulted in only minor changes 
in performance by industry standard measures. The influence of isoflavones on growth of 
infected pigs was mild and less pronounced than previous PRRSV-infection models evaluating 
individual isoflavone supplementation or soy protein inclusion. However, there were significant 
differences in a few of the cellular immune responses, which indicated that isoflavones may 
influence systemic immune responses in the context of this challenge model. The key differences 
noted were reduced band neutrophilia during the early acute infection period and an increased 
helper-to-cytotoxic T-cell ratio during the mid-to-late acute infection period. Both findings 
suggest a more appropriate immune response in the face of pathogenic challenge, though these 
effects may not be specific to PRRSV. Due to decreased mobilization of immature innate 
immune cells and increased proportions of helper T-cells, we speculate that isoflavones may be 
providing support to the immune system in its response to PRRSV but due to the short timeline 
utilized in this experiment we may have missed the benefits of that support as pigs transitioned 
from acute infection to recovery. 
 In order to address this speculation, a second experiment was performed using the same 
PRRSV-challenge protocol. However, this experiment was conducted following an extended 
timeline to capture the transition from acute infection to recovery in order to determine what 
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influence isoflavones had on performance over the entire growth period from weaning to market. 
Similar to the first experiment, isoflavones had inconsistent effects on growth performance 
across the entire growth period, resulting mainly in lower finishing weights in supplemented 
pigs, a finding that was not maintained when pigs reached market for processing. Again, as in the 
first experiment, isoflavones appeared to influence certain cellular immune responses but not in 
the same way. Instead of decreasing band neutrophil proportions, isoflavones in this experiment 
increased the relative proportion and count of mature neutrophils during the acute infection 
period and increased the proportion of memory T-cells at 20 days post-inoculation (DPI), but 
had no influence on other T-cell subpopulations. These effects may have influenced the 
differences observed between experimental treatments during the recovery period, including 
decreased time to total oral fluid viral clearance and development of anti-PRRSV neutralizing 
antibodies in isoflavone-supplemented pigs, but the connection remains unclear. However, one 
particularly striking outcome from this study was the impact isoflavones had on total pathogen-
associated mortality. Recognizing that this model was complicated by the presence of secondary 
bacterial infections, isoflavone supplementation decreased mortality in supplemented pigs by 
~50% compared with those not receiving isoflavones. If a true finding, this reduction of pig 
losses has significant financial implications for pork producers facing PRRSV and associated 
secondary infections in their systems.  
 Similar to the unclear connection between changes in immune outcomes and downstream 
effects on recovery outcomes, an additional source of uncertainty regarding the biological 
mechanisms of isoflavone activity in vivo is whether isoflavones induce a majority of their 
activity directly or indirectly. Since they are a dietary component, they are subject to metabolism 
by both the animal and the gastrointestinal microbiome. To address this question, a third and 
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final experiment was performed to determine the influence of dietary isoflavones on the 
longitudinal composition of the gastrointestinal microbiome. Findings from this experiment 
suggested there were minimal effects on the global diversity of the fecal microbiome by dietary 
isoflavones with a majority of differences appearing to be related to PRRSV-infection directly. 
This is not unexpected regarding the impact of PRRSV, which has been shown to decrease 
microbiome diversity in pigs across several independent studies. However, differences due to 
isoflavone supplementation suggest that isoflavones only exert weak influence on the 
composition of microbial communities in the colon. Thus, our results suggest that positive 
effects of isoflavones observed in our experiments are due to direct action of isoflavones and not 
by modulation of the microbiome or its metabolic activity. 
 Considering the collective outcomes of these experiments, it is reasonable to conclude 
that soy isoflavones do not negatively impact the productivity of pathogen-challenged pigs and 
may provide some level of immune system support. However, there are several limitations that 
must be considered as pertinent to our interpretations. Due to low animal numbers and 
limitations of facilities available to conduct disease research in live animal models, it may be 
difficult to apply these findings in a commercial context, particularly when interpreting mortality 
rates. Additionally, due to the immunosuppressive properties of PRRSV and differences in strain 
virulence factors, it can be very difficult to induce the same infection conditions in successive 
experiments. Not being able to fully control the presence of secondary, opportunistic infections 
that are common in pigs challenged with PRRSV decreases the likelihood of perfectly 
reproducing immune outcomes, the effect of which is compounded by low animal numbers. 
Moving forward, it will be critical to identify locations and opportunities to use more animals for 
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this infection model, specifically if a highly virulent PRRSV strain like the one utilized for these 
experiments is utilized.  
 Another limitation of this research was the static concentration of isoflavones utilized. 
While it allowed us to identify potential mechanisms of action for isoflavones when included at 
levels typical of commercial swine diets, use of a static dietary concentration does not address 
whether increasing levels in the diet would confer additional benefits. Since we can reasonably 
conclude that isoflavones do not negatively impact performance in pathogen challenged pigs, a 
logical next step is to evaluate if increasing isoflavones in the diet would additionally benefit 
pigs facing immune stress or if at a certain level they begin to decrease performance. For that 
question to be addressed, we first need to understand what true isoflavone concentrations are 
observed across production phases in swine production systems at which point titration study 
approaches can be designed. Regardless of these limitations, based on our findings we suggest 
that soy isoflavones still exhibit potential to play a key part in the role of nutritional management 







APPENDIX A: CONCENTRATIONS OF SOY ISOFLAVONES IN STANDARD SWINE 
DIETS ACROSS PRODUCTION PHASES - A PRELIMINARY SURVEY STUDY 
Introduction 
 Looking to the future of soy isoflavone (ISF) research in swine production, a logical next 
step is to investigate the effect of increasing isoflavone concentrations in the diets fed to pigs 
facing a pathogenic challenge over that which is typically found in standard formulations. The 
experiments described in this dissertation utilized soy isoflavone concentrations that would 
mimic those expected to naturally occur in a corn-soybean meal (SBM) diet containing 
approximately 20% SBM. However, that inclusion rate represents an average value; in reality, 
the inclusion rate of SBM and utilization of further processed soy protein products varies by life 
stage in U.S. swine production. From weaning to market, crude protein (CP) content, which is 
mainly provided by soy protein sources in the United States, ranges from ~25% in young pigs (5-
7 kg body weight, BW) to less than 15% in finishing pigs (≥ 100 kg) due to differences in 
protein requirements for growth. For that reason, it is pertinent to understand the average levels 
of ISF in standard swine diets across different life stages. The objective of this preliminary 
survey was to investigate and categorize soy ISF concentrations of standard swine diet 
formulations by production phase. As such, we sought to provide a starting point for future 
research opportunities, particularly when determining experimental soy ISF inclusion levels.  
Materials and Methods 
Sample Collection and Analysis 
 A total of 16 feed samples were collected: 8 from standard diet formulations fed to 
resident swine herds at the University of Illinois at Urbana-Champaign and 8 from diet 
formulations used at regional, commercial swine farms. University feed samples were collected 
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either on site at the University of Illinois Swine Research Center (SRC) (Urbana, IL) or directly 
following mixing at the University of Illinois feed mill (Urbana, IL). Commercial feed samples 
were collected directly following mixing at the Zimmerman Feed and Grain, Inc. feed mill 
(Forrest, IL). Formulations from which feed samples were collected were categorized by 
standard swine production phases for both locations. For the sake of this dissertation, please refer 
to Table A.1 for specifications of individual swine production phases. Production phases 
represented by the university feed samples include: Gestation, Lactation, Nursery Phases 1-3, 
Grower Phases 1-2, and Finisher Phase. Production phases represented by commercial feed 
samples include: Early Nursery Phase (comparable to University Nursery Phase 1), Late Nursery 
Phase (comparable to University Nursery Phase 3), Grower Phase (comparable to University 
Grower Phases 1 and 2), and Late Finisher Phase.  
For all diets sampled, soybean meal (SBM) was the primary source of soy protein and 
inclusion levels were recorded. Please note that the commercial feed samples were collected 
from diets that contained byproduct feed ingredients that may contain additional sources of soy 
protein that were not able to be quantified. For commercial diets, only four diet formulations 
were tested but two individual samples were taken from each formulation and analyzed 
separately. Samples were collected into plastic bags from which a random sub-sample ≤ 10 g in 
weight was prepared and submitted for ISF analysis. Isoflavone concentrations of individual 
diets were quantified via HPLC at the USDA-ARS National Center for Agricultural Utilization 
Research (Peoria, IL) according to procedures of Berhow et al. (2006). 
Results 
 Results for SBM inclusion rates and isoflavone concentrations of individual diets can be 
found in Table A.2. The average SBM inclusion level of diet samples was approximately 21.5% 
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for university diets (range: 14% to 31.5%) and 19.5% for commercial diets (range: 6.4% to 
29.6%). Highest inclusion levels were found in late-nursery phase formulations and lowest 
inclusion levels were found in finisher phase formulations for both university and commercial 
diets. The average total ISF content of diet samples was approximately 867 mg/kg for university 
diets (range: 563 ± 16.65 mg/kg to 1,080 ± 18.5 mg/kg) and 1,246 mg/kg for commercial diets 
(range: 535 ± 20.4 mg/kg to 2,055 ± 157 mg/kg). Though the average SBM inclusion levels 
across all production phases were relatively similar between university and commercial diets, the 
higher average ISF content of the commercial diets may be partially explained by the presence of 
additional soy protein present in byproduct feeds utilized in these diets that were not able to be 
quantified. Referencing back to research summarized in this dissertation, our experimental ISF 
inclusion levels of 1,500-1,600 mg/kg was greater than all of the university diet samples 
analyzed, but only four of the diet samples analyzed from our commercial source. This could 
suggest that utilization of byproduct feeds contribute to greater levels of ISF in swine diets, over 
that which is expected based on SBM inclusion rates alone. Within both university and 
commercial diets, average variability across analyzed replicates of diet samples from different 
production phases for individual and total ISF content was relatively low (CV range: 2.97% to 
5.08%), though there were some samples that exhibited greater levels of variability particularly 
for genistein content (e.g., 10.6% CV for total genistein for University Nursery Phase 1 diet; 
18.4% CV for total genistein for Commercial Mid-Late Nursery Phase Sample 1). However, 
more samples are needed to better understand variability across different diets, especially when 
considering differences in soy ingredient sources and types. Additional visualizations of these 




Tables and Figures 
Table A.1. Swine production phase descriptions1 
Production Phase Description 
Gestation Includes pregnant female pigs from time of breeding/conception until farrowing (~115 days) 
Lactation Includes female pigs from farrowing until weaning (~21 days) 
Nursery Includes pigs from weaning until reaching ~25 kg body weight 
Grower Includes growing pigs weighing 25 kg-70 kg 
Finisher Includes growing pigs weighing 70 kg-130 kg 




Table A.2. Isoflavone and saponin content of swine diets categorized by production phase grouped by sampling location1 
 
SBM Inclusion (%) 
Isoflavones (mg/kg)2 
Diet ID Genistein Daidzein Glycitein Total 
University Diets      
Gestation 24.1 263 ± 2.15 214 ± 13.6 86.2 ± 2.77 564 ± 16.7 
Lactation 11.6 475 ± 2.60 401 ± 4.27 113 ± 3.01 989 ± 9.49 
Nursery Phase      
Phase 1 22.0 369 ± 39.2 294 ± 22.9 81.9 ± 3.46 745 ± 60.2 
Phase 2 29.5 518 ± 1.80 430 ± 6.65 133 ± 10.7 1,081 ± 18.5 
Phase 3 31.5 538 ± 29.1 420 ± 24.9 112 ± 6.91 1,069 ± 60.7 
Grower Phase      
Phase 1 22.0 372 ± 35.8 326 ± 34.9 155 ± 12.5 854 ± 81.8 
Phase 2 17.0 466 ± 22.4 357 ± 6.37 108 ± 2.37 931 ± 26.7 
Finisher Phase 14.0 321 ± 20.5 246 ± 5.78 135 ± 5.30 703 ± 30.8 
Commercial Diets3      
Mid/Late Nursery Phase4      
Sample 1 27.9 652 ± 21.5 1,073 ± 28.5 430 ± 6.65 1,967 ± 59.1 
Sample 2 27.9 765 ± 141 1,069 ± 38.5 223 ± 7.31 2,056 ± 157 
Late Nursery Phase      
Sample 1 29.6 684 ± 12.3 627 ± 10.4 222 ± 3.28 1,533 ± 25.6 
Sample 2 29.6 707 ± 25.8 640 ± 20.8 224 ± 6.80 1,570 ± 52.3 
Early Finisher Phase      
Sample 1 14.4 407 ± 25.4 377 ± 3.88 126 ± 2.81 911 ± 26.5 
Sample 2 14.4 361 ± 4.00 368 ± 9.37 124 ± 7.58 853 ± 20.5 
Late Finisher Phase      
Sample 1 6.4 194 ± 8.84 278 ± 9.20 71.1 ± 3.76 543 ± 20.9 
Sample 2 6.4 191 ± 3.01 270 ± 15.3 75.4 ± 2.39 536 ± 20.4 
1Abbreviations: SBM, soybean meal 
2 Data are expressed as average concentration ± standard deviation for each diet sample. 
3Commercial feed samples were collected from diets that contain byproduct feed ingredients that may contain additional sources of soy protein that were not able to be quantified; only 
SBM reported. 

























Figure A.1. Total dietary soybean meal inclusion (%) and total analyzed isoflavone concentrations 





Figure A.2. Analyzed genistein, daidzein, and glycitein 
concentrations (mg/kg) by diet sample, categorized by diet 
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APPENDIX B: DUNNETT’S ADJUSTMENT OF IMMUNE OUTCOME DATA FROM 
CHAPTER 3 
Introduction 
By request of the committee following my preliminary examination, in order to determine if 
dietary treatment modulated the immune response to PRRSV-infection in such a way that immune 
parameters were returned to or maintained at values comparable to the uninfected control group, certain 
data from this experiment were reanalyzed and a Dunnett’s adjustment was performed. Please note that 
in our original approach, we performed two separate statistical comparisons: 1) between our uninfected 
control group vs. our positive control group and 2) between all of our infected groups; this is the first 
time we compared our uninfected control against all infected treatments. These data correspond to those 
described in Chapter 3 of this dissertation document.  
Materials and Methods 
Experimental Outcomes Reanalyzed 
The following immune outcomes were able to be reanalyzed for a Dunnett’s adjustment. Non-
immune outcomes and outcomes for which no values were available for the uninfected control group 
were omitted: 
• Rectal Temperatures 
• RBC Measures 
• WBC Measures 
• Serum Cytokines (TNF-α and IFN-α only) 






For this reanalysis, a 1-way ANOVA was conducted using the MIXED procedure of SAS 9.4 
(SAS Institute, Inc., Cary, NC) to assess the overall effect of treatment separated by DPI for repeated 
measures and utilizing Rep as a random variable. As a reminder, each treatment represented a single 
level of soy protein (SPC/Control vs. ETSBM), a single level of ISF supplementation (no ISF added vs. 
ISF added), and a single level of infection (uninfected vs. PRRSV-infected), which resulted in 5 
experimental treatments (see Table B.1 below). Significance was accepted at P ≤ 0.05.  
Results 





Table B.1. Experimental treatments1 
Treatment Dietary treatment Infection status2 
Control Soy protein concentrate Uninfected 
Control Soy protein concentrate PRRSV-infected 
Control + ISF Soy protein concentrate + ISF PRRSV-infected 
ETSBM3 ETSBM PRRSV-infected 
ETSBM3 + ISF ETSBM + ISF PRRSV-infected 
1Abbreviations: ISF, soy isoflavones; PRRSV, porcine reproductive and respiratory syndrome virus, Mh, Mycoplasma hyopneumoniae. 
2All pigs were naturally co-infected with Mh prior to the start of the study at the source farm. 
3Enzyme-treated soybean meal (ETSBM) manufactured to contain a gentle soya-yeast (10% yeast components) supplement for piglet feed with a 





































Table B.2. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) 
infection on daily rectal temperatures (ºC) of weanling pigs1 
 Uninfected  PRRSV-infected   P-value 




ISF2  SEM Treatment 
0 39.36  39.86† 39.91† 39.69 39.65  0.25 0.043 
3 39.48  40.07 39.92 40.35† 40.11†  0.24 0.019 
6 39.65  40.12 40.42† 40.47† 40.18†  0.46 0.038 
8 39.58  40.36 40.69 40.50 40.62  0.25 0.0004 
12 40.01  40.24 40.68 40.50 40.49  0.18 0.076 
14 39.88  40.29 40.21 40.29 40.40  0.18 0.479 
†
Difference (P < 0.05) between uninfected and infected groups by Dunnett’s adjustment when overall treatment effect was present. 
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = day post-inoculation; ISF = 
isoflavones. 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both 
uninfected and PRRSV-infected control pigs; Control + ISF: soy protein concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no 
supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 
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Table B.3. Effects of dietary soy isoflavone levels and porcine reproductive and respiratory virus (PRRSV) 
infection on red blood cell measures in weanling pigs1 
 Uninfected  PRRSV-infected   P-value 
Item Control2  Control2 
Control 
+ ISF2 ETSBM2 
ETSBM 
+ ISF2  SEM Treatment 
RBC, × 106/µL          
0 DPI 6.53  6.66
 6.84 6.49 6.81  0.23 0.367 
3 DPI 6.20  6.00 6.14 5.90 6.29  0.24 0.204 
6 DPI 5.97  6.05 6.17 5.87 6.00  0.24 0.773 
14 DPI 5.85  5.31 5.58 5.25 5.43  0.17 0.111 
HGB, g/dL          
0 DPI 12.3  11.9 12.5 12.2 12.5  0.36 0.792 
3 DPI 11.5  10.6 11.1 10.8 11.4  0.30 0.080 
6 DPI 10.9  10.4 10.9 10.5 10.8  0.36 0.604 
14 DPI 11.0  9.0
† 9.5† 9.1† 9.5†  0.45 0.001 
HCT, %          
0 DPI 35.1  37.4 39.1 37.9 39.1  1.80 0.513 
3 DPI 35.7  33.4 34.9 33.8 35.6  0.93 0.064 
6 DPI 34.0  32.9 34.4 33.1 33.7  1.00 0.666 
14 DPI 34.7  28.5
† 30.3† 28.8† 30.0†  1.36 0.001 
MCV, fl          
0 DPI 58.6  56.2 57.2 58.5 57.5  2.02 0.584 
3 DPI 57.9  55.7 56.9 57.3 56.7  1.46 0.515 
6 DPI 57.4  54.6 55.8 56.4 56.1  1.47 0.379 
14 DPI 59.6  53.7
† 54.2† 55.0† 55.3†  1.58 0.005 
MCH, pg          
0 DPI 18.6  17.9 18.3 18.8 18.4  0.73 0.598 
3 DPI 18.4  17.7 18.1 18.3 18.1  0.65 0.656 
6 DPI 18.2  17.3 17.7 17.9 18.0  0.54 0.338 
14 DPI 18.8  17.0† 17.1
† 17.4† 17.5†  0.54 0.009 
MCHC, g/dL          
0 DPI 31.8  31.6 32.0 32.0 32.0  0.26 0.851 
3 DPI 31.7  31.6
b 31.9b 31.9b 29.3a  1.25 0.472 
6 DPI 31.7  31.5 31.8 31.6 32.0  0.32 0.573 
14 DPI 31.5  31.6 31.6 31.6 31.7  0.24 0.996 
†
Difference (P < 0.05) between uninfected and infected groups by Dunnett’s adjustment when overall treatment effect was present. 
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = day post-inoculation; 
ISF = isoflavones; RBC = red blood cells; HGB = hemoglobin; HCT = packed cell volume; MCV = mean corpuscular volume; MCH = mean corpuscular 
hemoglobin; MCHC = mean corpuscular hemoglobin concentration 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to 
both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein concentrate + supplemented ISF, fed to PRRSV-infected pigs only; 




Table B.4. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) infection on differential leukocyte counts and relative 
population proportions in weanling pigs1 
 Uninfected  PRRSV-infected   P-value 




ISF2  SEM Treatment 
WBC, × 103/µL          
0 DPI 15.2  13.3
 13.4 14.8 17.2  1.89 0.270 
3 DPI 16.1  12.2
 9.83† 14.2 13.7  1.73 0.032 
6 DPI 16.4  11.8
 12.7 24.4 14.5  1.74 0.241 
14 DPI 16.6  23.1
 24.5 23.2 23.5  3.17 0.134 
NEU, % of WBC          
0 DPI 49.1  45.3 38.9 47.5 40.5  3.09 0.091 
3 DPI 46.3  56.5 57.1 57.8 55.1  5.83 0.637 
6 DPI 38.7  51.5
 54.2 59.1 47.4  5.10 0.059 
14 DPI 35.7  49.9
 43.2 46.9 39.4  4.82 0.197 
BAND, % of WBC          
0 DPI 0.00  0.135 0.00 0.550 0.333  0.27 0.839 
3 DPI 1.10  6.00
 1.10 6.63 3.18  1.23 0.469 
6 DPI 0.304  6.11
† 2.45 5.25† 5.27†  1.64 0.011 
14 DPI 0.087  1.27 4.44 1.77 3.63  1.17 0.119 
LYM, % of WBC          
0 DPI 47.1  45.7 51.3 45.3
 51.7  3.14 0.345 
3 DPI 47.1  31.1
 35.8 31.0 37.5  6.57 0.090 
6 DPI 52.9  32.2
† 32.8† 27.7† 38.1  4.81 0.007 
14 DPI 51.7  39.5
 41.9 45.0 47.7  4.37 0.359 
†Difference (P < 0.05) between uninfected control and respective infected group by Dunnett’s adjustment when overall treatment effect was present. 
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = day post-inoculation; ISF = isoflavones; WBC = white blood cells; NEU = neutrophils; BAND = 
immature neutrophils aka. band cells; LYM = lymphocytes; MONO = monocytes; EOSIN = eosinophils; BASO = basophils.  
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 






Table B.4. Continued 
 Uninfected  PRRSV-infected   P-value 




ISF2  SEM Treatment 
MONO, % of WBC          
0 DPI 2.77  7.09
 7.19 5.56 6.00  1.23 0.131 
3 DPI 4.47  3.25 2.10 2.98 2.62  0.98 0.395 
6 DPI 6.06  6.50 7.53 5.42 5.62  1.24 0.705 
14 DPI 4.73  4.81 5.86 3.70 5.07  1.47 0.847 
EOSIN, % of WBC          
0 DPI 1.19  1.63 2.11 1.14 1.42  1.66 0.351 
3 DPI 0.993  2.25 3.80
† 1.04 1.31  1.22 0.014 
6 DPI 1.79  3.06 2.49 2.25 3.40  0.92 0.769 
14 DPI 2.95  4.07
 4.15 2.19 3.61  1.22 0.394 
BASO, % of WBC          
0 DPI 0.200  0.100 0.207 0.00 0.083  0.10 0.556 
3 DPI 0.100  0.917 0.300 0.364 0.182  0.36 0.469 
6 DPI 0.200  0.636 0.455 0.250 0.182  0.17 0.241 
14 DPI 0.500  0.400
 0.261 0.294 0.558  0.30 0.667 
†Difference (P < 0.05) between uninfected control and respective infected group by Dunnett’s adjustment when overall treatment effect was present. 
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = day post-inoculation; ISF = isoflavones; WBC = white blood cells; NEU = neutrophils; BAND = 
immature neutrophils aka. band cells; LYM = lymphocytes; MONO = monocytes; EOSIN = eosinophils; BASO = basophils.  
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 




Table B.5. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) 
infection on serum cytokine concentrations (pg/mL) in weanling pigs1 
 Uninfected  PRRSV-infected   P-value 
Item, pg/mL Control2  Control2 
Control 
+ ISF2 ETSBM2 
ETSBM 
+ ISF2  SEM Treatment 
TNF-α          
0 DPI 128  33.2
† 38.7† 39.6 50.0†  38.4 0.017 
3 DPI 72.7  89.7 120 85.1 104  24.8 0.584 
6 DPI 58.7  75.1 140 59.9 73.4  31.0 0.077 
14 DPI 52.2  152
 113 187 353  52.1 0.158 
IFN-α          
0 DPI 18.6  101
 202 16.4 134  112 0.642 
3 DPI 19.3  1,132
 1,483 1,643† 2,156†  431 0.024 
6 DPI 142  501 428 529 396  170 0.401 
14 DPI 5.31  44.6
 17.1 21.6 50.2  48.0 0.511 
†Difference (P < 0.05) between uninfected control and respective infected group by Dunnett’s adjustment when overall treatment effect was present. 
1Values represent least square means of 10 to 12 pigs. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = day post-inoculation; ISF = 
isoflavones; TNF-α = tumor necrosis factor-α; IFN-α = interferon-α; BDL = below detectable limits. 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both 
uninfected and PRRSV-infected control pigs; Control + ISF: soy protein concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no 









Table B.6. Effects of dietary soy isoflavones level and porcine reproductive and respiratory virus (PRRSV) infection on peripheral blood T cell 
immunophenotypes of weanling pigs1 
 Uninfected  PRRSV-infected   P-value 




ISF2  SEM Treatment 
T-Cell, %  
(CD3+)3 
55.30  53.21 53.01 53.89 59.02  7.29 0.665 
Helper T-Cell, %  
(CD3+CD4+)4 
22.03  20.18 23.09 18.03 26.41  2.08 0.075 
Cytotoxic T-Cell, %  
(CD3+CD8+)4 
12.44  22.78† 22.43† 22.71† 19.20  3.04 0.004 
Dual-Positive T-Cell, % 
(CD3+CD4+CD8+)4 
4.30  6.66† 6.32† 6.15 5.13  1.26 0.038 
Dual-Positive T-Cell Expressing IFN-γ, % 
(CD3+CD4+CD8+IFNγ+)4 
90.10  79.72† 79.25† 77.94† 83.41  4.05 0.022 
          
Dual-Positive T-Cell Expressing IFN-γ MFI 
(CD3+CD4+CD8+IFNγ+)5 
764.1  501.0 515.4 490.6 577.3  99.0 0.001 
          
CD4:CD8 Ratio 2.15  1.06
 1.17 0.918 1.53  0.18 < 0.0001 
†Difference (P < 0.05) between uninfected control and respective infected group by Dunnett’s adjustment when overall treatment effect was present. 
1Values represent least square means of 10 to 12 pigs with collection of blood occurring at 12 DPI. All pigs received allotted treatment diet starting -7 DPI. Abbreviations: DPI = day post-inoculation; ISF = isoflavones. 
2The following diet names have been assigned to a respective experimental diet groups: Control: soy protein concentrate + no supplemented ISF, fed to both uninfected and PRRSV-infected control pigs; Control + ISF: soy protein 
concentrate + supplemented ISF, fed to PRRSV-infected pigs only; ETSBM: ETSBM + no supplemented ISF, fed to PRRSV-infected pigs only; ETSBM + ISF: ETSBM + supplemented ISF, fed to PRRSV-infected pigs only. 
3Percent of total lymphocytes that are positive for cell-surface marker CD3. 
4Percent of CD3-positive lymphocytes that are also positive for cell-surface markers CD4, CD8, CD4/CD8, or CD4/CD8 and intercellular IFN-γ 
5Median fluorescence intensity (MFI) is a measure of the fluorescence intensity in a fluorescence channel being measured. It provides an alternative measurement to percent positive for comparison of cell populations between 
individuals. It is less sensitive to outliers, which is important for very small cell populations like the dual-positive T-cells.  
 
